Sentence,class,file
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.183Table 2.",Non-OADS,/arxiv_data1/oa_pdf/68/1e/kjim-29-183.PMC3956988.pdf
"Air pollution and tuberculosis www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.183and the SO2 krigged values between January 1, 1997  and December 31, 2006, using 27 monitoring stations,  categorized by deciles.",OADS,/arxiv_data1/oa_pdf/68/1e/kjim-29-183.PMC3956988.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.183ing airway-covering f luid, SO2 dissolves quickly into  the aqueous phase.",Non-OADS,/arxiv_data1/oa_pdf/68/1e/kjim-29-183.PMC3956988.pdf
Air pollution and tuberculosis www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.183Acknowledgments This study was supported by grant n umber  03-2009- 0120 from the S eoul National University Hospital  Re- search Fund.,Non-OADS,/arxiv_data1/oa_pdf/68/1e/kjim-29-183.PMC3956988.pdf
Available from: http://kosis.kr/abroad/abroad_01List.,Non-OADS,/arxiv_data1/oa_pdf/68/1e/kjim-29-183.PMC3956988.pdf
Available from: http://goo.gl/XY4XQ.,OADS,/arxiv_data1/oa_pdf/68/1e/kjim-29-183.PMC3956988.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.183cultural dimensions of gender and tuberculosis.",Non-OADS,/arxiv_data1/oa_pdf/68/1e/kjim-29-183.PMC3956988.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:191-202 http://dx.doi.org/10.3904/kjim.2014.29.2.191 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Surgical Medical Research  Centre, Havana; 2Centre of  Natural Products, National Centre  for Scientific Research, Havana;  3Software Group, National Centre  for Scientific Research, Havana,  Cuba Received : May 16, 2013 Revised : June 5, 2013 Accepted : August 5, 2013 Correspondence to Sarahí Mendoza, Ph.D. Centre of Natural Products,  National Centre for Scientific  Research, 198 st/19 and 21, Atabey,  Playa, Havana, Cuba  Tel: +537-2714225 E-mail: sarahi.mendoza@cnic.edu.cuBackground/Aims:  Nonsteroidal anti-inflammatory drugs relieve osteoarthritis  (OA) symptoms but cause adverse effects.",Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.191pathological process.",Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
"D-002 on osteoarthritis symptoms www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.191with a fixed, not stratified randomization method,  using balanced blocks and an allocation ratio of 1:1.",Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.191placebo was another secondary outcome.",Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
D-002 on osteoarthritis symptoms www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.191Table 2.,Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.191both groups.",Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
D-002 on osteoarthritis symptoms www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.1910.0001).,Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.191Vital signs and blood parameters did not change  significantly during the study, and individual values  remained within normal ranges (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
"D-002 on osteoarthritis symptoms www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.191surprising, as it may occur in any efficacy measurement  based on a subjective assessment and, particularly, in  placebo-controlled studies in subjects with OA [34].",Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.191are preliminary, and the efficacy of D-002 in patients  with OA should be investigated extensively in further  studies.",Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
D-002 on osteoarthritis symptoms www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.19120.,Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
Available from: http://www.one.cu/ publicaciones/03estadisticassociales/Salud%20en%20 Cifras%20Cuba%202010/edo.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.191dez R, Mas R. Antioxidant effect of D-002 on gastric  mucosa of rats with experimentally induced injury.",Non-OADS,/arxiv_data1/oa_pdf/bd/07/kjim-29-191.PMC3956989.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:203-209 http://dx.doi.org/10.3904/kjim.2014.29.2.203 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of Internal Medicine,  Maryknoll Medical Center,  Busan; 2Department of Internal  Medicine, Inje University College  of Medicine, Busan, Korea Received : January 11, 2013 Revised : March 25, 2013 Accepted : September 11, 2013 Correspondence to Tae-Ik Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ad/63/kjim-29-203.PMC3956990.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.203factors for CIAKI is existing chronic renal disease  [2,9,10]; however, age, the volume of contrast medium  used, concurrent diabetes mellitus (DM), congestive  heart failure, and anemia have also been implicated.",Non-OADS,/arxiv_data1/oa_pdf/ad/63/kjim-29-203.PMC3956990.pdf
Renin-angiotensin-system blockers and contrast-medium-induced acute kidney injury www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.203[–]) (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/ad/63/kjim-29-203.PMC3956990.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.203ing showed that the adjusted OR for CIAKI increased  significantly to 1.552 among those receiving RAS  blockers (Table 4).",OADS,/arxiv_data1/oa_pdf/ad/63/kjim-29-203.PMC3956990.pdf
Renin-angiotensin-system blockers and contrast-medium-induced acute kidney injury www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.203through the nephrons [ 19-21].,Non-OADS,/arxiv_data1/oa_pdf/ad/63/kjim-29-203.PMC3956990.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.203clinical judgments can also be a confounding factor in  retrospective studies examining the effect of contrast  medium volume on CIAKI.",Non-OADS,/arxiv_data1/oa_pdf/ad/63/kjim-29-203.PMC3956990.pdf
Renin-angiotensin-system blockers and contrast-medium-induced acute kidney injury www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.203tion and a method for risk stratification.,Non-OADS,/arxiv_data1/oa_pdf/ad/63/kjim-29-203.PMC3956990.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:210-216 http://dx.doi.org/10.3904/kjim.2014.29.2.210 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Cardiology, Keimyung  University Dongsan Medical  Center, Daegu; 2Division of  Cardiology, Kyungpook  National University Hospital,  Daegu; 3Division of  Cardiology, Daegu Fatima  Hospital, Daegu; 4Division of  Cardiology, Yeungnam University  Hospital, Daegu; 5Division of  Cardiology, Daegu Catholic  University Hospital, Daegu, Korea    Received : April 13, 2013 Revised : June 28, 2013 Accepted : August 5, 2013 Correspondence  to Chang-Wook Nam, M.D.",Non-OADS,/arxiv_data1/oa_pdf/94/f6/kjim-29-210.PMC3956991.pdf
"Antiplatelet combination pill www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.210Although this new combination antiplatelet pill has  shown  biological effects similar to those of typical  dual antiplatelet medications in laboratory tests,  there  is a lack of clinical data in patients who had undergone  DES implantation.",Non-OADS,/arxiv_data1/oa_pdf/94/f6/kjim-29-210.PMC3956991.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.210signed-rank test.",OADS,/arxiv_data1/oa_pdf/94/f6/kjim-29-210.PMC3956991.pdf
"Antiplatelet combination pill www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.210blood count , creatinine, liver enzyme s, and cardiac  enzyme s, the value s at follow-up w ere similar t o those  at baseline.",Non-OADS,/arxiv_data1/oa_pdf/94/f6/kjim-29-210.PMC3956991.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.210therapy  with antihypertensive agents, the use of sin - gle-pill therapy was associated with a increase in drug  compliance, compared with the use of separate dual- pill therapy  (OR , 1.21; 95% CI , 1.00  to 1.47) [ 10].",Non-OADS,/arxiv_data1/oa_pdf/94/f6/kjim-29-210.PMC3956991.pdf
Antiplatelet combination pill www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.210timing of the  platelet function test s could have  affect ed the results .,Non-OADS,/arxiv_data1/oa_pdf/94/f6/kjim-29-210.PMC3956991.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.2101818.",Non-OADS,/arxiv_data1/oa_pdf/94/f6/kjim-29-210.PMC3956991.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:217-225 http://dx.doi.org/10.3904/kjim.2014.29.2.217 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivision of Endocrinology  and Metabolism, Department  of Internal Medicine, Korea  University College of Medicine,  Seoul, Korea Received : January 23, 2013 Revised : March 14, 2013 Accepted : March 25, 2013 Correspondence to  Dong Seop Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/c1/86/kjim-29-217.PMC3956992.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.217tion and endothelial dysfunction [6].",Non-OADS,/arxiv_data1/oa_pdf/c1/86/kjim-29-217.PMC3956992.pdf
Changes in the primary aldosteronism www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.217ing seated for at least 5 to 15 minutes in the morning.,Non-OADS,/arxiv_data1/oa_pdf/c1/86/kjim-29-217.PMC3956992.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.217od, is summarized in Table 2.",OADS,/arxiv_data1/oa_pdf/c1/86/kjim-29-217.PMC3956992.pdf
"Changes in the primary aldosteronism www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.217level and BP were not reduced significantly without  MR antagonist treatment, and they were finally diag - nosed as having IHA.",Non-OADS,/arxiv_data1/oa_pdf/c1/86/kjim-29-217.PMC3956992.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.217BP reductions after treatment.",Non-OADS,/arxiv_data1/oa_pdf/c1/86/kjim-29-217.PMC3956992.pdf
"Changes in the primary aldosteronism www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.217fewer in number, with an increasing trend towards  IHA.",Non-OADS,/arxiv_data1/oa_pdf/c1/86/kjim-29-217.PMC3956992.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.217suspicion and screening are important to prevent the  occurrence of TOD in PA.",Non-OADS,/arxiv_data1/oa_pdf/c1/86/kjim-29-217.PMC3956992.pdf
Changes in the primary aldosteronism www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.217steronism: causes and consequences.,Non-OADS,/arxiv_data1/oa_pdf/c1/86/kjim-29-217.PMC3956992.pdf
"ORIGINAL ARTICLE Korean J Intern Med 2014;29:226-230 http://dx.doi.org/10.3904/kjim.2014.29.2.226 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDivision of Nephrology,  Department of Internal Medicine,  Yeungnam University Medical  Center, Daegu, Korea Received : September 13, 2012 Revised : October 16, 2012 Accepted : December 7, 2012 Correspondence to  Jun Young Do, M.D.",Non-OADS,/arxiv_data1/oa_pdf/0a/f4/kjim-29-226.PMC3956993.pdf
Effect of heparin on calcium www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.226METHODS We included 107 patients under maintenance hemo - dialysis (HD) in our hospital HD unit.,Non-OADS,/arxiv_data1/oa_pdf/0a/f4/kjim-29-226.PMC3956993.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.226(95% CI, -0.6648 to -0.2131; p < 0.001) and the intercept  was 2.2418 (95% CI, 1.3417 to 3.1419; p < 0.001).",OADS,/arxiv_data1/oa_pdf/0a/f4/kjim-29-226.PMC3956993.pdf
Effect of heparin on calcium www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.226rin binds significant amounts of ionized calcium and  reduces the ionized calcium level [8].,Non-OADS,/arxiv_data1/oa_pdf/0a/f4/kjim-29-226.PMC3956993.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.226whole blood ionized calcium was measured within 15  minutes after sampling.",OADS,/arxiv_data1/oa_pdf/0a/f4/kjim-29-226.PMC3956993.pdf
"Korean J Intern Med 2014;29:231-235 http://dx.doi.org/10.3904/kjim.2014.29.2.231 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgCASE REPORTDermatomyositis associated with hepatitis B   virus-related hepatocellular carcinoma Suh Yoon Yang1, Bong Ki Cha1, Gihyeon Kim2, Hyun Woong Lee1, Jae Gyu Kim1, Sae Kyung Chang1, and  Hyung Joon Kim1 Departments of 1Internal Medicine  and 2Radiology, Chung-Ang  University College of Medicine,  Seoul, Korea Received : September  26, 2012 Revised  : October 18, 2012 Accepted: November 2, 2012 Correspondence to Hyung Joon Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/48/bd/kjim-29-231.PMC3956994.pdf
232 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.231 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/48/bd/kjim-29-231.PMC3956994.pdf
"233 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.231 Yang SY, et al.",OADS,/arxiv_data1/oa_pdf/48/bd/kjim-29-231.PMC3956994.pdf
234 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.231 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/48/bd/kjim-29-231.PMC3956994.pdf
"235 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.231 Yang SY, et al.",OADS,/arxiv_data1/oa_pdf/48/bd/kjim-29-231.PMC3956994.pdf
"Korean J Intern Med 2014;29:236-240 http://dx.doi.org/10.3904/kjim.2014.29.2.236 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org CASE REPORTHypersensitivity myocarditis confirmed by cardiac  magnetic resonance imaging and endomyocardial  biopsy  Yumi Park, Sung Gyun Ahn, Anna Ko, Sang Ho Ra, Jaehwang Cha, Yong Gwan Jee, and Ji Hyun Lee Department of Internal Medicine,  Yonsei University Wonju College  of Medicine, Wonju, Korea Received : August  29, 2012 Revised  : October 22, 2012 Accepted: October 24, 2012 Correspondence to Sung Gyun Ahn, M.D.",Non-OADS,/arxiv_data1/oa_pdf/4f/bd/kjim-29-236.PMC3956995.pdf
"237 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.236 Park Y, et al.",OADS,/arxiv_data1/oa_pdf/4f/bd/kjim-29-236.PMC3956995.pdf
                               238 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.236 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/4f/bd/kjim-29-236.PMC3956995.pdf
"239 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.236 Park Y, et al.",OADS,/arxiv_data1/oa_pdf/4f/bd/kjim-29-236.PMC3956995.pdf
                               240 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.236 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/4f/bd/kjim-29-236.PMC3956995.pdf
"Korean J Intern Med 2014;29:241-245 http://dx.doi.org/10.3904/kjim.2014.29.2.241 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgCASE REPORTIsolated dilatation of the inferior vena cava  Jae-Joon Kim1, Kyoung-Im Cho2, Ji-Hoon Kang1, Ja-Jun Goo1, Kyoung-Nyoun Kim1, Ja-Young Lee1,    and Seong-Man Kim1 1Department of Internal Medicine,  Maryknoll Medical Center, Busan;  2Department of Internal Medicine,  Kosin University School of  Medicine, Busan, Korea Received : August  22, 2012 Revised  : October 23, 2012 Accepted: November 9, 2012 Correspondence to Kyoung-Im Cho, M.D.",Non-OADS,/arxiv_data1/oa_pdf/34/49/kjim-29-241.PMC3956996.pdf
242 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.241 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/34/49/kjim-29-241.PMC3956996.pdf
"243 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.241 Kim JJ, et al.",OADS,/arxiv_data1/oa_pdf/34/49/kjim-29-241.PMC3956996.pdf
244 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.241 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/34/49/kjim-29-241.PMC3956996.pdf
"245 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.241 Kim JJ, et al.",OADS,/arxiv_data1/oa_pdf/34/49/kjim-29-241.PMC3956996.pdf
"Korean J Intern Med 2014;29:246-249 http://dx.doi.org/10.3904/kjim.2014.29.2.246 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org CASE REPORTIfosfamide-induced Fanconi syndrome with   diabetes insipidus Ah Young Leem, Han Sang Kim, Byung Woo Yoo, Beo Deul Kang, Min Hwan Kim, Sun Young Rha,   and Hyo Song Kim Division of Medical Oncology,  Yonsei Cancer Center, Yonsei  University College of Medicine,  Seoul, Korea  Received : December  2, 2012 Revised  : December  20, 2012 Accepted: January 4, 2014 Correspondence  to   Hyo Song Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/74/c9/kjim-29-246.PMC3956997.pdf
"247 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.246 Leem AY, et al.",OADS,/arxiv_data1/oa_pdf/74/c9/kjim-29-246.PMC3956997.pdf
                              248 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.246 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/74/c9/kjim-29-246.PMC3956997.pdf
"249 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.246 Leem AY, et al.",OADS,/arxiv_data1/oa_pdf/74/c9/kjim-29-246.PMC3956997.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:250-252 http://dx.doi.org/10.3904/kjim.2014.29.2.250 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Hematology and  Oncology, Department of  Internal Medicine, Cancer Center  Dongnam Institute Radiological  and Medical Sciences, Busan;  2Division of Hematology and  Oncology, Department of Internal  Medicine, 3Department of  Laboratory Medicine, Yeungnam  University College of Medicine,  Daegu, KoreaChronic myeloid leukemia as a secondary    malignancy after diffuse large B-cell lymphoma Ha-young Lee1, Kyung Hee Lee2, Myung Soo Hyun2, Min Kyoung Kim2, Sung Ae Koh2, and     Hee Soon Cho3 Received : March 16, 2013 Revised : July 10, 2013 Accepted : August 19, 2013 Correspondence to Kyung Hee Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/8c/ba/kjim-29-250.PMC3956998.pdf
"251 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.250 Lee H Y, et al.",OADS,/arxiv_data1/oa_pdf/8c/ba/kjim-29-250.PMC3956998.pdf
252 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.250 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/8c/ba/kjim-29-250.PMC3956998.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:253-255 http://dx.doi.org/10.3904/kjim.2014.29.2.253 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Division of Infectious Diseases,  Department of Internal Medicine,  Eulji General Hospital, Seoul;  2Division of Infectious Diseases,  Department of Internal Medicine,  Inje University Busan Paik  Hospital, Busan; 3Division of  Infectious Diseases, Department  of Internal Medicine, Kangwon  National University School of  Medicine, Chuncheon; 4Division  of Infectious Diseases, Chungnam  National University Hospital,  Daejeon; 5Department of Internal  Medicine, Inje University Sanggye  Paik Hospital, Seoul, KoreaDiagnosis of scrub typhus: introduction of the   immunochromatographic test in Korea Ki-Deok Lee1, Chisook Moon2, Won Sup Oh3, Kyung Mok Sohn4, and Baek-Nam Kim5 Received : November 23, 2013 Revised : December 30, 2013 Accepted : December 31, 2013 Correspondence to  Baek-Nam Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/6c/29/kjim-29-253.PMC3956999.pdf
254 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.253 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/6c/29/kjim-29-253.PMC3956999.pdf
"255 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.253 Lee KD, et al.",OADS,/arxiv_data1/oa_pdf/6c/29/kjim-29-253.PMC3956999.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:256-258 http://dx.doi.org/10.3904/kjim.2014.29.2.256 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgDepartments of 1Internal Medicine  and 2Pathology, Ulsan University  Hospital, University of Ulsan  College of Medicine, Ulsan, KoreaSuccessful treatment of enteropathy associated  with common variable immunodeficiency Seung Won Choi1, Kwang Won Seo1, Ji-Seon Oh1, Jong Soo Lee1, and Hee Jeong Cha2 Received : May 31, 2013 Revised : September 1, 2013 Accepted : September 12, 2013 Correspondence to Seung Won Choi, M.D.",Non-OADS,/arxiv_data1/oa_pdf/ac/85/kjim-29-256.PMC3957000.pdf
"257 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.256 Choi SW, et al.",OADS,/arxiv_data1/oa_pdf/ac/85/kjim-29-256.PMC3957000.pdf
258 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.256 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/ac/85/kjim-29-256.PMC3957000.pdf
"LETTER TO THE EDITOR Korean J Intern Med 2014;29:259-261 http://dx.doi.org/10.3904/kjim.2014.29.2.259 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org1Department of General Medi - cine, Hokkaido Social Insurance  Hospital , Sapporo ; 2Department  of Medicine II, Hokkaido Univer - sity Graduate School of Medicine,  Sapporo, JapanSuccessful treatment with tacrolimus of refractory  adult-onset Still’s disease Masashi Ohe1, Kenji Oku2, Michihito Kono2, and Toshiyuki Bohgaki2 Received : September 23, 2013 Revised : November 20, 2013 Accepted : December 3, 2013 Correspondence to Masashi Ohe, M.D., Ph.D. Department of General   Medicine, Hokkaido Social  Insurance Hospital, 1-8-3-18  Nakanoshima, Toyohira-ku,   Sapporo 062-8618, Japan Tel: +81-11-831-5151 Fax: +81-11-821-3851 E-mail: masshi@isis.ocn.ne.jpTo the Editor, Adult-onset Still’s disease (AOSD) is a  systemic inflammatory disorder char - acterized by high fever, arthralgia,  transient rash, hepatosplenomegaly,  lymphadenopathy, liver dysfunction  and leukocytosis.",Non-OADS,/arxiv_data1/oa_pdf/24/ae/kjim-29-259.PMC3957001.pdf
260 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.259 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/24/ae/kjim-29-259.PMC3957001.pdf
"261 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.259 Ohe M, et al.",OADS,/arxiv_data1/oa_pdf/24/ae/kjim-29-259.PMC3957001.pdf
"Korean J Intern Med 2014;29:262 http://dx.doi.org/10.3904/kjim.2014.29.2.262 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org IMAGE OF INTERESTA 32-year-old man was referred to the  gastroenterology department for dys - phagia with both solids and liquids.",Non-OADS,/arxiv_data1/oa_pdf/e8/d5/kjim-29-262.PMC3957002.pdf
"Korean J Intern Med 2014;29:263-264 http://dx.doi.org/10.3904/kjim.2014.29.2.263 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgIMAGE OF INTERESTAn 81-year-old obese woman was ad - mitted due to decompensated diabetes  and a lower urinary tract infection.",Non-OADS,/arxiv_data1/oa_pdf/79/7d/kjim-29-263.PMC3957003.pdf
264 www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.263The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/79/7d/kjim-29-263.PMC3957003.pdf
"GUIDELINE Korean J Intern Med 2014;29:265-280 http://dx.doi.org/10.3904/kjim.2014.29.2.265 Copyright © 2014 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.orgGuideline on the prevention and control of seasonal  influenza in healthcare setting Ji Hyeon Baek1, Yu Bin Seo2, Won Suk Choi3, Sae Yoon Kee4, Hye Won Jeong5, Hee Young Lee6,   Byung Wook Eun7, Eun Ju Choo8, Jacob Lee2, Sung Ran Kim9, Young Keun Kim10, Joon Young Song1,  Seong-Heon Wie11, Jin-Soo Lee1, Hee Jin Cheong3, Woo Joo Kim3, and Transgovernmental Enterprise for  Pandemic Influenza in Korea  1Department of Internal Medicine,  Inha University School of Medicine,  Incheon; 2Department of Internal  Medicine, Hallym University College  of Medicine, Seoul; 3Department of  Internal Medicine, Korea University  College of Medicine, Seoul;  4Department of Internal Medicine,  Konkuk University School of Medicine,  Chungju; 5Department of Internal  Medicine, Chungbuk National  University College of Medicine,  Cheongju; 6Gachon University Gil  Hospital Cancer Center, Gachon  University Gil Medical Center,  Incheon; 7Department of Pediatrics,  Eulji University School of Medicine,  Daejeon; 8Department of Internal  Medicine, Soonchunhyang University  College of Medicine, Bucheon;  9Infection Control Unit, Korea  University Guro Hospital, Seoul;  10Department of Internal Medicine,  Yonsei University Wonju College  of Medicine, Wonju; 11Department  of Internal Medicine, The Catholic  University of Korea College of  Medicine, Seoul, Korea Received : February 15, 2014 Accepted: February 20, 2014 Correspondence to Jin-Soo Lee , MD Department of Internal Medi - cine, Inha University School of  Medicine, 27 Inhang-ro, Jung-gu,  Incheon 400-711, Korea  Tel: +82-32-890-3616 Fax: +82-32-882-6578 E-mail: ljinsoo@inha.ac.krINTRODUCTION Background and purpose Influenza is an acute respiratory disease caused by influenza virus infection.",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265Method of development As the first step, a guideline development committee  was organized consisting of six professionals including  infectious disease specialists, an infectious control  nurse, and a methodology specialist, so that specialists  from multiple disciplines could participate in the de - velopment process.",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"Database and search terms for clinical guidelines Database Homepage Search terms National Guideline Clearinghouse http://www.guideline.gov Influenza NHS Evidence http://www.evidence.nhs.uk Influenza Guideline International Network http://www.g-i-n.net Influenza PubMed http://www.ncbi.nlm.nih.gov/pubmed Influenza AND Systematic [sb] NHS, National Health Service.",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Influenza in healthcare settings www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265committee.,Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265ized patients [9-11].",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"Influenza in healthcare settings www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265Diagnosis When ILI develops during influenza season, it can be  clinically diagnosed as influenza.",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265(including neuromuscular diseases, epilepsy, cerebral  infarction, cerebral palsy, etc.",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Influenza in healthcare settings www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265can also transmit influenza virus from contaminated  surfaces to eyes or mouth through hands.,Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265bility of false negative results of RAT.",OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Influenza in healthcare settings www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265contact with other patients.,Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265When there is not enough space for quarantine, a barri - er can be used to divide the space.",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Influenza in healthcare settings www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265influenza [1].,Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265phylactic use of antiviral agents in high risk groups can  be considered according to the evidence.",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Influenza in healthcare settings www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265sure prophylaxis should be limited to high risk expos - ers.,Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265spiratory symptoms continue for more than 7 days, the  duration is extended until the symptoms disappear.",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Influenza in healthcare settings www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Available from: http://www.cdc.go.kr/ CDC/info/CdcKrInfo0402.jsp?menuIds=HOME001- MNU1132-MNU1138-MNU0045 .,Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
"2, March 2014  www.kjim.org http://dx.doi.org/10.3904/kjim.2014.29.2.265acteristics of inf luenza-like-illness case definitions in  predicting inf luenza in hospitalized Canadian adults.",Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Available from:  http://www.cdc.gov/f lu/professionals/infectioncontrol/ healthcaresettings.htm.,Non-OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Available from: http://www.epa.gov/oppad001/h1n1- guide.html.,OADS,/arxiv_data1/oa_pdf/b1/ad/kjim-29-265.PMC3957004.pdf
Availability and implementation: Source code and executables are available at https://github.com/WaveCNV.,OADS,/arxiv_data1/oa_pdf/60/6e/btt611.PMC3957071.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/6e/btt611.PMC3957071.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/af/cf/ijbsv10p0236.PMC3957079.pdf
Recent completion of the pig  draft genome assembly and discovery of more than  twenty million single nucleotide polymorphisms  (SNPs)  in the genome  (http://www.ncbi.nlm.nih.gov /SNP/) have allowed the community to further a d- vance genome wide associat ion studies for the ident i- fication of QTLs related to many economically i m- portant traits in the species.,Non-OADS,/arxiv_data1/oa_pdf/af/cf/ijbsv10p0236.PMC3957079.pdf
Genes in these DSRs were iden-tified using the Sscrofa 10.2 assembly (http://www.animalgenome.org/cgi -bin/gbrowse/ pig).,Non-OADS,/arxiv_data1/oa_pdf/af/cf/ijbsv10p0236.PMC3957079.pdf
"Among these 27 DSRs, five supported the QTL re- gions previously reported for the birth weight in pigs:  QTL#5232 on SSC1, QTL#369 on SSC4, QTL#3189 on  SSC5, QTL#1012 on SSC6, QTL#187 and QTL#5197 on  SSC 7 (Table  2 and Figure  2, http://cn.animalgenome .org/cgi -bin/QTLdb/index).",Non-OADS,/arxiv_data1/oa_pdf/af/cf/ijbsv10p0236.PMC3957079.pdf
All  QTL informa tion for birth weight was retrieved from the Animal QTLdb release 21 (http://cn.animalgenome.org/cgi -bin/QTLdb/index).,OADS,/arxiv_data1/oa_pdf/af/cf/ijbsv10p0236.PMC3957079.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.or g/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/8d/ijbsv10p0245.PMC3957080.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/47/f6/ijbsv10p0257.PMC3957081.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/03/59/ijbsv10p0268.PMC3957082.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/eb/c3/ijbsv10p0278.PMC3957083.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/85/ac/ijbsv10p0285.PMC3957084.pdf
This is an open- access article distributed under the terms of the Creative Commons Licen se (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b7/06/ijbsv10p0296.PMC3957085.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e4/d1/ijbsv10p0309.PMC3957086.pdf
Sequence analysis of the chicken CARP  gene   The CARP cDNA sequence (NM_204405) was  compared with the chicken genomic database  (http://genome.ucsc.edu) through BLAST analysis.,OADS,/arxiv_data1/oa_pdf/e4/d1/ijbsv10p0309.PMC3957086.pdf
The 5’ -flanking region was  analyzed using online software (http://cbrc.jp/ research/db/ TFSEARCH.html) to predict the put a- tive regulatory elements.,OADS,/arxiv_data1/oa_pdf/e4/d1/ijbsv10p0309.PMC3957086.pdf
"m iRNAs targeting the CARP  3'-UTR were predicted using miRBase  (http://miRBase.org), with an E -value cut -off of 6 for  the predictions.",OADS,/arxiv_data1/oa_pdf/e4/d1/ijbsv10p0309.PMC3957086.pdf
AREsite (http://rna.tbi .univie.ac.at/   cgi-bin/AREsite.cgi) was  employed to identify AU  -rich elements ( AREs) in the CARP mRNA 3' -UTR s e- quence.,OADS,/arxiv_data1/oa_pdf/e4/d1/ijbsv10p0309.PMC3957086.pdf
The siRNA sequence targeting CARP was d e- signed using Invitrogen’s BLOCKiT RNA i designer  (http://rnaidesigner.invitrogen.com/sirna).,OADS,/arxiv_data1/oa_pdf/e4/d1/ijbsv10p0309.PMC3957086.pdf
"Genomic organization and sequence analysis  of the chicken CARP  gene   To determine the genomic structure of the  chicken  CARP  gene, its cDNA sequence (NM_204405)  was compared with sequ ences in the chicken genome  database (http://genome.ucsc.edu).",OADS,/arxiv_data1/oa_pdf/e4/d1/ijbsv10p0309.PMC3957086.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/50/a0/ijbsv10p0321.PMC3957087.pdf
This is an open- access article distributed under the terms of the Creativ e Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/3d/ijbsv10p0327.PMC3957088.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/df/ijbsv10p0338.PMC3957089.pdf
"The primers listed in Table  1 were selected  from recent publications as indicated or designed  with Primer 3 (Version 0.4.0., http://frodo.wi.mit.",Non-OADS,/arxiv_data1/oa_pdf/38/df/ijbsv10p0338.PMC3957089.pdf
"(May 22–24, 2006), U.S. Department of Energy http://science.energy.gov/ ,/media/bes/pdf/reports/files/ssl_rpt.pdf.",OADS,/arxiv_data1/oa_pdf/46/e2/srep04400.PMC3957127.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/46/e2/srep04400.PMC3957127.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4400 | DOI: 10.1038/srep04400 5",Non-OADS,/arxiv_data1/oa_pdf/46/e2/srep04400.PMC3957127.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Moon, S.H.",Non-OADS,/arxiv_data1/oa_pdf/71/81/srep04408.PMC3957128.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4408 | DOI: 10.1038/srep04408 6",Non-OADS,/arxiv_data1/oa_pdf/71/81/srep04408.PMC3957128.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dc/47/srep04394.PMC3957129.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4394 | DOI: 10.1038/srep04394 7",Non-OADS,/arxiv_data1/oa_pdf/dc/47/srep04394.PMC3957129.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/36/8e/srep04402.PMC3957131.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4402 | DOI: 10.1038/srep04402 5",Non-OADS,/arxiv_data1/oa_pdf/36/8e/srep04402.PMC3957131.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/22/6d/srep04395.PMC3957132.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4395 | DOI: 10.1038/srep04395 7",Non-OADS,/arxiv_data1/oa_pdf/22/6d/srep04395.PMC3957132.pdf
Figure 1a produced at http://iridl.ldeo.columbia.edu/ and used with permission (data from ref.,Non-OADS,/arxiv_data1/oa_pdf/8c/1c/srep04393.PMC3957133.pdf
Correlations computed at http://climexp.knmi.nl/42 IF comp IF Had1 IF Had3 IF ERSST AC Had1 AC Had3 AC ERSST IF comp 1 IF Had1 0.48 1 IF Had3 0.34 0.78 1 IF ERSST 0.37 0.81 0.78 1 AC Had1 0.57 0.75 0.43 0.64 1 AC Had3 0.59 0.60 0.31 0.61 0.74 1 AC ERSST 0.54 0.68 0.49 0.66 0.76 0.70 1 Figure 4 |Reconstructions for sea surface and air temperature for the Agulhas Current and South Africa.,OADS,/arxiv_data1/oa_pdf/8c/1c/srep04393.PMC3957133.pdf
Figure produced at http://climexp.knmi.nl/42and used with permission.www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4393 | DOI: 10.1038/srep04393 6,Non-OADS,/arxiv_data1/oa_pdf/8c/1c/srep04393.PMC3957133.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8c/1c/srep04393.PMC3957133.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4393 | DOI: 10.1038/srep04393 8",Non-OADS,/arxiv_data1/oa_pdf/8c/1c/srep04393.PMC3957133.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4392 | DOI: 10.1038/srep04392 14",Non-OADS,/arxiv_data1/oa_pdf/08/46/srep04392.PMC3957134.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/98/97/srep04397.PMC3957144.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4397 | DOI: 10.1038/srep04397 4",Non-OADS,/arxiv_data1/oa_pdf/98/97/srep04397.PMC3957144.pdf
"The map was generated using GeoMapApp (version 2) (http://www.geomapapp.org/).Table 2 |Hierarchical AMOVA table and corresponding values for FCT (difference among groups), FSC (differences among collec-tions within groups), and FST (differences among all collections) Hierarchical structure FCT FSC FST Location .Time 20.00398 0.17006 ** 0.16676 ** Time.Location 0.08570 **0.09948 ** 0.17666 ** *P#0.05, **P#0.001.www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4396 | DOI: 10.1038/srep04396 4",OADS,/arxiv_data1/oa_pdf/41/a6/srep04396.PMC3957146.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/41/a6/srep04396.PMC3957146.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4396 | DOI: 10.1038/srep04396 6",Non-OADS,/arxiv_data1/oa_pdf/41/a6/srep04396.PMC3957146.pdf
"Typically without KOH/plasma treatment, the number of APTES molecules bound to PS is low due to the lack of the polar, hydrogen Table 3 |Comparison of NIF with various sandwich ELISA procedures and the commercial kits for the detection of HFA Manufacturer/ Immunoassay Procedures Antibody binding Sensitivity (ng mL21) References New ELISA format (NIF) One-step 0.01 This work ELISA-covalent binding of antibody Covalent 0.03 This work5using the covalent immobilization of the antibody as described by Dixit et al.5 Conventional ELISA Passively adsorbed 0.5 This workRnD systems Passively adsorbed 0.37 http://www.rndsystems.com/pdf/DY1184.pdfBiovendor Passively adsorbed 0.35 http://www.biovendor.com/product/immunoassays/fetuin-a- ahsg-human-elisa Alpco Diagnostics Passively adsorbed 5.00 http://www.alpco.com/pdfs/43/43-NSEHU-E01.pdfImmunology Consultants Laboratory, Inc. Passively adsorbed 6.25 http://www.life-sciences.com.br/pdf/icllab.pdfGenway Biotech, Inc. Passively adsorbed 6.25 http://www.genwaybio.com/images/gw_tds/elisa_kits/40- 374-130036.pdf Assay Pro Passively adsorbed 6.25 http://www.assaypro.com/datasheet/eg3501_1.pdf Figure 4 |Immunoassays based the NIF for (a) C-reactive protein (CRP), (b) human albumin and (c) human lipocalin-2.",Non-OADS,/arxiv_data1/oa_pdf/02/cf/srep04407.PMC3957147.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/cf/srep04407.PMC3957147.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4407 | DOI: 10.1038/srep04407 7",Non-OADS,/arxiv_data1/oa_pdf/02/cf/srep04407.PMC3957147.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4399 | DOI: 10.1038/srep04399 6",Non-OADS,/arxiv_data1/oa_pdf/67/ef/srep04399.PMC3957149.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4404 | DOI: 10.1038/srep04404 8",Non-OADS,/arxiv_data1/oa_pdf/d2/53/srep04404.PMC3957151.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/ce/6a/JFCM-20-162.PMC3957169.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/ce/6a/JFCM-20-162.PMC3957169.pdf
Available from: http://apps.who.int/ghodata/?vid=1805  [Last accessed on 2012 May 01].2. WHO: Global Health Ob servatory.,Non-OADS,/arxiv_data1/oa_pdf/78/97/JFCM-20-168.PMC3957170.pdf
Available  from: http://www.who.int/gho/countries/en/ [Last accessed on  2012 May 01].,Non-OADS,/arxiv_data1/oa_pdf/78/97/JFCM-20-168.PMC3957170.pdf
Available from:  http://www.who.int/entity/tobacco/mpower/en/ [Last accessed on  2012 May 01].,OADS,/arxiv_data1/oa_pdf/78/97/JFCM-20-168.PMC3957170.pdf
Available from: http://www.who.int/ tobacco/publications/industry/en/ [Last accessed on 2012 May 01].,Non-OADS,/arxiv_data1/oa_pdf/78/97/JFCM-20-168.PMC3957170.pdf
Available  from: http://www.who.int/tobacco/publications/surveillance/rep_ mortality_attributable/en/index.html [Last accessed on 2012 May 01].,Non-OADS,/arxiv_data1/oa_pdf/78/97/JFCM-20-168.PMC3957170.pdf
Available from: http://www.en.wikipedia.org/wiki/jeddah [Last  accessed on 2013 Mar 15].,Non-OADS,/arxiv_data1/oa_pdf/78/97/JFCM-20-168.PMC3957170.pdf
"Available from: http://www.alarabeya, net/articles/2012/10/24/245606.",Non-OADS,/arxiv_data1/oa_pdf/78/97/JFCM-20-168.PMC3957170.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/43/17/JFCM-20-173.PMC3957171.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b0/42/srep04406.PMC3957278.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4406 | DOI: 10.1038/srep04406 6",Non-OADS,/arxiv_data1/oa_pdf/b0/42/srep04406.PMC3957278.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ amiajnl-2012-001575).,OADS,/arxiv_data1/oa_pdf/cc/01/amiajnl-2012-001575.PMC3957379.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/cc/01/amiajnl-2012-001575.PMC3957379.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ amiajnl-2013-001993).,OADS,/arxiv_data1/oa_pdf/9c/c6/amiajnl-2013-001993.PMC3957400.pdf
"While we haveextensive clinical experience with single-gene pharmacogenetictests, 16in May 2011 we implemented array-based pre-emptive genotyping through a clinical research protocol, St. JudePG4KDS (http://www.stjude.org/pg4kds).",Non-OADS,/arxiv_data1/oa_pdf/9c/c6/amiajnl-2013-001993.PMC3957400.pdf
"Each alert also refers clinicians to other resources: add-itional consultation with pharmacists, the PharmacogeneticsT ab in the EHR, or the PG4KDS web page (http://www.stjude.org/pg4kds), so that clinicians can learn more about the rele-vance of pharmacogenetic results for high-risk patients at thetime of prescribing.",Non-OADS,/arxiv_data1/oa_pdf/9c/c6/amiajnl-2013-001993.PMC3957400.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Osheroff JA, Teich JM, Middleton B, et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/c6/amiajnl-2013-001993.PMC3957400.pdf
http://www.genenames.org (accessed 29 Mar 2013).,OADS,/arxiv_data1/oa_pdf/9c/c6/amiajnl-2013-001993.PMC3957400.pdf
http://www.fda.gov/Drugs/DrugSafety/ucm339112.htm (accessed 28 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/9c/c6/amiajnl-2013-001993.PMC3957400.pdf
Available from: https://www.orpha.,Non-OADS,/arxiv_data1/oa_pdf/ec/39/APC-6-167.PMC3957449.pdf
Available from: http://www.sts.,Non-OADS,/arxiv_data1/oa_pdf/0e/62/APC-6-206.PMC3957463.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2014, 9: 23527 - http://dx.doi.org/10.3402/ljm.v9.23527 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
"When strategies of screening for DV in primaryJinan Usta and Rim Taleb 2 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 23527 - http://dx.doi.org/10.3402/ljm.v9.23527",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
"It is thought to supplement screening effortsand allows providers to focus on assessment, counseling, and referral for those at risk.Domestic violence in primary care Citation: Libyan J Med 2014, 9: 23527 - http://dx.doi.org/10.3402/ljm.v9.23527 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
"Signs and symptoms suggestive of abuse /C147Injuries that point to a defensive position over the face (bruises and marks on the inside of the arms, back) /C147Injuries to the chest and stomach, reproductive organs, and anus /C147The illness or injuries do not match the cause given /C147Delay in requesting medical care /C147Injuries and bruises of various colors, indicating injuries occurring regularly over a period of time /C147Repeat injuries, someone who is ‘accident prone’ /C147Injuries during pregnancy /C147Repeated reproductive health problems: repeat miscarriage, early delivery, sexually transmitted diseases /C147Psychological or behavioral problems /C147Suicide attempts or signs of depression /C147Repeat and chronic medical complaints, pelvic problems and pains, psychological diseases /C147Behavioral signs: multiple visits, lack of commitment to appointments, not displaying emotion or crying easily, inability to undertake daily interactions, negligence, defensive positions, stilted speech, avoiding eye contact and animosity in body language Partner’s behavior /C147Extreme and irrational jealousy or possessiveness /C147Attempts to control time spent with the healthcare providers /C147Speaking on behalf of the patient /C147Insisting on staying close to the patient, who hesitates to speak before the partnerJinan Usta and Rim Taleb 4 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 23527 - http://dx.doi.org/10.3402/ljm.v9.23527",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
"Check for barriers to access and discuss solutionsDomestic violence in primary care Citation: Libyan J Med 2014, 9: 23527 - http://dx.doi.org/10.3402/ljm.v9.23527 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
Available from: http://www.dos.gov.jo/sdb_pop/sdb_pop_e/pop_2009.pdf[cited 5 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
Available from: http://www.who.int/mediacentre/news/releases/2008/pr02/ 2008_iraq_family_health_survey_report.pdf [cited 5 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
Available from: http://www.measuredhs.com/pubs/pdf/FR176/FR176.pdf [cited5 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
"2009; 40: 1 /C113.Jinan Usta and Rim Taleb 6 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 23527 - http://dx.doi.org/10.3402/ljm.v9.23527",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
Available from: http://www.infoforhealth.org/pr/l11edsum.shtml [serial online].,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
American Medical Association; Available from: http://www.ama-assn.org/a ma/pub/physician-resources/ medical-ethics/code-medical-ethics/opinion202 [cited 5 October2013].,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
American Congress of Obstetri- cians and Gynecologists ; Available from: http://www.acog.org/ About_ACOG/ACOG_Departments/Violence_Against_Women/ Screening_Tools__Domestic_Violence [cited 5 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
Available from: http://www.uspreventiveservicestaskforce.org/3rduspstf/ famviolence/famviolrs.htm [cited 30 August 2013].,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
Avail-able from: http://www.who.int/reproductivehealth/publications/ violence/9789241548595/en/ [cited 3 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
"ACP press: American College of Physicians;2009.Domestic violence in primary care Citation: Libyan J Med 2014, 9: 23527 - http://dx.doi.org/10.3402/ljm.v9.23527 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/cd/f8/LJM-9-23527.PMC3957738.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/03/01/nss-6-037.PMC3958496.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNature and Science of Sleep 2014:6 37–42Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  37OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NSS.S5931 7Sleep apnea in children with refractory  monosymptomatic nocturnal enuresis ashraf el-Mitwalli1 adel Salah Bediwy2 ashraf ahmed Zaher1 Tamer Belal1 abdel Baset M Saleh3 1Neurology Department, Faculty  of Medicine, Mansoura University,   Mansoura, 2chest Department,   Faculty of Medicine, Tanta University,   Tanta, 3chest Department, Faculty  of Medicine, Mansoura University,   Mansoura, egypt correspondence: adel Salah Bediwy   chest Department, Faculty of Medicine,  Tanta University hospital, Tanta, egypt   Tel +20 10 0561 1515   email adelsalah1@yahoo.co mBackground:  Children with nocturnal enuresis (NE) are believed to have deep sleep with high  arousal threshold.",Non-OADS,/arxiv_data1/oa_pdf/03/01/nss-6-037.PMC3958496.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/03/01/nss-6-037.PMC3958496.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/01/nss-6-037.PMC3958496.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 289–300International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  289RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IJWH.S4978 1Profile of pazopanib and its potential   in the treatment of epithelial ovarian cancer Brittany A Davidson Angeles Alvarez Secord Division of Gynecologic Oncology,   Duke Cancer Institute, Department  of Obstetrics and Gynecology, Duke  University Medical Center, Durham,   NC, USA Correspondence: Angeles Alvarez Secord   DUMC 3079, Division of Gynecologic  Oncology, Duke Cancer Institute, Duke  University Medical Center, Durham,   NC 27710, USA   Tel +1 919 684 3765   Fax +1 919 684 8719   email secor002@mc.duke.ed uAbstract:  Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer.",Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Available from: http://globocan.iarc.fr/Pages/ fact_sheets_population.aspx .,OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Available from: http://www.nccn.org/professionals/ physician_gls/pdf/ovarian.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Available at: http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Available from: http://www.fda.gov/NewsEvents/  Newsroom/PressAnnouncements/ucm302065.htm .,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Available  from: http://clinicaltrials.gov/show/NCT0161020 6.,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01644825?term =NCT01644825&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Available  from: http://clinicaltrials.gov/ct2/show/NCT01035658?term=NCT010 35658&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Available from: http://clinicaltrials.gov/ct2/ show/NCT01402271?term=NCT01402271&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a6/fb/ijwh-6-289.PMC3958497.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4b/4c/idr-7-057.PMC3958498.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 57–62Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  57ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IDR.S5698 4Mortality and molecular epidemiology associated  with extended-spectrum β-lactamase production in  Escherichia coli  from bloodstream infection Rasmus leistner1 christian sakellariou1 stephan gürntke1 axel Kola1 Ivo steinmetz2 christian Kohler2 Yvonne Pfeifer3 christoph eller3 Petra gastmeier1 Frank schwab1 1Institute of hygiene and  environmental Medicine, national  Reference center for the surveillance  of nosocomial Infections, charité  Universitätsmedizin Berlin, Berlin,   germany; 2Friedrich löffler  Institute of Medical Microbiology,   Universitätsmedizin greifswald,   greifswald, germany; 3Robert  Koch Institute, F g13 nosocomial  Pathogens and antibiotic Resistance,   Wernigerode, germany correspondence: Rasmus leistner   Institute of hygiene and environmental   Medicine, national Reference center   for the surveillance of nosocomial   Infections, charité Universitätsmedizin   Berlin, 27 hindenburgdamm,   Berlin 12203, germany   email rasmus.leistner@charite.d eBackground:  The rate of infections due to extended-spectrum β-lactamase (ESBL)-producing  Escherichia coli  is growing worldwide.",Non-OADS,/arxiv_data1/oa_pdf/4b/4c/idr-7-057.PMC3958498.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/4b/4c/idr-7-057.PMC3958498.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4b/4c/idr-7-057.PMC3958498.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/7c/opth-8-555.PMC3958499.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 555–559Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  555Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/ 10.2147/OPTH.S5930 9axial length estimation error caused by hidden  double-peak on partial coherence interferometry  in an eye with epiretinal membrane: a case report Y oshiyuki Kitaguchi shinsaku Yano Fumi Gomi Department of Ophthalmology,   sumitomo Hospital, Osaka, Japan Correspondence: Fumi Gomi   Department of Ophthalmology,  sumitomo Hospital, 5-3-20   Nakanoshima, Kita-ku, Osaka-shi,   Osaka, Japan 530-0005   tel +816 6443 1261   email gomi.fumi@gmail.co mAbstract:  Here we report a patient in whom there was a myopic shift after combined cataract  surgery and pars plana vitrectomy against the epiretinal membrane, related to axial measurement  estimation error caused by a hidden double-peak appearance on partial coherence interfero- metry measurement.",Non-OADS,/arxiv_data1/oa_pdf/a9/7c/opth-8-555.PMC3958499.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a9/7c/opth-8-555.PMC3958499.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/7c/opth-8-555.PMC3958499.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/a2/ndt-10-459.PMC3958500.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 459–470Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  459Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/NDT .S4006 6when to start aripiprazole therapy in patients  with bipolar mania Kiran Kumar Sayyaparaju1 Heinz Grunze1 Kostas N Fountoulakis2 1Newcastle University, institute of  Neuroscience, Academic Psychiatry,   Newcastle upon Tyne, UK; 23rd  Department of Psychiatry, Division of  Neurosciences, School of Medicine,   Aristotle University of Thessaloniki,   Greece Correspondence: Heinz Grunze   Newcastle University, institute of   Neuroscience, Academic Psychiatry,   Campus of Aging and vitality, wolfson   Research Centre, westgate Road,   Newcastle upon Tyne, UK   Tel +44 0 191 208 1372   Fax +44 0 191 208 1387   email heinz.grunze@ncl.ac.u kAbstract:  Aripiprazole is a third generation atypical antipsychotic with compelling evidence  as a highly effective treatment option in the management of acute manic and mixed episodes  of bipolar I disorders.",Non-OADS,/arxiv_data1/oa_pdf/b9/a2/ndt-10-459.PMC3958500.pdf
"Available from: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2013/021436s037,021713s029,021729s021,021 866s022lbl.pd f. Accessed September 27, 2013.",Non-OADS,/arxiv_data1/oa_pdf/b9/a2/ndt-10-459.PMC3958500.pdf
"Available  from: http://www.gencat.cat/salut/depsan/units/aatrm/pdf/guia_  trastorn_  bipolar_aiaqs_2010ca.pd f. Accessed January 17, 2014.",OADS,/arxiv_data1/oa_pdf/b9/a2/ndt-10-459.PMC3958500.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/b9/a2/ndt-10-459.PMC3958500.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/a2/ndt-10-459.PMC3958500.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/a5/opth-8-529.PMC3958501.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 529–535Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  529Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/OPTH.S6010 5Utility values for glaucoma in Brazil   and their correlation with visual function ricardo augusto Paletta  guedes1–3 Vanessa Maria Paletta  guedes1–3 sirley Maria Freitas2 alfredo Chaoubah1 1Federal University of Juiz de Fora,   2Paletta guedes Ophthalmological  Center, 3santa Casa de Misericórdia  hospital, Juiz de Fora, Brazil Correspondence: ricardo augusto   Paletta guedes Ophthalmological Center,  2644/1001 avenida rio Branco, Centro,   Juiz de Fora, Mg 36016-311, Brazil   Tel/fax +55 32 3213 1927   email palettaguedes@yahoo.co mPurpose:  We sought to identify the utility values in a group of Brazilian patients with primary  open-angle glaucoma (POAG), and to assess its impact on visual acuity (V A) and mean devia - tion index values.",Non-OADS,/arxiv_data1/oa_pdf/35/a5/opth-8-529.PMC3958501.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/35/a5/opth-8-529.PMC3958501.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/a5/opth-8-529.PMC3958501.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/d6/hiv-6-039.PMC3958502.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS – Research and Palliative Care 2014:6 39–47HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  39ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/HIV.S5391 0Clinical characteristics and outcomes   in 303 HIV-infected patients with invasive   fungal infections: data from the Prospective   Antifungal Therapy Alliance registry,   a multicenter, observational study Tafireyi Marukutira1 Shirish Huprikar2 nkechi Azie3 Shun-Ping Quan3 Herwig-Ulf Meier-Kriesche3 David l Horn4 1Botswana-Baylor Children’s Clinical  Centre of excellence, gaborone,   Botswana, 2Icahn School of Medicine  at Mount Sinai, new Y ork, nY,   3Astellas Scientific and Medical Affairs,   Inc, northbrook, Il, 4David Horn llC,   Doylestown, PA, USA Correspondence: Tafireyi Marukutira   Botswana-Baylor Children’s Clinical   Centre of excellence, Hospital Way,   Private Bag BR129, gaborone, Botswana   Tel +267 319 0083   Fax +267 319 0079   email tcmarukutira@yahoo.co mAbstract:  This analysis aimed to characterize the epidemiology, diagnosis, treatment, and   outcomes of invasive fungal infections (IFIs) in patients with human immunodeficiency virus  (HIV).",Non-OADS,/arxiv_data1/oa_pdf/e8/d6/hiv-6-039.PMC3958502.pdf
Available  from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217757 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/d6/hiv-6-039.PMC3958502.pdf
Available from: http://www.cdc.gov/hiv/ topics/ surveillance /resources/reports /.,OADS,/arxiv_data1/oa_pdf/e8/d6/hiv-6-039.PMC3958502.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/e8/d6/hiv-6-039.PMC3958502.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/d6/hiv-6-039.PMC3958502.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/76/70/ijn-9-1393.PMC3958504.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1393–1402International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1393OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S5621 2acute toxicity of nickel nanoparticles in rats after  intravenous injection ruth r Magaye1,* Xia Yue1,* Baobo Zou1 hongbo shi1 hongsheng Yu2 Kui liu1 Xialu lin1 Jin Xu1 cui Yang3 aiguo Wu3 Jinshun Zhao1 1Public health Department,  2affiliated hospital of Medical school,  Zhejiang Provincial Key laboratory  of Pathological and Physiological  Technology, Ningbo University,   3Key laboratory of Magnetic Materials  and Devices, Division of Functional  Materials and Nano-devices, Ningbo  Institute of Materials Technology  and engineering (NIMT e), chinese  academy of sciences, Ningbo,  People’s republic of china *These authors contributed equally to  this work correspondence: Baobo Zou   Public health Department, Zhejiang  Provincial Key laboratory of Pathological  and Physiological Technology,   Ningbo University, 818 Fenghua road,  Jiangbei District, Ningbo,   People’s republic of china   email zoubaobo@nbu.edu.c n    Jinshun Zhao   Public health  Department, Zhejiang  Provincial Key laboratory of Pathological  and Physiological Technology,   Ningbo University, 818 Fenghua road,  Jiangbei District, Ningbo,   People’s republic of china   email jinshunzhao@nbu.edu.c nAbstract : This study was carried out to add scientific data in regard to the use of metallic  nanoparticles in nanomedicine.",Non-OADS,/arxiv_data1/oa_pdf/76/70/ijn-9-1393.PMC3958504.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/76/70/ijn-9-1393.PMC3958504.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/70/ijn-9-1393.PMC3958504.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/5e/ndt-10-453.PMC3958519.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 453–458Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  453OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5644 1suicide risk among Thai illicit drug users   with and without mental/alcohol use disorders Phunnapa  Kittirattanapaiboon1 sirijit suttajit2 Boonsiri Junsirimongkol1 surinporn likhitsathian2 Manit srisurapanont2 1Department of Mental health,   Ministry of Public health, Nonthaburi,   Thailand; 2Department of Psychiatry,   Faculty of Medicine, chiang Mai  University, chiang Mai, Thailand correspondence: Phunnapa  Kittirattanapaiboon   Bureau of Mental health service  administration, Department of Mental  health, Ministry of Public health,   Tivanon road, Muang,   Nonthaburi,11000 Thailand   Tel +66 2149 5539   Fax +66 2149 5538   email phunnapa@hotmail.co mBackground : It is not yet known if the increased risk of suicide in substance abusers is caused  by the causal and/or coexisting relationship between substance use and psychiatric disorders.",Non-OADS,/arxiv_data1/oa_pdf/4f/5e/ndt-10-453.PMC3958519.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/4f/5e/ndt-10-453.PMC3958519.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/5e/ndt-10-453.PMC3958519.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/34/ndt-10-471.PMC3958520.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 471–477Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  471OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/NDT .S5697 1reliability and validity of the Thai version   of the Yale–Brown Obsessive compulsive   scale – second edition in clinical samples Thanita hiranyatheb ratana saipanish Manote lotrakul Department of Psychiatry, Faculty  of Medicine, ramathibodi hospital,   Mahidol University, Bangkok, Thailand correspondence: Thanita hiranyatheb   Department of Psychiatry, Faculty of  Medicine, ramathibodi hospital, Mahidol  University, 270 rama Vi rd, Phayathai,  ratchathewee, Bangkok, Thailand 10400   Tel +66 2 201 1929   Fax +66 2 354 7299   email thanita.hin@mahidol.ed uPurpose:  The Y ale–Brown Obsessive Compulsive Scale (Y -BOCS) is regarded as the most  accep table tool for measuring obsessive–compulsive disorder symptom severity.",Non-OADS,/arxiv_data1/oa_pdf/5b/34/ndt-10-471.PMC3958520.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5b/34/ndt-10-471.PMC3958520.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/34/ndt-10-471.PMC3958520.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/b8/ijgm-7-175.PMC3958521.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 175–177International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  175Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/ 10.2147/IJGM.S5930 0Comment to: the effects of an 8-week  multicomponent inpatient treatment program  on body composition and anaerobic fitness in  overweight and obese children and adolescents thomas  radtke1 Bruno H Knöpfli2 Johannes H Wildhaber3 Jürg Hammer4 1Division of Cardiovascular  Prevention, rehabilitation and Sports  Medicine, Swiss Cardiovascular  Center, Inselspital, University   Hospital and University of Bern,    Bern, 2Kinder und Jugendmedizin,    Zurich, 3Department of Pediatrics,   Hospital Fribourg, Fribourg, 4Division  of Intensive Care and Pulmonology,   University Children’s Hospital Basel,   Basel, Switzerland Correspondence: thomas radtke   Division  of Cardiovascular Prevention,   rehabilitation and Sports Medicine,   Swiss Cardiovascular Center, Inselspital,   University Hospital and University of   Bern, 3010 Bern, Switzerland   tel +41 31 632 7911   Fax +41 31 632 8977   email thomas.radtke@insel.c hDear editor We note with surprise a recent paper entitled “The effects of an 8-week  multicomponent  inpatient treatment program on body composition and anaerobic fitness in over - weight and obese children and adolescents” by Karner-Rezek et al1 published in the  International Journal of General Medicine  concerning the effects of an 8-week mul - ticomponent inpatient treatment program on body composition and anaerobic fitness  in overweight and obese children and adolescents.",Non-OADS,/arxiv_data1/oa_pdf/ef/b8/ijgm-7-175.PMC3958521.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/ef/b8/ijgm-7-175.PMC3958521.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/b8/ijgm-7-175.PMC3958521.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/3d/opth-8-543.PMC3958522.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 543–554Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  543REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4156 2Journal name: Clinical Ophthalmology Journal Designation: REVIEW Y ear: 2014 Volume: 8 Running head verso: Fung and Whitson Running head recto: Unoprostone isopropyl ophthalmic solution 0.15% for glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S41562 An evidence-based review of unoprostone  isopropyl ophthalmic solution 0.15%   for glaucoma: place in therapy Derrick S Fung Jess T Whitson Department of Ophthalmology,   University of Texas Southwestern  Medical Center, Dallas, TX, USAAbstract:  Glaucoma is a progressive, neurodegenerative optic nerve disease that can cause  significant visual morbidity and affects over 60 million people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0c/3d/opth-8-543.PMC3958522.pdf
Available from: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2012/021214s006s007lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/3d/opth-8-543.PMC3958522.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journalClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/0c/3d/opth-8-543.PMC3958522.pdf
Visit http://www.dovepress.com/ testimonials.php to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 554Fung and Whitson 71.,Non-OADS,/arxiv_data1/oa_pdf/0c/3d/opth-8-543.PMC3958522.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2d/c5/ijwh-6-307.PMC3958523.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 307–312International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  307RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IJWH.S5255 5Reviewing the options for local estrogen  treatment of vaginal atrophy Sarah H Lindahl Sutter east Bay Medical Foundation,   SeBMF – Diablo Division, Castro  valley, CA, USA Correspondence: Sarah H Lindahl   Sutter east Bay Medical Foundation,   20101 Lake Chabot Blvd,   Castro valley, CA 94546, USA   Tel +1 510 886 3400   Fax +1 510 581 6517   email shlindobgyn@yahoo.co mBackground:  Vaginal atrophy is a chronic condition with symptoms that include vaginal dryness,  pain during sex, itching, irritation, burning, and discharge, as well as various urinary problems.",Non-OADS,/arxiv_data1/oa_pdf/2d/c5/ijwh-6-307.PMC3958523.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/2d/c5/ijwh-6-307.PMC3958523.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2d/c5/ijwh-6-307.PMC3958523.pdf
Available from: http://www.fda.gov/ downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM135336.,Non-OADS,/arxiv_data1/oa_pdf/2d/c5/ijwh-6-307.PMC3958523.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/08/ce-9-049.PMC3958524.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCore Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/3d/08/ce-9-049.PMC3958524.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/08/ce-9-049.PMC3958524.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/22/c2/ijgm-7-159.PMC3958525.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 159–173International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  159RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S5888 8The role of primary care physicians   in early diagnosis and treatment   of chronic gastrointestinal diseases Aristofanis Gikas1 John K Triantafillidis2 1Health Center of Kalivia, Kalivia,   Attiki, Greece; 2Inflammatory Bowel  Disease Unit, IASO General Hospital,   Athens, Greece Correspondence: Aristofanis Gikas   Themistokleous 1 7, Maroussi,   15122, Greece   Tel +30 212 102 5094   Fax +30 229 904 8706   email argikas@ath.forthnet.g rAbstract:  Chronic gastrointestinal disorders are a source of substantial morbidity, mortality,  and cost.",Non-OADS,/arxiv_data1/oa_pdf/22/c2/ijgm-7-159.PMC3958525.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/22/c2/ijgm-7-159.PMC3958525.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/22/c2/ijgm-7-159.PMC3958525.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/e8/ceg-7-053.PMC3958527.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2014:7 53–59Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  53REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S4874 1Golimumab for the treatment of ulcerative colitis Mark Löwenberg1 Nanne KH de Boer2 Frank Hoentjen3 1Department of Gastroenterology  and Hepatology, Academic Medical  Center, Amsterdam, the Netherlands;   2Department of Gastroenterology and  Hepatology, vU University Medical  Centre, Amsterdam, the Netherlands;   3inflammatory Bowel Disease Center,   Radboud University Medical Center,   Nijmegen, the Netherlands Correspondence: Mark Löwenberg   Department of Gastroenterology and   Hepatology, Academic Medical Center,   Meibergdreef 9, 1105 AZ Amsterdam,   the Netherlands   Tel +31 20 566 3893   Email m.lowenberg@amc.uva.n lAbstract:  The introduction of therapeutic antibodies against tumor necrosis factor (TNF)  had a major impact on the treatment of ulcerative colitis (UC).",Non-OADS,/arxiv_data1/oa_pdf/ba/e8/ceg-7-053.PMC3958527.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/ba/e8/ceg-7-053.PMC3958527.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/e8/ceg-7-053.PMC3958527.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/a3/cia-9-421.PMC3958542.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 421–424Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  421CAse serIesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CIA.S5618 5Cutaneous factitia in elderly patients: alarm   signal for psychiatric disorders Anca Chiriac1 Liliana Foia2 Cristina Birsan1 Ancuta Goriuc2 Caius solovan3 1Department of Dermatology,   Nicolina Medical Center, Iaşi, Romania;   2surgical Department, Grigore T Popa  University of Medicine and Pharmacy,   Iaşi, Romania; 3Department of  Dermatology, Victor Babeş University  of Medicine and Pharmacy, Timişoara,   romania Correspondence: Liliana Foia   surgical Department, Grigore T Popa  University of Medicine and Pharmacy,   16 Universitatii Street, Iaşi 700115,  romania   email lilifoia@yahoo.co.u kBackground:  The factitious disorders, more commonly known in daily practice as pathomimia,  are expressed in dermatology units by skin lesions induced voluntarily by the patient, in order to  draw attention of the medical staff and/or the family members.",Non-OADS,/arxiv_data1/oa_pdf/a5/a3/cia-9-421.PMC3958542.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/a5/a3/cia-9-421.PMC3958542.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/a3/cia-9-421.PMC3958542.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/f3/ijwh-6-301.PMC3958543.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 301–305International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  301OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJWH.S5614 7Maternal and perinatal outcomes of delivery after  a previous cesarean section in enugu, southeast  nigeria: a prospective observational study   george O Ugwu1 chukwuemeka a Iyoke1 Hyacinth e Onah1 Vincent e egwuatu2 Frank O ezugwu2 1Department of Obstetrics and  gynaecology, University of nigeria  T eaching Hospital (Un TH), Ituku- Ozalla, enugu, nigeria; 2Department  of Obstetrics and gynaecology, enugu  state University Teaching Hospital  (esUTH), Parklane, enugu, nigeria correspondence: george O Ugwu   Department of Obstetrics and   gynaecology, University of nigeria   Teaching Hospital, Ituku-Ozalla, PMB   01129, enugu, enugu state, nigeria   Tel +234 803 565 3435   email ugwugeo@yahoo.co mBackground:  Obstetricians in developing countries appear generally reluctant to conduct  vaginal delivery in women with a previous Cesarean because of lack of adequate facilities for  optimal fetomaternal monitoring.",Non-OADS,/arxiv_data1/oa_pdf/fd/f3/ijwh-6-301.PMC3958543.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/fd/f3/ijwh-6-301.PMC3958543.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/f3/ijwh-6-301.PMC3958543.pdf
"Available from:  http://www.rcog.org.uk/files/rcog-corp/GTG4511022011.pd f. Accessed  August 13, 2013.",OADS,/arxiv_data1/oa_pdf/fd/f3/ijwh-6-301.PMC3958543.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8b/13/ijn-9-1379.PMC3958544.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1379–1391International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1379ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5262 5Cytotoxicity and genotoxicity caused by yttrium  oxide nanoparticles in HEK293 cells Vellaisamy Selvaraj1 Sravanthi Bodapati1 Elizabeth Murray2 Kevin M Rice1 Nicole Winston1,3 T olou Shokuhfar4 Yu Zhao4 Eric Blough1,3,5 1Center for Diagnostic Nanosystems,   2Department of Integrated Science  and T echnology, 3Department  of Pharmaceutical Sciences and  Research, School of Pharmacy,   Marshall University, Huntington, WV,   USA; 4Department of Mechanical  Engineering and Engineering  Mechanics, Michigan T echnological  University, Houghton, MI, USA;   5Department of Pharmacology,   Physiology and T oxicology, School  of Medicine, Marshall University,   Huntington, WV, USA Correspondence: Eric Blough   Center for Diagnostic Nanosystems,  Room 241 N, Robert C Byrd  Biotechnology Science Center,   1700 Third Avenue, Marshall University,  Huntington, WV 25755-1090, USA   Tel +1 304 696 2708   Fax +1 304 696 3766   Email blough@marshall.ed uBackground:  The increased use of engineered nanoparticles (NPs) has caused new concerns  about the potential exposure to biological systems and the potential risk that these materials may  pose on human health.",Non-OADS,/arxiv_data1/oa_pdf/8b/13/ijn-9-1379.PMC3958544.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/8b/13/ijn-9-1379.PMC3958544.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/13/ijn-9-1379.PMC3958544.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/9c/ijn-9-1403.PMC3958545.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1403–1412International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1403OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S5915 1Detection of haplotype mutations of the MD-2  gene promoter associated with Der p2-induced  allergy using a nanostructured biosensor Yu-Ting chin1 en-chih liao2 chia-che Wu1 gou-Jen Wang1,3,4 Jaw-Ji Tsai2 1Department of Mechanical  engineering, National chung-hsing  University, 2Department of Medical  education and research, Taichung  Veterans general hospital, 3graduate  Institute of Biomedical engineering,   4PhD Program in Tissue engineering  and regenerative Medicine, National  chung-hsing University, Taichung,   Taiwan correspondence: gou-Jen Wang   graduate Institute of Biomedical  engineering, National chung-hsing  University, 250 Kuo-Kuang road,  Taichung 402, Taiwan   Tel +88 64 2284 0725 ext 320   Fax +88 64 2287 7170   email gjwang@dragon.nchu.edu.t w    Jaw-Ji Tsai   Department of Medical education and  research, Taichung Veterans general  hospital, 1650 Taiwan Boulevard sect 4,  Taichung 40705, Taiwan   Tel +88 64 2359 2525 ext 4000   Fax +88 64 2359 2705   email jawji@vghtc.gov.t wAbstract : Group 2 allergens (Der p2) have been reported to be a major cause of the human  immune response to dust mite allergens.",Non-OADS,/arxiv_data1/oa_pdf/3c/9c/ijn-9-1403.PMC3958545.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3c/9c/ijn-9-1403.PMC3958545.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/9c/ijn-9-1403.PMC3958545.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/4f/opth-8-537.PMC3958546.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 537–542Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  537Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5562 3Choroidal neovascularization secondary   to Best’s vitelliform macular dystrophy   in two siblings of a Malay family Koh alisa-Victoria1 Tan Jin-Poi1 ismail shatriah1 embong Zunaina1 Nor Fariza Ngah2 1Department of Ophthalmology,   school of Medical sciences,   Universiti sains Malaysia, Kubang  Kerian, Kelantan, 2Department of  Ophthalmology, Hospital selayang,   Lebuhraya selayang-Kepong, Batu  Caves, selangor, Malaysia Correspondence: ismail shatriah   Department of Ophthalmology, school  of Medical sciences, Universiti sains  Malaysia, Kubang Kerian,   Kelantan 16150, Malaysia   email shatriah@kck.usm.m yAbstract:  Best’ s vitelliform macular dystrophy complicated with choroidal neovascularization  is rare in children.",Non-OADS,/arxiv_data1/oa_pdf/09/4f/opth-8-537.PMC3958546.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/09/4f/opth-8-537.PMC3958546.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/4f/opth-8-537.PMC3958546.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/51/ce-9-041.PMC3958547.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCore Evidence 2014:9 41–48Core Evidence Dove press submit your manuscript | www.dovepress.co m Dove press  41REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S3977 0Mavrilimumab: an evidence based review of its  potential in the treatment of rheumatoid arthritis Manuela Di Franco Maria Chiara Gerardi Bruno Lucchino Fabrizio Conti Reumatologia, Dipartimento di  Medicina Interna e Specialità Mediche,   Sapienza Università di Roma, Rome,   Italy Correspondence: Manuela Di Franco   Reumatologia, Dipartimento di   Medicina Interna e Specialità Mediche,   Sapienza Università di Roma, Viale del   Policlinico 155, 00161, Rome, Italy   Tel +39 06 4997 4639   Email manuela.difranco@uniroma1.i tAbstract:  Rheumatoid arthritis (RA) management has greatly improved with the development  of biologic disease modifying antirheumatic drugs, but a proportion of patients do not improve  despite the biologic drugs currently available.",Non-OADS,/arxiv_data1/oa_pdf/29/51/ce-9-041.PMC3958547.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01706926?,Non-OADS,/arxiv_data1/oa_pdf/29/51/ce-9-041.PMC3958547.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01712399?term = mavrilimumab&rank =3.,Non-OADS,/arxiv_data1/oa_pdf/29/51/ce-9-041.PMC3958547.pdf
Available from: http://clinicaltrials.gov/ct2/show/NC T01715896?term =mavrilimumab&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/29/51/ce-9-041.PMC3958547.pdf
Available from:  http://clinicaltrials.gov/ct2/show/NCT00995449?term =kb003&rank =2.,Non-OADS,/arxiv_data1/oa_pdf/29/51/ce-9-041.PMC3958547.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/29/51/ce-9-041.PMC3958547.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/51/ce-9-041.PMC3958547.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/aa/ijwh-6-281.PMC3958548.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:6 281–288International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  281ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IJWH.S5790 0Postmenopausal vaginal atrophy: evaluation   of treatment with local estrogen therapy Mary Jane Minkin1 Ricardo Maamari2 Suzanne Reiter3 1Department of Gynecology  and Reproductive Medicine, Yale  University School of Medicine , New  Haven, CT, USA; 2Novo Nordisk Inc.,   Plainsboro, NJ, USA; 3Mid-County  Health Center, Largo, FL, USA Correspondence: Mary Jane Minkin   Gynecology and Reproductive Medicine,  Yale University School of Medicine,   40 Temple Street, New Haven,   CT 06510, USA   Tel +1 203 789 2011   Fax +1 203 865 1708   Email mjm6@email.med.yale.ed uAbstract:  Postmenopausal vaginal atrophy, resulting from decreased estrogen production,  frequently requires treatment.",Non-OADS,/arxiv_data1/oa_pdf/c5/aa/ijwh-6-281.PMC3958548.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/c5/aa/ijwh-6-281.PMC3958548.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c5/aa/ijwh-6-281.PMC3958548.pdf
"Division of Neurosurgery, Department of Surgery, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong   Tel : +852-2255-3368,  Fax : +852-2818-4350,  E-mail : gilberto@hkucc.hku.hk • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 103-105, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.103 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/5e/28/jkns-55-103.PMC3958572.pdf
"Department of Neuroradiology, University Hospital of Zürich, 8091 Zürich, Switzerland  Tel : +41442558657,  Fax : +41442554504,  E-mail : Gerasimos.Baltsavias@usz.ch • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 106-109, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.106 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/2a/9b/jkns-55-106.PMC3958573.pdf
"Key Words :  Tarlov cysts · Laminectomy.Technical Note • Received : February 4, 2013  • Revised : June 5, 2013  • Accepted : January 10, 2014 • Address for reprints : Young-Jin Kim, M.D., Ph.D.  Department of Neurosurgery, Dankook University College of Medicine, 201 Manghyang-ro, Cheonan 330-714, Korea  Tel : +82-41-550-3979,  Fax : +82-41-552-6870,  E-mail : spine1225@naver.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 110-113, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.110 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/6b/c2/jkns-55-110.PMC3958574.pdf
"Department of Neurosurgery, Yeungnam University Medical Center, Yeungnam University School of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 705-703, Korea  Tel : +82-53-620-3790,  Fax : +82-53-620-3770,  E-mail : jyjns@yu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 69-72, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.69 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/20/6b/jkns-55-69.PMC3958575.pdf
"Key Words :  Fusion · Percutaneous · Removal.Clinical Article • Received : August 26, 2013  • Revised : November 26, 2013  • Accepted : January 10, 2014 • Address for reprints : Seok Won Kim, M.D., Ph.D.  Department of Neurosurgery, College of Medicine, Chosun University, 365 Pilmun-daero, Dong-gu, Gwangju 501-717, Korea  Tel : +82-62-220-3126,  Fax : +82-62-227-4575,  E-mail : chosunns@chosun.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 73-77, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.73 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/ae/9e/jkns-55-73.PMC3958576.pdf
"Key Words :  Carpal tunnel syndrome · Ultrasonography · Diagnosis · Severity.Clinical Article • Received : June 22, 2013  • Revised : December 18, 2013  • Accepted : January 15, 2014 • Address for reprints : Se-Hyuck Park, M.D., Ph.D.  Department of Neurosurgery, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, 150 Seongan-ro, Gangdong-gu, Seoul 134-701, Korea   Tel : +82-2-2224-2236,  Fax : +82-2-473-7387,  E-mail : sehyuck@hallym.or.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 78-82, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.78 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/03/4d/jkns-55-78.PMC3958577.pdf
"Key Words :  Restless legs syndrome · Spinal stenosis · Lumbar disc herniation · Insomnia · Pramipexole · Pregabalin.Clinical Article • Received : September 2, 2013  • Revised : November 19, 2013  • Accepted : January 10, 2014 • Address for reprints : Yong Jun Cho, M.D., Ph.D.  Department of Neurosurgery, Chuncheon Sacred Heart Hospital, Hallym University Medical Center, Hallym University College of Medicine, 77 Sakju-ro, Chuncheon 200-704,     Korea  Tel : +82-33-240-5173,  Fax : +82-33-242-9970,  E-mail : nssur771@hallym.or.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 83-88, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.83 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/c8/5a/jkns-55-83.PMC3958578.pdf
"Department of Neurosurgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan  Tel : +81-4-2995-1656,  Fax : +81-4-2996-5207,  E-mail : s.takeuchi@room.ocn.ne.jp • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 89-91, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.89 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr Fig.",Non-OADS,/arxiv_data1/oa_pdf/f5/cd/jkns-55-89.PMC3958579.pdf
"Key Words :  Carotid-cavernous fistula · Ehler-Danlos syndrome · Transvenous embolization.Case Report • Received : January 15, 2013  • Revised : July 17, 2013  • Accepted : January 10, 2014 • Address for reprints : Hyun-Seung Kang, M.D., Ph.D.  Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea  Tel : +82-2-2072-1351,  Fax : +82-2-744-8459,  E-mail : hsk4428@yahoo.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 92-95, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.92 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/eb/be/jkns-55-92.PMC3958580.pdf
"Available at : http://www.hgmd.cf.ac.uk/ac/gene.php?gene=COL3A1over, they allow the use of smaller delivery devices for insertion  and exert less pressure on the CS and ICA than balloons do.",Non-OADS,/arxiv_data1/oa_pdf/eb/be/jkns-55-92.PMC3958580.pdf
"Department of Neurosurgery, Daejeon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 64 Daeheung-ro, Jung-gu, Daejeon 301-723, Korea   Tel : +82-42-220-9525,  Fax : +82-42-222-6601,  E-mail : hyungjin@catholic.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 96-98, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.96 Copyright © 2014 The Korean Neurosurgical Society  Print  ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/19/60/jkns-55-96.PMC3958581.pdf
"Case Report • Received : October 11, 2013  • Revised : January 11, 2014  • Accepted : January 15, 2014 • Address for reprints : Chang Hwa Choi, M.D., Ph.D.  Department of Neurosurgery, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 602-739, Korea   Tel : +82-51-240-7257,  Fax : +82-51-244-0282,  E-mail : chwachoi@pusan.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 55  : 99-102, 2014http://dx.doi.org/10.3340/jkns.2014.55.2.99 Copyright © 2014 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/2a/db/jkns-55-99.PMC3958582.pdf
"Black  coat color was used to identify WDB (A rat strain “BLK” which we  described in previous papers [14, 20, 21] has been renamed “WDB/Nips” and registered to Rat Genome Database, http://rgd.mcw.edu/wg/home, with the RGD ID 7411634).",Non-OADS,/arxiv_data1/oa_pdf/1f/58/jrd-60-078.PMC3958585.pdf
"Statistics Data regarding the outgrowth rate and the establishment efficiency  at P5 were analyzed by Fisher’s exact probability test using js-STAR 2012, a program available online (http://www.physics.csbsju.edu/stats/Index.html).",OADS,/arxiv_data1/oa_pdf/1f/58/jrd-60-078.PMC3958585.pdf
"The mechanical shear force stimulates endothelial protein ac-Original Article http://dx.doi.org/10.4070/kcj.2014.44.2.105 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Nitric Oxide Synthase Inhibition Attenuates Cardiac Response  to Hemodilution with Viscogenic Plasma Expander Surapong Chatpun, PhD1 and Pedro Cabrales, PhD2 1Institute of Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand  2Department of Bioengineering, University of California, San Diego, CA, USA Background and Objectives: Increased vascular wall shear stress by elevated plasma viscosity significantly enhances the endothelial ni- tric oxide synthase (eNOS) activity during an acute isovolemic hemodilution.",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/kcj-44-105.PMC3958604.pdf
"Received: October 22, 2013 Revision Received: January 2, 2014Accepted: January 13, 2014 Correspondence: Surapong Chatpun, PhD, Institute of Biomedical Engi- neering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, ThailandTel: 66-7445-1743, Fax: 66-7445-1744E-mail: surapong.c@psu.ac.th • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tivities including nitric oxide synthesis (NOS) by endothelial nitric  oxide synthase (eNOS).1)2) Nitric oxide (NO) is an important mediator  that has various physiological functions such as vascular tone reg-ulation, platelet activation prevention, vascular smooth muscle pro - liferation inhibition and myocardial contractility regulation.",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/kcj-44-105.PMC3958604.pdf
106 NOS Inhibition on Cardiac Function during Acute Anemia http://dx.doi.org/10.4070/kcj.2014.44.2.105 www.e-kcj.org concert with the increased aortic eNOS protein expression during  extreme hemodilution.,Non-OADS,/arxiv_data1/oa_pdf/0b/3e/kcj-44-105.PMC3958604.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.105 www.e-kcj.org Cardiac function The closed-chest method was used to assess cardiac function.18)  Briefly, the right common carotid artery was exposed allowing to  insert a 1.4 Fr PV conductance catheter (PV catheter; SPR-839, Mil - lar Instruments, Houston, TX, USA).",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/kcj-44-105.PMC3958604.pdf
"108 NOS Inhibition on Cardiac Function during Acute Anemia http://dx.doi.org/10.4070/kcj.2014.44.2.105 www.e-kcj.org All of the statistics were performed using GraphPad Prism 5.04  (GraphPad Software, San Diego, CA, USA).",OADS,/arxiv_data1/oa_pdf/0b/3e/kcj-44-105.PMC3958604.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.105 www.e-kcj.org NAME had a higher LV pressure than the animals hemodiluted with  HVPE only, especially at 15 minutes after hemodilution.",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/kcj-44-105.PMC3958604.pdf
"110 NOS Inhibition on Cardiac Function during Acute Anemia http://dx.doi.org/10.4070/kcj.2014.44.2.105 www.e-kcj.org As L-NAME significantly increased MAP and reduced CO, the  treated group presented a higher systemic vascular resistance (SVR)  compared to the control group (p<0.05) as presented in Fig.",Non-OADS,/arxiv_data1/oa_pdf/0b/3e/kcj-44-105.PMC3958604.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.105 www.e-kcj.org strated a slight decrease in HR after hemodilution.,Non-OADS,/arxiv_data1/oa_pdf/0b/3e/kcj-44-105.PMC3958604.pdf
112 NOS Inhibition on Cardiac Function during Acute Anemia http://dx.doi.org/10.4070/kcj.2014.44.2.105 www.e-kcj.org 93:13176-81.,Non-OADS,/arxiv_data1/oa_pdf/0b/3e/kcj-44-105.PMC3958604.pdf
"Though not advocated by the standard practice guidelines, these very elderly patients are often treated half-heartedly, and an invasive strategy is often avoided in Case Report http://dx.doi.org/10.4070/kcj.2014.44.2.113 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Unprotected Left Main Percutaneous Coronary Intervention  in a 108-Year-Old Patient Afzalur Rahman, MD and AKM Monwarul Islam, MD Department of Cardiology, National Institute of Cardiovascular Diseases, Dhaka, Bangladesh With the increase in life expectancy, the proportion of very elderly people is increasing.",Non-OADS,/arxiv_data1/oa_pdf/bf/b6/kcj-44-113.PMC3958605.pdf
"Received: August 8, 2013 Revision Received: September 26, 2013Accepted: October 1, 2013 Correspondence: AKM Monwarul Islam, MD, Department of Cardiology, Na - tional Institute of Cardiovascular Diseases, Dhaka 1207, BangladeshTel: 8801712564487, Fax: 8802-8142986E-mail: drmonwarbd@yahoo.com • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.them.",Non-OADS,/arxiv_data1/oa_pdf/bf/b6/kcj-44-113.PMC3958605.pdf
"114 Unprotected Left Main PCI http://dx.doi.org/10.4070/kcj.2014.44.2.113 www.e-kcj.org pain; there was triple vessel disease with involvement of the left  main coronary artery (LMCA); there was 75% stenosis in the distal LMCA, 95% stenosis in the proximal segment and 75% stenosis in the mid segments of the left anterior descending (LAD) artery, 75% osteo-proximal and 90% distal stenosis in the left circumflex (LCX) artery, and total occlusion of the right coronary artery from the ori - gin (Fig.",Non-OADS,/arxiv_data1/oa_pdf/bf/b6/kcj-44-113.PMC3958605.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.113 www.e-kcj.org echocardiography revealed improvement in regional left ventricular  wall motion, with an ejection fraction of 58%, and the troponin I was negative (0.1 18 ng/mL).",Non-OADS,/arxiv_data1/oa_pdf/bf/b6/kcj-44-113.PMC3958605.pdf
116 Unprotected Left Main PCI http://dx.doi.org/10.4070/kcj.2014.44.2.113 www.e-kcj.org plex coronary lesions.,Non-OADS,/arxiv_data1/oa_pdf/bf/b6/kcj-44-113.PMC3958605.pdf
Available from: http://www.ons.gov.uk/ons/dcp171778_303741.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/b6/kcj-44-113.PMC3958605.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.113 www.e-kcj.org pared with bare-metal coronary stents among elderly patients.,Non-OADS,/arxiv_data1/oa_pdf/bf/b6/kcj-44-113.PMC3958605.pdf
"4) Case Report http://dx.doi.org/10.4070/kcj.2014.44.2.118 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Transvenous Pacemaker Lead Removal in Pacemaker Lead Endocarditis with Large Vegetations: A Report of Two Cases Hyunsoo Cho, MD, Mihyun Kim, MD, Jae-Sun Uhm, MD, Hui-Nam Pak, MD,  Moon-Hyoung Lee, MD, and Boyoung Joung, MD Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Pacemaker lead endocarditis is treated with total removal of the infected device and proper antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/b2/9f/kcj-44-118.PMC3958606.pdf
"Received: July 11, 2013 Revision Received: September 15, 2013Accepted: October 5, 2013 Correspondence: Boyoung Joung, MD, Divison of Cardiology, Severance  Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yon-sei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: 82-2-2228-8460, Fax: 82-2-393-2041E-mail: cby6908@yuhs.ac • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.We present two patients with pacemaker lead endocarditis with  large vegetations (>2 cm).",Non-OADS,/arxiv_data1/oa_pdf/b2/9f/kcj-44-118.PMC3958606.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.118 www.e-kcj.org three separate sets of blood cultures were collected and later re- vealed methicillin-resistant, Staphylococcus aureus.",Non-OADS,/arxiv_data1/oa_pdf/b2/9f/kcj-44-118.PMC3958606.pdf
120 Transvenous Removal of Infected Pacemaker Leads http://dx.doi.org/10.4070/kcj.2014.44.2.118 www.e-kcj.org calis until day 18.,Non-OADS,/arxiv_data1/oa_pdf/b2/9f/kcj-44-118.PMC3958606.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.118 www.e-kcj.org rate.6) A variety of percutaneous lead-removal techniques are avail - able, and only a small minority of patients require open cardiovas- cular surgery for complete device removal.7) Although there has been  no study comparing transvenous and surgical removal of leads in large vegetation pacemaker endocarditis, removal via open thora-cotomy has been advocated for leads with large vegetations due to the possibility of dislodging emboli.",Non-OADS,/arxiv_data1/oa_pdf/b2/9f/kcj-44-118.PMC3958606.pdf
"This Case Report http://dx.doi.org/10.4070/kcj.2014.44.2.122 Print ISSN 1738-5520 • On-line ISSN 1738-5555 A Case of Sudden Cardiac Death due to Pilsicainide-Induced  Torsades de Pointes Shimpei Nakatani, MD, Masayuki Taniike, MD, Nobuhiko Makino, MD, Yasuyuki Egami, MD,  Ryu Shutta, MD, Jun Tanouchi, MD, and Masami Nishino, MD Division of Cardiology, Osaka Rosai Hospital, Osaka, Japan An 84-year-old male received oral pilsicainide, a pure sodium channel blocker with slow recovery kinetics, to convert his paroxysmal atrial  fibrillation to a sinus rhythm; the patient developed sudden cardiac death two days later.",Non-OADS,/arxiv_data1/oa_pdf/2f/29/kcj-44-122.PMC3958607.pdf
"Received: July 20, 2013 Revision Received: September 3, 2013Accepted: October 15, 2013 Correspondence: Masami Nishino, MD, Division of Cardiology, Osaka Ro- sai Hospital, 1179-3, Nagasone-cho, Sakai-city, Osaka 591-8025, JapanTel: 81-72-252-3561, Fax: 81-72-250-5492E-mail: mnishino@orh.go.jp • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.case may present a concern about the proarrhythmic effects of an  oral pilsicainide for treatment of atrial fibrillation in octogenarian patients.",Non-OADS,/arxiv_data1/oa_pdf/2f/29/kcj-44-122.PMC3958607.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.122 www.e-kcj.org ed anticoagulant treatment with warfarin but did not receive any  other drugs, including any other antiarrhythmic drugs.",Non-OADS,/arxiv_data1/oa_pdf/2f/29/kcj-44-122.PMC3958607.pdf
"124 Sudden Death by Pilsicainide http://dx.doi.org/10.4070/kcj.2014.44.2.122 www.e-kcj.org drug after myocardial infarction was reported in the Cardiac Arrhyth - mia Suppression Trial study;4) however, it is unknown whether pilsi - cainide also increases the rate of sudden death for patients with atri - al fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/2f/29/kcj-44-122.PMC3958607.pdf
"Case A 48-year-old woman presented with exertional angina and pal-Case Report http://dx.doi.org/10.4070/kcj.2014.44.2.125 Print ISSN 1738-5520 • On-line ISSN 1738-5555 An Unusual Pattern of All Three Coronary Arteries Originating from  a Single Coronary Artery Arising from the Right Sinus of Valsalva Isa Oner Yuksel, MD, Sakir Arslan, MD, Nermin Bayar, MD, Selcuk Kucukseymen, MD, Erkan Koklu, MD, and Bekir Erol, MD Antalya Education and Research Hospital, Antalya, Turkey Anomalous origin of coronary arteries is generally asymptomatic and a rare disease.",Non-OADS,/arxiv_data1/oa_pdf/a7/9f/kcj-44-125.PMC3958608.pdf
"Received: May 11, 2013 Revision Received: June 25, 2013Accepted: September 26, 2013 Correspondence: Isa Oner Yuksel, MD, Antalya Education and Research  Hospital, Antalya 07030, TurkeyTel: 90 2422494400, Fax: 90 2422494462E-mail: drisayuksel2@hotmail.com • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pitations for a long time.",Non-OADS,/arxiv_data1/oa_pdf/a7/9f/kcj-44-125.PMC3958608.pdf
126 Single Coronary Artery from Right Sinus of Valsalva http://dx.doi.org/10.4070/kcj.2014.44.2.125 www.e-kcj.org cording to studies.,Non-OADS,/arxiv_data1/oa_pdf/a7/9f/kcj-44-125.PMC3958608.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.125 www.e-kcj.org studies in the Asturias Principality: main angiographic and clinical  characteristics].,Non-OADS,/arxiv_data1/oa_pdf/a7/9f/kcj-44-125.PMC3958608.pdf
"Images in Cardiovascular Medicine http://dx.doi.org/10.4070/kcj.2014.44.2.128 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Balloon Valvuloplasty for Bioprosthetic Tricuspid Valve Stenosis Emmanouil Petrou, MD, Vasiliki Vartela, MD, Chrysafios Girasis, MD,  Maria Boutsikou, MD, Ioannis Iakovou, MD, and Gregory Pavlides, MD Cardiology Department, Onassis Cardiac Surgery Center, Athens, Greece Received: July 29, 2013 / Revision Received: September 3, 2013 / Accepted: October 8, 2013 Correspondence: Emmanouil Petrou, MD, Cardiology Department, Onassis Cardiac Surgery Center, 356 Sygrou Ave., GR-17674, Kallithea-Athens, Greece Tel: 306945112509, Fax: 302102751028, E-mail: emmgpetrou@hotmail.com • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.On admission, the patient was on atrial fibrillation and physical ex - amination was compatible with right heart failure.",Non-OADS,/arxiv_data1/oa_pdf/af/0f/kcj-44-128.PMC3958609.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.128 www.e-kcj.orgFig.,OADS,/arxiv_data1/oa_pdf/af/0f/kcj-44-128.PMC3958609.pdf
"De-spite corrective or palliative repair of congenital heart lesions, the right ventricle, which may be the subpulmonary or systemic ventricular Review http://dx.doi.org/10.4070/kcj.2014.44.2.59 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Functional Assessment for Congenital Heart Disease Yiu-fai Cheung, MD Division of Paediatric Cardiology, Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China Significant improvement in survival of children with congenital cardiac malformations has resulted in an increasing population of adoles - cent and adult patients with congenital heart disease.",Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
"Correspondence: Yiu-fai Cheung, MD, Division of Paediatric Cardiology,  Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital,  The University of Hong Kong, 102 Pokfulam Road, Hong Kong, ChinaTel: 852-22554090, Fax: 852-25539491E-mail: xfcheung@hku.hk • The author has no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.chamber, and the functional single ventricle are particularly vulner - able to functional impairment.",Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
"60 Functional Assessment for CHD http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org repair of tetralogy of Fallot (TOF), as the pulmonary valve annulus  is usually small.",Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
61 Yiu-fai Cheung http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org unfavourable ventricular-ventricular interactions are discussed be- low.,Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
62 Functional Assessment for CHD http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org diastolic flow in the pulmonary artery coincident with atrial systole  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
"63 Yiu-fai Cheung http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org during myocardial acceleration (IVA), can be calculated as the differ - ence between peak and baseline myocardial velocities divided by the  time interval from onset of the wave during isovolumic contrac-tion at zero-crossing to the time at peak velocity.",OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
"64 Functional Assessment for CHD http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org frame rate of 40 to 80 per second provides spatial and temporal in- formation for quantification of strain, strain rate, and ventricular twist and torsion.",OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
65 Yiu-fai Cheung http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org the LV segments (Fig.,Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
"66 Functional Assessment for CHD http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org cardiographic study showed that reduced septal curvature is relat- ed to impairment of LV 3D systolic strain, mechanical dyssynchro-ny, and reduced ventricular torsion in repaired TOF patients with and without pulmonary valve replacement.",Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
"67 Yiu-fai Cheung http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org paired TOF, improvement in RV free wall strain has been noted.91)  Transcatheter pulmonary valve replacement in patients with repaired  TOF and other congenital heart diseases has also resulted in im-provement of LV circumferential and longitudinal strain and longi-tudinal dyssynchrony.",Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
68 Functional Assessment for CHD http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org fraction.,OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
"69 Yiu-fai Cheung http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org demonstrated using 2D speckle tracking echocardiography reduc- tion of global systemic LV longitudinal, circumferential, and radial strain.",OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
"70 Functional Assessment for CHD http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org 631-9, vii.",Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
71 Yiu-fai Cheung http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org 420-4.,Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
72 Functional Assessment for CHD http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org 68.,Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
73 Yiu-fai Cheung http://dx.doi.org/10.4070/kcj.2014.44.2.59 www.e-kcj.org with complete transposition after atrial repair.,Non-OADS,/arxiv_data1/oa_pdf/c3/44/kcj-44-59.PMC3958610.pdf
"ET-2 mainly expressed in the kidney and ET-3 in the brain and intes -Editorial http://dx.doi.org/10.4070/kcj.2014.44.2.74 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Beyond Vasodilator: Anti-Apoptotic Effect  of Endothelin Receptor Antagonist Sung-A Chang, MD Division of Cardiology, Department of Medicine, Cardiovascular Imaging Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Correspondence: Sung-A Chang, MD, Division of Cardiology, Department  of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, KoreaTel: 82-2-3410-1679, Fax: 82-2-3410-3849E-mail: sunga.chang@samsung.com • The author has no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tine.3) ET is secreted from the abluminal side of the cells towards the  adjacent vascular smooth muscle cells.",Non-OADS,/arxiv_data1/oa_pdf/92/e5/kcj-44-74.PMC3958611.pdf
75 Sung-A Chang http://dx.doi.org/10.4070/kcj.2014.44.2.74  www.e-kcj.orgcin-induced cardiomyopathy in a mouse model.,Non-OADS,/arxiv_data1/oa_pdf/92/e5/kcj-44-74.PMC3958611.pdf
"76 Copyright © 2014 The Korean Society of CardiologyKorean Circulation Journal Introduction The benefits of statin in the primary and secondary prevention  for coronary artery diseases are well established.1-5) Clinical studies Original Article http://dx.doi.org/10.4070/kcj.2014.44.2.76 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Effect of High Dose Rosuvastatin Loading before Primary  Percutaneous Coronary Intervention on Infarct Size in Patients  with ST-Segment Elevation Myocardial Infarction Ji Won Kim, MD, Kyeong Ho Yun, MD, Eun Kyoung Kim, MD, Yong Cheol Kim, MD, Dai-Yeol Joe, MD, Jum Suk Ko, MD, Sang Jae Rhee, MD, Eun Mi Lee, MD, Nam Jin Yoo, MD, Nam-Ho Kim, MD, Seok Kyu Oh, MD, and Jin-Won Jeong, MD Department of Cardiovascular Medicine, Regional Cardiocerebrovascular Center, Wonkwang University Hospital, Iksan, Korea Background and Objectives: High dose rosuvastatin loading before percutaneous coronary interventions (PCI) reduces the myocardial  damage and the incidence of adverse cardiac events in patients with stable angina and acute coronary syndrome.",Non-OADS,/arxiv_data1/oa_pdf/d2/ab/kcj-44-76.PMC3958612.pdf
"Received: November 12, 2013 Revision Received: December 13, 2013Accepted: December 30, 2013 Correspondence: Kyeong Ho Yun, MD, Department of Cardiovascular  Medicine, Regional Cardiocerebrovascular Center, Wonkwang University Hospital, 895 Muwang-ro, Iksan 570-711, KoreaTel: 82-63-859-2524, Fax: 82-63-852-8480E-mail: dryunkh@gmail.com • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.showed in the era of percutaneous coronary intervention (PCI) a  high dose statin loading before a PCI may improve the clinical out - comes in patients with stable angina and acute coronary syndrome (ACS) with a reduction of periprocedural myocardial damage.",Non-OADS,/arxiv_data1/oa_pdf/d2/ab/kcj-44-76.PMC3958612.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.76 www.e-kcj.org of High-Dose AtorvaSTATIN Loading Before Primary PCI in ST-Ele- vation Myocardial Infarction (STATIN STEMI) trial demonstrated a 80 mg atorvastatin loading improved the coronary flow and perfu-sion after primary PCI.,Non-OADS,/arxiv_data1/oa_pdf/d2/ab/kcj-44-76.PMC3958612.pdf
78 High Dose Statin Loading in STEMI http://dx.doi.org/10.4070/kcj.2014.44.2.76 www.e-kcj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/d2/ab/kcj-44-76.PMC3958612.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.76 www.e-kcj.org significant univariate analysis following variables were selected and  inserted into the logistic regression analysis: rosuvastatin loading, pain to balloon time, anterior infarction, angiographic slow flow and final MBG.",OADS,/arxiv_data1/oa_pdf/d2/ab/kcj-44-76.PMC3958612.pdf
"80 High Dose Statin Loading in STEMI http://dx.doi.org/10.4070/kcj.2014.44.2.76 www.e-kcj.org pain to balloon time >210 minutes (OR=2.05; 95% CI=1.38-3.05; p<  0.001), anterior infarction (OR=3.89; 95% CI=2.56-5.91; p<0.001) and MBG <3 (OR=2.93; 95% CI=1.92-4.48; p<0.001) were indepen - dent predictors of the large (>18%) infarct size (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/d2/ab/kcj-44-76.PMC3958612.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.76 www.e-kcj.org the plaque stability.,Non-OADS,/arxiv_data1/oa_pdf/d2/ab/kcj-44-76.PMC3958612.pdf
"82 Copyright © 2014 The Korean Society of CardiologyKorean Circulation Journal Introduction Dual antiplatelet therapy with aspirin and P2Y 12 receptor blockers  is recommended for reducing ischemic events in patients with acute Original Article http://dx.doi.org/10.4070/kcj.2014.44.2.82 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Randomized Comparison of the Platelet Inhibitory Efficacy between Low Dose Prasugrel and Standard Dose Clopidogrel in Patients  Who Underwent Percutaneous Coronary Intervention Han-Young Jin, MD, Tae-Hyun Yang, MD, Kyu-Nam Choi, MD, Jeong-Sook Seo, MD,  Jae-Sik Jang, MD, Dae-Kyeong Kim, MD, and Dong-Soo Kim, MD Division of Cardiology, Department of Internal Medicine, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea Background and Objectives: Increased bleeding rates with standard dose prasugrel have led to increased questions about the effective- ness and safety of the lower maintenance dose.",Non-OADS,/arxiv_data1/oa_pdf/de/93/kcj-44-82.PMC3958613.pdf
"Received: November 1, 2013 Revision Received: January 9, 2014Accepted: January 16, 2014 Correspondence: Tae-Hyun Yang, MD, Division of Cardiology, Department  of Internal Medicine, Inje University College of Medicine, Busan Paik Hos-pital, 75 Bokji-ro, Busanjin-gu, Busan 614-735, KoreaTel: 82-51-890-6403, Fax: 82-51-892-0273E-mail: yangthmd@naver.com • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.coronary syndrome (ACS) who are undergoing percutaneous coro- nary intervention (PCI).1)2) However, many studies have demonstrat - ed wide inter-individual variability in the platelet response to clopi-dogrel.",Non-OADS,/arxiv_data1/oa_pdf/de/93/kcj-44-82.PMC3958613.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.82 www.e-kcj.org codynamic study showed that 5 mg prasugrel was not inferior to 10  mg prasugrel in patients ≥75 years old or weighing <60 kg, in which  the lower dose prasugrel was considered to reduce the rate of hem - orrhagic complications.14)15) However, pharmacodynamic effects of  5 mg prasugrel in heavier weight and younger patients who under - went percutaneous coronary stent implantation are unknown.",Non-OADS,/arxiv_data1/oa_pdf/de/93/kcj-44-82.PMC3958613.pdf
"84 Comparison of Low Dose Prasugrel and Standard Dose Clopidogrel http://dx.doi.org/10.4070/kcj.2014.44.2.82 www.e-kcj.org gregation in response to ADP, BASE, and percent inhibition.16) The per- cent platelet inhibition is calculated as: {(BASE-PRU)/BASE }×100.",OADS,/arxiv_data1/oa_pdf/de/93/kcj-44-82.PMC3958613.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.82 www.e-kcj.org ferent among the three groups.,OADS,/arxiv_data1/oa_pdf/de/93/kcj-44-82.PMC3958613.pdf
86 Comparison of Low Dose Prasugrel and Standard Dose Clopidogrel http://dx.doi.org/10.4070/kcj.2014.44.2.82 www.e-kcj.org Discussion The present randomized study is the first to assess the platelet  inhibitory efficacy of a lower maintenance dose (5 mg daily) of pra - sugrel compared with a standard dose of clopidogrel and 10 mg  prasugrel in patients <75 years and ≥60 kg who underwent PCI.,Non-OADS,/arxiv_data1/oa_pdf/de/93/kcj-44-82.PMC3958613.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.82 www.e-kcj.org years old) with low body weight (<60 kg) and in elderly patients ( ≥75  years) with non-low body weight.,Non-OADS,/arxiv_data1/oa_pdf/de/93/kcj-44-82.PMC3958613.pdf
88 Comparison of Low Dose Prasugrel and Standard Dose Clopidogrel http://dx.doi.org/10.4070/kcj.2014.44.2.82 www.e-kcj.org clopidogrel loading doses on platelet function: magnitude of platelet  inhibition is related to active metabolite formation.,Non-OADS,/arxiv_data1/oa_pdf/de/93/kcj-44-82.PMC3958613.pdf
"89 Copyright © 2014 The Korean Society of CardiologyKorean Circulation Journal Introduction Pheochromocytoma is a rare catecholamine-producing tumor  with a highly variable clinical presentation.1) Pheochromocytoma  presentation may include numerous cardiovascular manifestations  and is usually identified with prevalent cardiac manifestations or Original Article http://dx.doi.org/10.4070/kcj.2014.44.2.89 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Impact of Pheochromocytoma on Left Ventricular Hypertrophy and QTc Prolongation: Comparison with Takotsubo Cardiomyopathy Seon Yoon Choi, MD, Kyoung Im Cho, MD, You Jin Han, MD, Ga In You, MD, Je Hun Kim, MD,  Jeong Ho Heo, MD, Hyun Soo Kim, MD, Tae Joon Cha, MD, and Jae Woo Lee, MD Cardiovascular Research Institute, Kosin University School of Medicine, Busan, Korea Background and Objectives: Excessive catecholamine causes the alteration of cardiac structure and function.",Non-OADS,/arxiv_data1/oa_pdf/68/19/kcj-44-89.PMC3958614.pdf
"Received: August 20, 2013 Revision Received: October 31, 2013Accepted: January 23, 2014 Correspondence: Kyoung Im Cho, MD, Cardiovascular Research Institute,  Kosin University School of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 602-702, KoreaTel: 82-51-990-6105, Fax: 82-51-990-3005E-mail: kyoungim74@gmail.com • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.paroxysmal hypertension associated with other signs and symp- toms of catecholamine excess.2)3) Although sinus tachycardia with  palpitations is the most prevalent cardiac rhythm abnormality, pheochromocytoma can induce more serious arrhythmias or con-duction disturbances, such as prolongation of the QTc interval and ventricular tachycardia followed by cardiac arrest.",Non-OADS,/arxiv_data1/oa_pdf/68/19/kcj-44-89.PMC3958614.pdf
"90 LVH, QTc Prolongation and Pheochromocytoma http://dx.doi.org/10.4070/kcj.2014.44.2.89 www.e-kcj.org are usually normal in pheochromocytoma; therefore, the difference  in QTc interval prolongation between pheochromocytoma and TC is not evaluated.",Non-OADS,/arxiv_data1/oa_pdf/68/19/kcj-44-89.PMC3958614.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.89 www.e-kcj.org LVH with increased RWT (>0.43).,OADS,/arxiv_data1/oa_pdf/68/19/kcj-44-89.PMC3958614.pdf
"92 LVH, QTc Prolongation and Pheochromocytoma http://dx.doi.org/10.4070/kcj.2014.44.2.89 www.e-kcj.org none of the patients had significant stenotic lesions in their coro- nary arteries.",Non-OADS,/arxiv_data1/oa_pdf/68/19/kcj-44-89.PMC3958614.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.89 www.e-kcj.org er in men (pheochromocytoma: male 50%, female 40%; TC: male  100%, female; 31%).",Non-OADS,/arxiv_data1/oa_pdf/68/19/kcj-44-89.PMC3958614.pdf
"94 LVH, QTc Prolongation and Pheochromocytoma http://dx.doi.org/10.4070/kcj.2014.44.2.89 www.e-kcj.org synergistic partner with arterial hypertension in the pathogenesis  of cardiac hypertrophy, even with a transient surge, which might be attenuated by estrogen.",Non-OADS,/arxiv_data1/oa_pdf/68/19/kcj-44-89.PMC3958614.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.89 www.e-kcj.org amines to receptors may be more important than their passage  through the circulation to induce LVH.,Non-OADS,/arxiv_data1/oa_pdf/68/19/kcj-44-89.PMC3958614.pdf
"96 LVH, QTc Prolongation and Pheochromocytoma http://dx.doi.org/10.4070/kcj.2014.44.2.89 www.e-kcj.org clinical meaning of the study.",Non-OADS,/arxiv_data1/oa_pdf/68/19/kcj-44-89.PMC3958614.pdf
"PAH is associated with sig - nificant morbidity and mortality.1) Elevated pulmonary vascular re- sistance results in high right ventricular systolic pressures causing  right ventricular remodeling, ultimately progressing to heart failure.Original Article http://dx.doi.org/10.4070/kcj.2014.44.2.97 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Apoptosis and Inflammation Associated Gene Expressions  in Monocrotaline-Induced Pulmonary Hypertensive  Rats after Bosentan Treatment Young Mi Hong, MD1,4, Jung Hyun Kwon, MD1, Shinkyu Choi, PhD2, and Kwan Chang Kim, MD3,4 1Departments of Pediatrics, 2Physiology, 3Thoracic & Cardiovascular Surgery, and 4Ewha Womans University Global Top 5 Research Program, Ewha Womans University  School of Medicine, Seoul, Korea Background and Objectives: Vascular wall remodeling in pulmonary hypertension can be caused by an aberration in the normal balance  between proliferation and apoptosis of endothelial cell in the pulmonary artery.",Non-OADS,/arxiv_data1/oa_pdf/ad/f1/kcj-44-97.PMC3958615.pdf
"Received: August 16, 2013 Revision Received: November 13, 2013Accepted: January 16, 2014 Correspondence: Kwan Chang Kim, MD, Department of Thoracic & Car- diovascular Surgery, Ewha Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, KoreaTel: 82-2-2650-2841, Fax: 82-2-2653-3718E-mail: mdkkchang@ewha.ac.kr • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Pulmonary arterial hypertension is a progressive and lethal dis- ease.",Non-OADS,/arxiv_data1/oa_pdf/ad/f1/kcj-44-97.PMC3958615.pdf
"98 Apoptosis Gene Expressions in Pulmonary Hypertension after Bosentan Treatment http://dx.doi.org/10.4070/kcj.2014.44.2.97 www.e-kcj.org pathway.4)  Recent studies in idiopathic PAH have implicated a failure of vas - cular smooth muscle apoptosis in the disease pathogenesis.6)7) How - ever, data about endothelial cell apoptosis and proliferation are rare  in idiopathic PAH.8) Other recent studies have suggested a role for  periarterial inflammatory cell mediators in the pathogenesis of PAH.",Non-OADS,/arxiv_data1/oa_pdf/ad/f1/kcj-44-97.PMC3958615.pdf
http://dx.doi.org/10.4070/kcj.2014.44.2.97 www.e-kcj.org Detection System (Fig.,OADS,/arxiv_data1/oa_pdf/ad/f1/kcj-44-97.PMC3958615.pdf
"100 Apoptosis Gene Expressions in Pulmonary Hypertension after Bosentan Treatment http://dx.doi.org/10.4070/kcj.2014.44.2.97 www.e-kcj.org B groups compared with the C group in week 4 (4.41 ±0.49 vs. 1 ±  0.30, p=0.023) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/ad/f1/kcj-44-97.PMC3958615.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.97 www.e-kcj.org Discussion This study provides evidence that MCT increases apoptosis and inflammation, and that bosentan improves apoptosis and inflamma - tion in a rat model of PAH.",Non-OADS,/arxiv_data1/oa_pdf/ad/f1/kcj-44-97.PMC3958615.pdf
102 Apoptosis Gene Expressions in Pulmonary Hypertension after Bosentan Treatment http://dx.doi.org/10.4070/kcj.2014.44.2.97 www.e-kcj.org with the C group in week 4.,Non-OADS,/arxiv_data1/oa_pdf/ad/f1/kcj-44-97.PMC3958615.pdf
"http://dx.doi.org/10.4070/kcj.2014.44.2.97 www.e-kcj.org liferative ECs.7) Irreversible PAH is strongly associated with impaired  EC apoptosis and antiapoptotic signaling from perivascular inflam- matory cells.7) These changes are associated with intimal prolifera- tion and vessel narrowing, may contribute to clinical outcomes as-sociated with PAH.",Non-OADS,/arxiv_data1/oa_pdf/ad/f1/kcj-44-97.PMC3958615.pdf
104 Apoptosis Gene Expressions in Pulmonary Hypertension after Bosentan Treatment http://dx.doi.org/10.4070/kcj.2014.44.2.97 www.e-kcj.org 8.,Non-OADS,/arxiv_data1/oa_pdf/ad/f1/kcj-44-97.PMC3958615.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):115-121 http://dx.doi.org/10.3341/kjo.2014.28.2.1 15 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.115 Original ArticleCurrent Practice Pattern for Dry Eye Patients in South Korea:  A Multicenter Study Jong Suk Song1, Joon Young Hyon2, Doh Lee3, Euisang Chung4, Chulyoung Choi4, Jeongbok Lee5,                     Hyo Myung Kim1, Korea Corneal Disease Study Group 1Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea  2Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 3Department of Ophthalmology, Inje University College of Medicine, Goyang, Korea 4Department of Ophthalmology, Sungkyunkwan University College of Medicine, Seoul, Korea 5Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose:  To assess current practice patterns for dry eye patients in South Korea and to evaluate the preference  according to the ages and clinic types of physicians.",Non-OADS,/arxiv_data1/oa_pdf/3f/69/kjo-28-115.PMC3958626.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):122-129  http://dx.doi.org/10.3341/kjo.2014.28.2.122 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.122 Original ArticleThe Correlation of Routine Tear Function Tests and Conjunctival  Impression Cytology in Dry Eye Syndrome Prachi Kumar1, Rahul Bhargava2, Manoj Kumar2, Somesh Ranjan2, Manjushri Kumar3, Pratima Verma1 1Department of Pathology, Santosh Hospital, Santosh Medical College, Ghaziabad, India 2Department of Ophthalmology, Santosh Hospital, Santosh Medical College, Ghaziabad, India 3Department of Microbiology, Narayan Medical College Hospital, Sasaram, India Purpose:  To establish the strength of the association between routine tear function tests and conjunctival im - pression cytology (CIC) and to determine whether they simulate the morphological and cytological changes  that occur on the ocular surface in dry eye.",Non-OADS,/arxiv_data1/oa_pdf/ea/ce/kjo-28-122.PMC3958627.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):130-137 http://dx.doi.org/10.3341/kjo.2014.28.2.130 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.130 Original ArticleComparison of Surgically-induced Astigmatism after Combined  Phacoemulsification and 23-Gauge Vitrectomy:  2.2-mm vs. 2.75-mm Cataract Surgery Yong-Ky u K i m1*, Yong Woo Kim2*, Se Joon Woo1, Kyu Hyung Park1 1Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 2Department of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea Purpose:  The 2.2-mm microincision cataract surgery and small-gauge vitrectomy system is known to result in  less surgically-induced astigmatism (SIA) in comparison to conventional surgical methods.",Non-OADS,/arxiv_data1/oa_pdf/e9/6c/kjo-28-130.PMC3958628.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):138-149   http://dx.doi.org/10.3341/kjo.2014.28.2.138 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.138 Original ArticleReproducibility of Peripapillary Retinal Nerve Fiber Layer Thickness  Measured by Spectral Domain Optical Coherence Tomography in  Pseudophakic Eyes Gyu Ah Kim1,2, Ji Hyun Kim1, Jun Mo Lee1, Kyoung Soo Park1 1Siloam Eye Hospital, Seoul, Korea 2Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea Purpose:  To assess the reproducibility of circumpapillary retinal nerve fiber layer (cpRNFL) thickness measurement  (measurement agreement) and its color-coded classification (classification agreement) by Cirrus spec  tral domain  optical coherence tomography (OCT) in pseudophakic eyes.",Non-OADS,/arxiv_data1/oa_pdf/ce/ce/kjo-28-138.PMC3958629.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):150-154 http://dx.doi.org/10.3341/kjo.2014.28.2.150 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.150 Original ArticleChanges in the Accommodation-convergence Relationship after the  Artisan Phakic Intraocular Lens Implantation for Myopic Patients Ik Hee Ryu1, Jinu Han2, Hyung Keun Lee2, Jin Kook Kim3, Sueng-Han Han2 1Eye & U Eye Clinic, Seoul, Korea 2Institute of Vision Research, Department of Ophthalmology, Gangnam Severance Hospital, Yonsei University College of Medicine,  Seoul, Korea 3B & VIIT Eye Center, Seoul, Korea Purpose:  To evaluate the change of accommodation-convergence parameters after implantation of Artisan  phakic intraocular lens (PIOL).",Non-OADS,/arxiv_data1/oa_pdf/df/cc/kjo-28-150.PMC3958630.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):155-158  http://dx.doi.org/10.3341/kjo.2014.28.2.155 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.155 Original ArticleOcular Findings in Children with Single Umbilical Artery : A Case Series of 14 Children Jongshin Kim1*, Kyo Hoon Park2, Jeong-Min Hwang1 1Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 2Department of Obsterics & Gynecology, Seoul National University Bundang Hospital, Seoul National University College of  Medicine, Seongnam, Korea Purpose:  Single umbilical artery (SUA) is the most common malformation of the umbilical cord.",Non-OADS,/arxiv_data1/oa_pdf/7a/e6/kjo-28-155.PMC3958631.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):159-163 http://dx.doi.org/10.3341/kjo.2014.28.2.159 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.159 Original ArticleSpecific Visual Symptoms and Signs of Meares-Irlen Syndrome  in Korean  Minwook Chang1, Seung-Hyun Kim1, Joo-Young Kim2, Yoonae A. Cho1 1Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea 2MISVIS Ltd., Seoul, Korea Purpose:  To discriminate the visual symptoms and signs of Meares-Irlen syndrome (MIS) and nonspecific dys - lexia from other ophthalmologic diseases (NODs).",Non-OADS,/arxiv_data1/oa_pdf/1e/2c/kjo-28-159.PMC3958632.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):164-169 http://dx.doi.org/10.3341/kjo.2014.28.2.164 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.164 Original ArticleUsing ImageJ to Evaluate Optic Disc Pallor in Traumatic  Optic Neuropathy Sunah Kang1, Ungsoo Samuel Kim1,2     1Department of Ophthalmology, Kim ’s Eye Hospital, Seoul, Korea 2Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea Purpose:  To evaluate optic disc pallor using ImageJ in traumatic optic neuropathy (TON).",Non-OADS,/arxiv_data1/oa_pdf/53/b4/kjo-28-164.PMC3958633.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):170-176  http://dx.doi.org/10.3341/kjo.2014.28.2.170 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.170 Original ArticleEffect of Macrophage Migration Inhibitory Factor on Corneal  Sensitivity after Laser In Situ Keratomileusis in Rabbit Joon Young Hyon1, Stacey Hose2, Celine Gongora3, Debasish Sinha2, Terrence O’Brien4 1Department of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea 2Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA 3CNRS UMR 5160, CRLC, Montpellier, France 4Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, FL, USA Purpose:  To investigate the effect of macrophage migration inhibitory factor (MIF) on corneal sensitivity after  laser in situ keratomileusis  (LASIK) surgery.",Non-OADS,/arxiv_data1/oa_pdf/56/6e/kjo-28-170.PMC3958634.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):177-180  http://dx.doi.org/10.3341/kjo.2014.28.2.177 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.177Ranibizumab Injection for Corneal Neovascularization Refractory  to Bevacizumab Treatment  Ye Jin Ahn, Hyung Bin Hwang, Sung Kun Chung Department of Ophthalmology and Visual Science, Yeouido St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea  Corneal avascularity is essential for the preservation of  optimal vision.",Non-OADS,/arxiv_data1/oa_pdf/40/83/kjo-28-177.PMC3958635.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):181-185  http://dx.doi.org/10.3341/kjo.2014.28.2.181 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.181Sutureless Intrascleral Pocket Technique of Transscleral Fixation of  Intraocular Lens in Previous Vitrectomized Eyes Yong-Wu n Cho1, In-Young Chung1,2, Ji-Myong Yoo1,2, Seong-Jae Kim1,2 1Department of Ophthalmology, Gyeongsang National University College of Medicine, Jinju, Korea 2Gyeongsang Institute of Health Science, Gyeongsang National University, Jinju, Korea Transscleral fixation of posterior chamber intraocular  lenses (PCIOLs) is a well-established and effective method  for implantation of PCIOLs in the absence of sufficient  capsular support.",Non-OADS,/arxiv_data1/oa_pdf/39/ae/kjo-28-181.PMC3958636.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):186-188   http://dx.doi.org/10.3341/kjo.2014.28.2.186 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.186Bilateral Acute Anterior Uveitis and Optic Disc Edema Following  a Snake Bite Praveen K Kumar, Shashi Ahuja, Praveen S Kumar Department of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Poisonous snakes are found throughout the world, and  nearly 60,000 people are bitten by snakes every year on the  Indian subcontinent, with a mortality rate of 25%  [1].",Non-OADS,/arxiv_data1/oa_pdf/96/aa/kjo-28-186.PMC3958637.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):189-191   http://dx.doi.org/10.3341/kjo.2014.28.2.189 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.189Acetazolamide for Cystoid Macular Oedema in Bietti Crystalline  Retinal Dystrophy Geoffrey K Broadhead1-3, Andrew A Chang1-3 1Sydney Institute of Vision Science, Sydney, Australia 2Sydney Retina Clinic & Day Surgery, Sydney, Australia 3Save Sight Institute, The University of Sydney, Sydney, Australia Bietti crystalline retinal dystrophy is a rare, autosomal,  recessively inherited disorder that is more common in pa - tients of East Asian descent.",Non-OADS,/arxiv_data1/oa_pdf/27/53/kjo-28-189.PMC3958638.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):192-193   http://dx.doi.org/10.3341/kjo.2014.28.2.192 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.192Reversal of Early Central Retinal Vein Occlusion by Alleviating Optic  Nerve Edema with an Intravitreal Dexamethasone Implant Young Joo Cho, Dong Hyun Lee, Hae Min Kang, Min Kim, Hyoung Jun Koh Department of Ophthalmology, The Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea The SCORE (Standard Care vs Corticosteroid for Reti - nal Vein Occlusion) study revealed the benefit of steroid  treatment in central retinal vein occlusion (CRVO) associ - ated with macular edema (ME) [1].",Non-OADS,/arxiv_data1/oa_pdf/d9/86/kjo-28-192.PMC3958639.pdf
"Case ReportpISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2014;28(2):194-196  http://dx.doi.org/10.3341/kjo.2014.28.2.194 © 2014 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.194A Case of Ocular Myasthenia Gravis Presenting as Double Depressor Palsy Kwanbok Lee1, Ungsoo Samuel Kim1,2 1Department of Ophthalmology, Kim ’s Eye Hospital, Seoul, Korea 2Department of Ophthalmology, Konyang University College of Medicine, Daejeon, Korea Double depressor palsy (DDP), which is a rare condition,  refers to simultaneous paralysis of the inferior rectus mus - cle and superior oblique muscle of the same eye.",Non-OADS,/arxiv_data1/oa_pdf/52/14/kjo-28-194.PMC3958640.pdf
The movements were present at rest but fluctuated in intensity (Video 1).Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
Bilateral Gluteal Dyskinesia Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
"J Bone Joint Surg 2006;88-B:1580–1583, doi: http://dx.doi.org/10.1302/0301-620X.88B12.18182.",Non-OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
"Orthop Clin N Am 2005;36:163–170, doi: http://dx.doi.org/10.1016/j.ocl.2005.01.003.",OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
"Acta Orthop Scand 1981;52:73–75, doi: http://dx.doi.org/10.3109/17453678108991762.",Non-OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
"Lancet 1986;712–715, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
"Mov Disord 1994;9:531–538, doi: http://dx.doi.org/10.1002/ mds.870090505.",OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
"Neurology 2010;74:e103–e104, doi: http://dx.doi.org/10.1212/WNL.0b013e3181e2410f.",Non-OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
"Clin Obstet Gynecol 1999;42:699– 715, doi: http://dx.doi.org/10.1097/00003081-199909000-00021.",Non-OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
"Mov Disord 2004;9:13–21, doi: http://dx.doi.org/ 10.1002/mds.870090104.Bilateral Gluteal Dyskinesia Sorokin A, Mittal SO, DiCapua D, et al.",OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/bc/df/tre-04-221-5106-1.PMC3958715.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/56/e5/srep04410.PMC3958716.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4410 | DOI: 10.1038/srep04410 8",Non-OADS,/arxiv_data1/oa_pdf/56/e5/srep04410.PMC3958716.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c2/2e/srep04415.PMC3958717.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4415 | DOI: 10.1038/srep04415 8",Non-OADS,/arxiv_data1/oa_pdf/c2/2e/srep04415.PMC3958717.pdf
The proximity of peaks to genes was determined using the galaxy bioinformatics server (http://galaxyproject.org/)39.,OADS,/arxiv_data1/oa_pdf/63/0e/srep04412.PMC3958720.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/63/0e/srep04412.PMC3958720.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4412 | DOI: 10.1038/srep04412 11",Non-OADS,/arxiv_data1/oa_pdf/63/0e/srep04412.PMC3958720.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/18/03/srep04271.PMC3958721.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4271 | DOI: 10.1038/srep04271 11",Non-OADS,/arxiv_data1/oa_pdf/18/03/srep04271.PMC3958721.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/15/a5/srep04414.PMC3958722.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4414 | DOI: 10.1038/srep04414 8",Non-OADS,/arxiv_data1/oa_pdf/15/a5/srep04414.PMC3958722.pdf
http://dx.doi.org/10.1038/ 354161a0 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1016/ j.mib.2010.09.015 .,OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/ 10.1002/cm.21054 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1111/j.1365-2958.2010.07183.x .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1128/JB.01245-10 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/ 10.1128/JB.00176-12 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
75:4891– 4899. http://dx.doi.org/10.1128/IAI.00484-07 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1126/ science.1108472 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1038/nature08970 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1002/ jobm.200610236 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1002/ jobm.200610236 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1073/ pnas.95.10.5752 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1038/ emboj.2012.76 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1016/j.cub.2004.06.048 .,OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1093/ emboj/16.17.5455 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1111/j.1365- 2958.2010.07536.x .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1016/j.cell.2009.12.042 .,OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
67:52– 65. http://dx.doi.org/10.1128/ MMBR.67.1.52-65.2003 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
2:2006.0008. http://dx.doi.org/10.1038/msb4100050 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/ 10.1016/0378-1119(95)00193-A .,OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1093/ emboj/16.17.5455 .,Non-OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
80:612– 627. http://dx.doi.org/10.1111/j.1365-2958.2011.07579.x .Marteyn et al.,OADS,/arxiv_data1/oa_pdf/52/b5/mBio.00022-14.PMC3958796.pdf
http://dx.doi.org/10.1099/0022-1317-72-1-103 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1002/jmv.21218 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1099/0022- 1317-64-1-177 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1371/journal.ppat.1003176 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1017/S0950268800052225 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1099/0022-1317-72-3-711 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
87: 8064 – 8074. http://dx.doi.org/10.1128/JVI.00240-13 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1016/0168- 1702(86)90005-5 .,OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1128/ JVI.01109-09 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1099/0022-1317-77-7-1489 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1016/0042- 6822(86)90003-6 .,OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1371/journal.pone.0058308 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1016/ j.tvjl.2007.07.022 .,OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1016/0042-6822(92)90089-8 .,OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1016/j.cvfa.2010.04.005 .,OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1016/0378-1119(80)90007-4 .,OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1006/ viro.1996.0111 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1093/bioinformatics/ btp352 .,Non-OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
http://dx.doi.org/10.1093/bib/ bbs017 .Hause et al.,OADS,/arxiv_data1/oa_pdf/a3/c8/mBio.00031-14.PMC3958797.pdf
148:223. http://dx.doi.org/10.1001/archdermatol.2011.2716 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
26:459 – 469. http://dx.doi.org/10.2164/jandrol.04104 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/ 10.1186/gb-2006-7-5-r40 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1046/j.1365-2958.2000.01938.x .,OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
62: 680 – 694. http://dx.doi.org/10.1111/j.1365-2958.2006.05414.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
Cell23:651– 662. http://dx.doi.org/10.1016/j.molcel.2006.07.004 .,OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1126/science.1200729 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1038/315156a0 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1111/j.1365-2958.2011.07773.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1084/jem.137.3.571 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
143:413– 422. http://dx.doi.org/10.1093/infdis/143.3.413 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1038/ 35024105 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1371/journal.pbio.0060087 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
104:178104. http://dx.doi.org/ 10.1103/PhysRevLett.104.178104 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
52:873– 893. http://dx.doi.org/10.1111/ j.1365-2958.2004.04026.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
75: 4743– 4753. http://dx.doi.org/10.1128/IAI.00687-07 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1046/j.1365-2958.1999.01459.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1111/j.1462- 5822.2011.01607.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
"Andrologia 39:60 – 65. http://dx.doi.org/10.1111/j.1439-0272.2007.00764.x .29.Lilja H, Oldbring J, Rannevik G, Laurell CB.",OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1172/ JCI113070 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
9:4553– 4557. http://dx.doi.org/10.1021/nl903153c .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1016/ j.cell.2010.11.035 .,OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1046/j.1462- 5822.2002.t01-1-00215.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
25:639 – 647. http://dx.doi.org/10.1046/j.1365- 2958.1997.4841857.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1097/00003081-198106000- 00005 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1016/S0010-7824(99)00010-4 .,OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1016/j.bpj.2012.04.020 .,OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1172/ JCI117290 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1016/S0378- 1119(96)00810-4 .,OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1046/j.1365-2958.1996.00128.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1126/science.1175653 .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1128/JB.186.3.730- 739.2004 .,OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
Methods 9:671– 675. http://dx.doi.org/ 10.1038/nmeth.2089 .,OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1016/j.bpj.2008.10.017 .,OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1111/j.1574- 6976.2010.00260.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
http://dx.doi.org/10.1111/ j.1574-6968.2007.00776.x .,Non-OADS,/arxiv_data1/oa_pdf/9c/29/mBio.01004-13.PMC3958800.pdf
Multiple sequence alignments were generated withthe BioEdit software program ( http://www.mbio.ncsu.edu/bioedit /bioedit.html ).,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
2:57– 60. http://dx.doi.org/10.1093/jpids/ pis070 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1056/NEJMsa1206589 .,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
7:683– 690. http://dx.doi.org/10.1016/S0955-2863(96)00132-5 .,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/ 10.3201/eid1408.071114 .Effect of Malnutrition on Norovirus Infection March/April 2014 Volume 5 Issue 2 e01032-13®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1128/JVI.02346-05 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1126/science.1077905 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
188: 77– 84. http://dx.doi.org/ 10.4049/jimmunol.1004027 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1210/en.2011-1623 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1021/ jf104240d .,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1210/en.2010-0008 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1016/ j.jnutbio.2009.02.007 .,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/ 10.1128/JVI.02096-06 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1016/j.virol.2011.09.030 .,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
83:6963– 6968. http://dx.doi.org/10.1128/ JVI.00284-09 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
Immunol.5:844 – 852. http://dx.doi.org/10.1038/nri1710 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/ 10.1073/pnas.97.13.7078 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/ 10.1128/IAI.06140-11 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1126/science.286.5438.287 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1128/JVI.07038-11 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1128/JVI.00237- 08.,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1126/ science.1198719 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1126/science.1208344 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1126/scitranslmed.3000322 6ra14.,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1097/ MOG.0b013e328331b6b4 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
The key role of segmented ﬁlamentous bacteria in the coordinated maturation of gut helper T cell responses.Immunity 31:677– 689. http://dx.doi.org/10.1016/j.immuni.2009.08.020 .,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1038/nature10213 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/ 10.1126/science.1210718 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1126/science.1211057 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1007/s00284-011-9972-7 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1371/ journal.pone.0048224 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
Health 4:59 – 64. http://dx.doi.org/10.1016/ j.jiph.2011.01.002 42.,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1007/ s00705-011-0996-x .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
Health16:680 – 684. http://dx.doi.org/10.1111/j.1365-3156.2011.02756.x .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
11:19. http://dx.doi.org/10.1186/1471-2431-11- 19.,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
29:855– 859. http://dx.doi.org/10.1097/INF.0b013e3181e8b346 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/ 10.1016/j.jcv.2011.03.004 49.,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
84:886 – 891. http://dx.doi.org/ 10.4269/ajtmh.2011.11-0116 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/ 10.1002/jmv.22108 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1128/JVI.00783-07 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
7:11. http://dx.doi.org/10.1186/1479-0556-7-11 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
BMC PublicHealth 13:619. http://dx.doi.org/10.1186/1471-2458-13-619 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1093/infdis/jis527 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1007/s00705-013- 1645-3 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1126/ science.1090727 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1086/591627 .,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1371/ journal.pbio.0020432 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
2:228. http://dx.doi.org/10.3389/fmicb.2011.00228 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
Nature 457: 480 – 484. http://dx.doi.org/10.1038/ nature07540 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://www.nature.com /nature/journal/vaop/ncurrent/full/nature12503.html#supplementary-information .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1073/ pnas.0909122107 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
Nature 453:620 – 625. http://dx.doi.org/10.1038/nature07008 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1371/journal.pone.0041079 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1093/molbev/msr121 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1136/ gut.2006.108266 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1093/nar/gkr349 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/ 10.1093/nar/gkp285 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
http://dx.doi.org/10.1038/nmeth.f.303 .,Non-OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
71: 8228 – 8235. http://dx.doi.org/10.1128/AEM.71.12.8228-8235.2005 .Hickman et al.,OADS,/arxiv_data1/oa_pdf/3a/c9/mBio.01032-13.PMC3958801.pdf
"Therefore, detection of rheumatoid factor should not be used alone indiagnosis of these conditions but used in conjunction with other clinical and assessment factors [ 73,74,90,201] Table 2 Psoriatic arthritis (PsA) screening tools Name Overview Comments Current tools PASQ [ 82] 10 items ?joint diagram Self-report PASE [ 84] Self-administered 15 itemsMaximum score: 75Threshold score =47 Sensitivity 82 %Speciﬁcity 73 % PEST [ 85] Self-administered 5 items ?joint diagram Maximum score: NAThreshold score =3 Sensitivity 97 %Speciﬁcity 79 % ToPAS [ 86] Self-administered 11 items ?pictures/diagram Maximum score: NAThreshold score =8 Sensitivity 86.8 %Speciﬁcity 93.1 % ToPAS II is available online (see http://www.ibridgenetwork.org/ uhn/toronto-psoriatic-arthritis-screen-ii-topas-ii) Tools in development ePASQ [ 87] 10 items ?joint diagram Self-reportExact match of paper versionElectronic application is available online (see http://www.nlrt.ca/screenTool.html) EARP [ 88] Self-administered 14 questionsSensitivity 85.2 % Speciﬁcity 91.6 % EARP Early Arthritis for Psoriatic Patients, ePASQ Electronic Psoriatic Arthritis Screening Questionnaire, NAnot applicable, PASE Psoriatic Arthritis Screening and Evaluation, PASQ Psoriatic Arthritis Screening Questionnaire, PEST Psoriasis Epidemiology Screening Tool, ToPAS Toronto Psoriatic Arthritis ScreeningDiagnosis and Treatment of Psoriatic Arthritis 427",Non-OADS,/arxiv_data1/oa_pdf/28/db/40265_2014_Article_191.PMC3958815.pdf
"Table 5 Summary of new and emerging treatments in psoriasis and psoriatic arthritis (PsA) MOA Drug Manufacturer Trial phase completedaOngoing trialsaPreliminary efﬁcacy data PDE4 inhibitor Apremilast Celgene Phase II, III Phase III ESTEEM (psoriasis), PALACE (PsA)Psoriasis [ 177] PsA [ 178,181] JAK Tofacitinib Pﬁzer Phase II Phase III psoriasis ?PsA (NCT01519089) Psoriasis [ 186,187] Anti-IL-17 agents Secukinumab (AIN-457)Novartis Phase II Phase III Psoriasis (NCT01365455)PsA (NCT01392326)Psoriasis [ 196–198] Brodalumab (AMG 827)Amgen Phase II Phase III Psoriasis (NCT01708603 and NCT01708629)Psoriasis [ 191] PsA [ 192] Ixekizumab (LY2439821)Eli Lilly Phase II Phase III Psoriasis (NCT01474512)PsA (NCT01695239)Psoriasis [ 193] Protein kinase C inhibitor Sotrastaurin (AEB071) Novartis Phase II None Psoriasis [ 194] Adenosine A3 receptor inhibitorCF101 Can-Fite BioPharmaPhase II Phase II/III Psoriasis (NCT01265667)Psoriasis [ 195] Calcineurin inhibitor Voclosporin (ISA247) Isotecknika Phase III None Psoriasis [ 200] Additional compounds in development for psoriasis or RA JAK1, JAK2 inhibitor LY3009104 (INCB28050, INCYTE)Eli Lilly Phase IIb study ongoing in psoriasis (NCT01490632) JAK3 inhibitor VX-509 Vertex Pharmaceuticals JAK inhibitor ASP015K Astellas Pharma Phase IIa trial in psoriasis completed (NCT01096862)In phase IIb development for RA IL-12/IL-23 synthesis inhibitorAplimod (STA-5326) Synta Pharmaceuticals IL-23 blocker SCH 900222 Merck Phase II trial in psoriasis completed (NCT01225731)Phase III trial in psoriasis planned (NCT01722331) Regulatory T cell activatorBT-061 Biotest Phase II trial in psoriasis completed (NCT01072383)Phase II trial in RA ongoing (NCT01481493) S1P1 receptor blocker ACT-128800 Actelion p38 MAPK blocker BMS-582949 Bristol-Myers SquibbPhase I/II trial in psoriasis completed; patent ﬁled in 2012 for treatment of RA (see http://www.highbeam.com/ doc/1P3-2609565631.html ) Fumaric acid FP187 Forward-Pharma Currently in phase II development for psoriasis (see http://www.forward-pharma.com/about_ us.html )434 P. J. Mease, A. W. Armstrong",Non-OADS,/arxiv_data1/oa_pdf/28/db/40265_2014_Article_191.PMC3958815.pdf
"UCB, 2013. http://www.ucb.pre sscentre.com/News/UCB-receives-CHMP- positive-opinion-for-Cimzia-certolizumab-pegol-in-active-psori- atic-arthritis-469.aspx (Accessed 17 Jan 2014).",Non-OADS,/arxiv_data1/oa_pdf/28/db/40265_2014_Article_191.PMC3958815.pdf
Apremilast achieves statistical sig- niﬁcance for the primary endpoint of the ﬁrst phase III study (PALACE-1) in patients with psoriatic arthritis [press release];2012. http://ir.celgene.com/phoenix.zhtml?c=111960&p=irol- newsArticle&ID=1714113&highlight= (Accessed 6 Aug 2013).,OADS,/arxiv_data1/oa_pdf/28/db/40265_2014_Article_191.PMC3958815.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1d/5b/srep04413.PMC3958917.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4413 | DOI: 10.1038/srep04413 7",Non-OADS,/arxiv_data1/oa_pdf/1d/5b/srep04413.PMC3958917.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9b/59/srep04216.PMC3958918.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4216 | DOI: 10.1038/srep04216 5",Non-OADS,/arxiv_data1/oa_pdf/9b/59/srep04216.PMC3958918.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b9/43/main.PMC3958919.pdf
http://dx.doi.org/10.1016/j.fob.2014.02.011 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/43/main.PMC3958919.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: IRS-1, Insulin receptor substrate-1; PI3K, phosphatidylinositol 3- kinase; KI, knock-in; BCA, bicinchoninic acid; BSA, bovine serum albumin; HRP, horseradish peroxidase; ELISA, enzyme-linked immunosorbent assay ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/b9/43/main.PMC3958919.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e3/27/main.PMC3958920.pdf
"First, T4LHyp epimerase (EC 5.1.1.8; encoded by LhpA ) http://dx.doi.org/10.1016/j.fob.2014.02.010 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e3/27/main.PMC3958920.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: L-Hyp, hydroxy- L-proline; T4LHyp, trans -4-hydroxy- L-proline; T3LHyp, trans -3-hydroxy- L-proline; C4LHyp, cis-4-hydroxy- L-proline; C4DHyp, cis- 4-hydroxy- D-proline; Pyr4 RH2C, D1-pyrroline-4 R-hydroxy-2-carboxylate; C4DHypDH, C4DHyp dehydrogenase; Pyr2C, D1-pyrroline-2-carboxylate; Pip2C, D1-piperidine-2-carboxylate; OCD, ornithine cyclodeaminase; LCD, L-lysine cyclodeaminase ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/e3/27/main.PMC3958920.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.02.010 .",OADS,/arxiv_data1/oa_pdf/e3/27/main.PMC3958920.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/4d/64/main.PMC3958921.pdf
http://dx.doi.org/10.1016/j.fob.2014.02.009 2211-5463/ /C2112014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/64/main.PMC3958921.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: BSA, bovine serum albumin; Endo H, endoglycosidase H; ER, endoplasmic reticulum; HRP, horseradish peroxidase; HUVEC, human umbilicalvein endothelial cells; ICAM-1, intercellular adhesion molecule-1; I jB, inhibitor of nuclear factor jB; IL-1, interleukin-1; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe- nyltetrazolium bromide; NF- jB, nuclear factor jB; PBS, phosphate-buffered saline; PNGase F, peptide: N-glycosidase F ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/4d/64/main.PMC3958921.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.02.009 .",OADS,/arxiv_data1/oa_pdf/4d/64/main.PMC3958921.pdf
"catalogued and meta-analyzed association study data  from ~27,000 published articles on the PD gene website (http://www.pdgene.org) [35].",OADS,/arxiv_data1/oa_pdf/12/bd/CG-15-2.PMC3958956.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/2d/cf/SJG-19-245.PMC3958971.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.,Non-OADS,/arxiv_data1/oa_pdf/4c/d6/SJG-19-252.PMC3958972.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/48/ea/SJG-19-258.PMC3958973.pdf
Available from: http://emedicine.medscape.com/ article/2086774‑overview#showall.,Non-OADS,/arxiv_data1/oa_pdf/ae/55/SJG-19-262.PMC3958974.pdf
Available from: http://www.sfar.org/acta/dossier/archives/ ca07/html/ca07 17/ca07 17.htm [Last accessed on 2012 Jul 07].,OADS,/arxiv_data1/oa_pdf/81/f3/SJG-19-271.PMC3958975.pdf
Available from:  http://seer.cancer.gov/csr/1975_2009_pops09/.,Non-OADS,/arxiv_data1/oa_pdf/5d/8a/SJG-19-278.PMC3958976.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/03/76/SJG-19-286.PMC3958977.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/03/76/SJG-19-286.PMC3958977.pdf
Available from: http://www.epid.gov.lk/web/index.,OADS,/arxiv_data1/oa_pdf/28/2d/JGID-5-127.PMC3958980.pdf
"The sequence for MB2,[30] was entered into the  http://www-bimas.cit.nih.gov/molbio/hla_bind/ and the  two sequences with the highest predicted binding for HLA",OADS,/arxiv_data1/oa_pdf/15/c5/JGID-5-131.PMC3958981.pdf
Available from: http://www.who.int/entity/ diseasecontrol_emergencies/toolkits/Hoa2.pdf.,OADS,/arxiv_data1/oa_pdf/85/15/JGID-5-149.PMC3958984.pdf
Available from:  http://www.emedicine.medscape.com/article/228392-overview.,Non-OADS,/arxiv_data1/oa_pdf/85/15/JGID-5-149.PMC3958984.pdf
Available from:  http://www.who.int/wer.,OADS,/arxiv_data1/oa_pdf/85/15/JGID-5-149.PMC3958984.pdf
Available from:  http://www.who.int/mediacentre/facesheets/fs115/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/85/15/JGID-5-149.PMC3958984.pdf
Available from: http://www.who.int/ schistosomiasis/epidemiology/en.,Non-OADS,/arxiv_data1/oa_pdf/85/15/JGID-5-149.PMC3958984.pdf
Available from: http://www.cdc.gov/ncidod/dhqp/pdf/ guidelines/Isolation2007.pdf  [Last Accessed on 2007 Jun 30].,OADS,/arxiv_data1/oa_pdf/aa/18/JGID-5-156.PMC3958986.pdf
Start a QR-code reading software (see list of free  applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/aa/18/JGID-5-156.PMC3958986.pdf
See http:// tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/aa/18/JGID-5-156.PMC3958986.pdf
"The search was performed in the  PubMed database (http://www.ncbi.nlm.nih.gov/pubmed) Table 1: West Nile Virus reports in the Western  Hemisphere, since its introduction Country First report Evidence in Isolation Antibodies North America USA 1999 Humans X X Horses X X Birds X X Mosquitoes X Canada 2001 Humans X Horses X Birds X Mosquitoes Mexico 2002 Humans X X Horses X X Birds X X Mosquitoes X Central America Belize 2003 Horses X Costa Rica 2004 Horses X El Salvador 2003 Horses X Guatemala 2003 Horses X Nicaragua 2006 Humans X Caribbean Islands Bahamas 2003 Humans X Cuba 2003 Humans X Horses X Birds X Guadeloupe 2002 Horses X Birds X Haiti 2004 Humans X Cayman Islands 2001 Humans X Jamaica 2002 Birds X Puerto Rico 2004 Humans X Birds X X Mosquitoes X Dominican 2002 Birds X Trinidad and Tobago 2004 Horses X Birds X South America Argentina 2005 Humans X Horses X X Birds Brazil 2009 Horses X Birds X Colombia 2004 Horses X Venezuela 2004 Horses X Birds X",OADS,/arxiv_data1/oa_pdf/77/10/JGID-5-168.PMC3958988.pdf
"We also are presenting on-line published information  from the health departments of  USA: CDC (http:// www.cdc.gov/), US Department of  Agriculture (http:// www.aphis.usda.gov/); Canada: Public Health Agency  of  Canada (http://www.phac-aspc.gc.ca); and Mexico:  National Center of  Epidemiological Surveillance (http:// www.cenave.gob.mx).",Non-OADS,/arxiv_data1/oa_pdf/77/10/JGID-5-168.PMC3958988.pdf
"Even more, the confirmed human case in 2004 in the  state of  Sonora highlighted the precedent that WNV  can coexist in an endemic DENV zone since this state is  considered high risk for dengue by public health authorities  (http://www.cenave.gob.mx/dengue/default.asp?id=32)  accessed 18 November 2011; and more recently the fatal  human case in the state of  Nuevo Leon where DENV also  circulates year by year.",Non-OADS,/arxiv_data1/oa_pdf/77/10/JGID-5-168.PMC3958988.pdf
http://www.phac-aspc.,Non-OADS,/arxiv_data1/oa_pdf/77/10/JGID-5-168.PMC3958988.pdf
http://www.cdc.gov/ncidod/dvbid/ westnile/birdspecies.htm Accessed June 2011.,Non-OADS,/arxiv_data1/oa_pdf/77/10/JGID-5-168.PMC3958988.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/77/10/JGID-5-168.PMC3958988.pdf
IFs are calculated for those journals that are indexed in the Journal Citation Reports (JCR) of Thomson Reuters (http://thomsonreuters.com/journal-citation-reports/).,OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
Journals employ several methods to increase its IF [1-3]  (http://www.newworldencyclopedia.org/entry/Impact_factor).,Non-OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
"There are instances whereby a single article, the IF of a journal rose from just 2.05 to about 50 in a single year as this one paper got a citation of 6,600; whereas, the best citation in the journal in the previous year was only 28 [4] (http://en.wikipedia.org/wiki/Impact_factor).",Non-OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
Journals that are not indexed in JCR of Thomson Reuters  find a place in the journal rankings system developed by SCIMAGO JCR (http://www.scimagojr.com/).,Non-OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
"The values for ‘Nature’ (http://www.nature.com/npg_/company_info/impact_factors.html), which is the foremost journal dealing with interdisciplinary science is included in the Table 1 to  show  its standing compared to others.",Non-OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
"The European Association of Science Editors (EASE) issued  an official statement in November 2007, recommending that JIFs be used only for measuring and comparing the influence of entire journals, not for the assessment of single papers, and certainly not for the assessment of researchers or research programs, either directly or as a surrogate (http://www.ease.org.uk/publications/impact-factor-statement).",Non-OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
"“Scientists join journal editors to fight impact-factor abuse”,  a news blog appeared in “Nature” and “Scientific insurgents say ‘Journal Impact Factors’ distort science” in Science Daily, both dated 16 May 2013 are noteworthy (Retrieved from http://www.sciencedaily.com /releases/2013/05/130516142537.",Non-OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
"Table 1: Ranking indicators of a few medical physics related journals for 2012 Journal JIF (2 years)* Cites/doc (2 years)** H-index** Docs** Nature 38.597 24.49 768 2,627International Journal of Radiation Oncology Biology  Physics4.524 4.48 163 1,1 74 Radiotherapy Oncology 4.52 4.71 100 288 Medical Physics 2.911 3.04 113 720Physics in Medicine and Biology 2.701 3.06 113 567Physica Medica 1.167 1.05 18 77Journal of Applied Clinical Medical Physics 0.959 0.55 23 228Radiation Protection Dosimetry 0.909 0.81 44 396Australasian Physical and Engineering Sciences in  Medicine0.885 0.85 16 70 Journal of Cancer Research and Therapeutics  (AROI, India)0.761 1.07 13 160 Journal of Medical Physics (AMPI, India) — 0.88 8 37 *http://www.cityu.edu.hk/ap/nru/ifactors.htm, **http://www.scimagojr.com/journalrank.php,  AROI: Association of Radiation Oncologists of India, A MPI: Association of Medical Physicists of India",Non-OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
A complete list of organizations which are signatories of DORA is given at http://www.ascb.org/SFdeclaration.html.,Non-OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
[http://www.the-scientist.,Non-OADS,/arxiv_data1/oa_pdf/1f/0c/JMP-38-155.PMC3958993.pdf
Available from:  http://nparc.cisti-icist.nrc-cnrc.gc.ca/npsi/ctrl?,Non-OADS,/arxiv_data1/oa_pdf/2c/ec/JMP-38-158.PMC3958994.pdf
Available from: http://www.nist.gov/pml/data/xraycoef/ [Last accessed date on 01-08-2013].,OADS,/arxiv_data1/oa_pdf/2c/ec/JMP-38-158.PMC3958994.pdf
"XCOM: Photon Cross Sections Database,  National Institute of Standards and Technology; XCOM v3.1; Available from: http://www.nist.gov/pml/data/xcom/index.cfm [Last access date on 01-08-2013].",OADS,/arxiv_data1/oa_pdf/2c/ec/JMP-38-158.PMC3958994.pdf
Available from: http://nparc.cisti-icist.nrc-cnrc.gc.ca/npsi/ctrl?action=shwart&index=an&req=8898504&lang=en [Last accessed date on 01-08-2013].,OADS,/arxiv_data1/oa_pdf/2c/ec/JMP-38-158.PMC3958994.pdf
"NUDAT 2.6, National Nuclear Data Center, Brookhaven National  Laboratory, Available from: http://www.nndc.bnl.gov/nudat2/index.jsp [Last accessed date on 01-08-2013].",OADS,/arxiv_data1/oa_pdf/2c/ec/JMP-38-158.PMC3958994.pdf
Available from: http://www.cancer.gov/cancertopics/types/prostate [Last cited on 2013 Apr 10].,Non-OADS,/arxiv_data1/oa_pdf/60/0f/JMP-38-165.PMC3958995.pdf
Available from: http://www.cancer.org/Cancer/ProstateCancer/DetailedGuide/prostate-cancer-key-statistics [Last updated on 2013 Jan 17; Last cited on 2013 Apr 10].,OADS,/arxiv_data1/oa_pdf/60/0f/JMP-38-165.PMC3958995.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/3a/a9/JMP-38-178.PMC3958997.pdf
Available from: http://www.PhysioNet.org/Challenge/2007.,Non-OADS,/arxiv_data1/oa_pdf/9a/47/JMSS-3-129.PMC3959003.pdf
"IRMA Group, Available from: http://www.irma-project.org.",Non-OADS,/arxiv_data1/oa_pdf/12/37/JMSS-3-150.PMC3959005.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/61/bb/IJPsyM-36-1.PMC3959011.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/a1/d7/IJPsyM-36-33.PMC3959015.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/15/2e/IJPsyM-36-4.PMC3959016.pdf
Available from: http://www.oas.samhsa.gov/2k9/171/171FemaleViolenceHTML.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/9d/IJPsyM-36-48.PMC3959019.pdf
Available from: http://www.orghealth.co.uk/uploads/PDFs/Resilience%20Assessment%20Questionnaire.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1c/9d/IJPsyM-36-48.PMC3959019.pdf
Available from: http://www.pubs.niaaa.nih.gov/publications/arh26-2/116-121.htm.,Non-OADS,/arxiv_data1/oa_pdf/be/59/IJPsyM-36-58.PMC3959021.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/1c/f7/IJPsyM-36-91.PMC3959031.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/1c/f7/IJPsyM-36-91.PMC3959031.pdf
Available  from: http://emedicine.medscape.com/article/1227921-overview#showall.,Non-OADS,/arxiv_data1/oa_pdf/c1/ad/IJPsyM-36-94.PMC3959032.pdf
© Cambridge University Press 2013 doi:10.1017/S0033291713001591ORIGINAL ARTICLE The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.The written permission of Cambridge University Press must be obtained for commercial re-use.,Non-OADS,/arxiv_data1/oa_pdf/c9/6c/S0033291713001591a.PMC3959155.pdf
Supplementary material For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0033291713001591.,Non-OADS,/arxiv_data1/oa_pdf/c9/6c/S0033291713001591a.PMC3959155.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/43/TONIJ-8-1.PMC3959176.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b9/4f/ncomms4345.PMC3959189.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Rieger, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/4f/ncomms4345.PMC3959189.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4345 6 NATURE COMMUNICATIONS | 5:3345 | DOI: 10.1038/ncomms4345 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/b9/4f/ncomms4345.PMC3959189.pdf
"wPosition for the SNP and indel markers according to version 5b.60 of the B73 reference sequence (MaizeSequence, http://www.maizesequence.org/).",OADS,/arxiv_data1/oa_pdf/ae/85/ncomms4438.PMC3959190.pdf
"After centrifugation at 10,000 gfor 10 min, 0.4 ml of each extract was combined and ﬁlter spun using 0.22- mm ﬁlters (ANPEL, Shanghai, China, http://www.anpel.com.cn/) before analysis using an LC-ESI-MS/MS system.The metabolite quantiﬁcation and annotation is performed by our newly developed method 57, which is described in detail in the Supplementary Notes.",Non-OADS,/arxiv_data1/oa_pdf/ae/85/ncomms4438.PMC3959190.pdf
"Data sets including genotypic,phenotypic, expression and the mass spec data of each line and detailed infor- mation of called SNPs from RNA-sequencing result can be viewed and downloaded from the website http://www.maizego.org/Resources.html.",OADS,/arxiv_data1/oa_pdf/ae/85/ncomms4438.PMC3959190.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/ae/85/ncomms4438.PMC3959190.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wen, W. et al.",Non-OADS,/arxiv_data1/oa_pdf/ae/85/ncomms4438.PMC3959190.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/fc/d5/ncomms4408.PMC3959191.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Malinen, A. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/fc/d5/ncomms4408.PMC3959191.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4420 8 NATURE COMMUNICATIONS | 5:3420 | DOI: 10.1038/ncomms4420 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.,Non-OADS,/arxiv_data1/oa_pdf/71/50/ncomms4420.PMC3959192.pdf
Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions.,Non-OADS,/arxiv_data1/oa_pdf/71/50/ncomms4420.PMC3959192.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4420 ARTICLE NATURE COMMUNICATIONS | 5:3420 | DOI: 10.1038/ncomms4420 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/71/50/ncomms4420.PMC3959192.pdf
"Single crystals of Y 2Ti2O737were cut and epi-polished on one side (SurfaceNet GmbH, http://www.surfacenet.de).",Non-OADS,/arxiv_data1/oa_pdf/6b/59/ncomms4439.PMC3959195.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications0.294 0.295 0.296 0.297 0.2980.6880.6900.6920.6940.6960.6980.7000.7020.704 Cubic [553] Experimental Tabulated bulk YTO Tabulated DTO Fully relaxed DTO Qx(Å–1)Qz(Å–1) Figure 7 | Reciprocal space mapping of bulk and epitaxial ﬁlms of spin ices.,Non-OADS,/arxiv_data1/oa_pdf/6b/59/ncomms4439.PMC3959195.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Bovo, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/59/ncomms4439.PMC3959195.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4439 8 NATURE COMMUNICATIONS | 5:3439 | DOI: 10.1038/ncomms4439 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/6b/59/ncomms4439.PMC3959195.pdf
"To calculate the forces, we ﬁrst obtain the EM total ﬁeld using a commercial ﬁnite-element-method package COMSOL Multiphysics (http://www.comsol.com/).",Non-OADS,/arxiv_data1/oa_pdf/c0/53/ncomms4307.PMC3959198.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c0/53/ncomms4307.PMC3959198.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wang, S. B. and Chan C. T. Lateral optical force on chiral particles near a surface.",OADS,/arxiv_data1/oa_pdf/c0/53/ncomms4307.PMC3959198.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4307 8 NATURE COMMUNICATIONS | 5:3307 | DOI: 10.1038/ncomms4307 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c0/53/ncomms4307.PMC3959198.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/29/6d/ncomms4425.PMC3959200.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Weits, D. A. et al.",Non-OADS,/arxiv_data1/oa_pdf/29/6d/ncomms4425.PMC3959200.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4425 10 NATURE COMMUNICATIONS | 5:3425 | DOI: 10.1038/ncomms4425 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/29/6d/ncomms4425.PMC3959200.pdf
Gene names corresponding to the 73proteins found in multiple HA-HACE1 puriﬁcations were submitted for statistical enrichment of gene ontology pathway analysis using the Gene Ontology For Functional Analysis software tools in ArrayTrack (ArrayTrackhttp://www.fda.,OADS,/arxiv_data1/oa_pdf/f0/81/ncomms4430.PMC3959209.pdf
Spectra were identiﬁed by converting Raw MS ﬁles to m/z XML using ReAdW and searched by a locally installed version of X!Tandem against a mouse IPI (International Protein Index; http://www.ebi.ac.uk/IPI) protein sequence database created on August 2010.,OADS,/arxiv_data1/oa_pdf/f0/81/ncomms4430.PMC3959209.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f0/81/ncomms4430.PMC3959209.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhang, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/81/ncomms4430.PMC3959209.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4430 14 NATURE COMMUNICATIONS | 5:3430 | DOI: 10.1038/ncomms4430 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f0/81/ncomms4430.PMC3959209.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/nature communications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/ba/ncomms4492.PMC3959210.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Takemura, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/79/ba/ncomms4492.PMC3959210.pdf
"The QM/MM implementation employed combines the use of the QM program QUICKSTEP48and the MM driver FIST, both part of the CP2 K package (freely available at the URL http://www.cp2k.berlios.de, released under GPLlicence).",Non-OADS,/arxiv_data1/oa_pdf/14/91/ncomms4462.PMC3959212.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/14/91/ncomms4462.PMC3959212.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Adhireksan, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/14/91/ncomms4462.PMC3959212.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4462 ARTICLE NATURE COMMUNICATIONS | 5:3462 | DOI: 10.1038/ncomms4462 | www.nature.com/naturecommunications 13 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/14/91/ncomms4462.PMC3959212.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/8e/15/ncomms4480.PMC3959213.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Yamamoto, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/8e/15/ncomms4480.PMC3959213.pdf
"To view a copy of this license, visit http://creativecommon-s.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4480 16 NATURE COMMUNICATIONS | 5:3480 | DOI: 10.1038/ncomms4480 | www.nature.com/naturecommunications &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/8e/15/ncomms4480.PMC3959213.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/27/ncomms4436.PMC3959214.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Fu, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/95/27/ncomms4436.PMC3959214.pdf
Probes with correctedP-valueo0.005 and a fold difference X2 in at least one of the comparisons between the subsets were considered for further analysis.Venn diagrams were constructed using an online tool http://www.bioin-fogp.cnb.csic.es/tools/venny/.,OADS,/arxiv_data1/oa_pdf/e2/8f/gene201369a.PMC3959220.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Genes and Immunity website (http://www.nature.com/gene)miRNA in Tregs of RA patients K Smigielska-Czepiel et al 125 &2014 Macmillan Publishers Limited Genes and Immunity (2014) 115 – 125",Non-OADS,/arxiv_data1/oa_pdf/e2/8f/gene201369a.PMC3959220.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj) APPENDIX PREDICT investigator group: Argentina: A Belgorosky, Buenos Aires.",Non-OADS,/arxiv_data1/oa_pdf/71/ae/tpj201314a.PMC3959225.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f6/83/ncomms4433.PMC3959286.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wang, S. J. et al.",Non-OADS,/arxiv_data1/oa_pdf/f6/83/ncomms4433.PMC3959286.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4433 ARTICLE NATURE COMMUNICATIONS | 5:3433 | DOI: 10.1038/ncomms4433 | www.nature.com/naturecommunications 9 &2014 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f6/83/ncomms4433.PMC3959286.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and re production in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2014, 4: 22110 - http://dx.doi.org/10.3402/iee.v4.22110 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a2/8d/IEE-4-22110.PMC3959429.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2014, 4: 22110 - http://dx.doi.org/10.3402/iee.v4.22110",Non-OADS,/arxiv_data1/oa_pdf/a2/8d/IEE-4-22110.PMC3959429.pdf
"PCI /C30Premise Condition Index.Conditions of the household and peridomicile in Brazil Citation: Infection Ecology and Epidemiology 2014, 4: 22110 - http://dx.doi.org/10.3402/iee.v4.22110 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a2/8d/IEE-4-22110.PMC3959429.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2014, 4: 22110 - http://dx.doi.org/10.3402/iee.v4.22110",Non-OADS,/arxiv_data1/oa_pdf/a2/8d/IEE-4-22110.PMC3959429.pdf
"LRT/C30likelihood ratio test; OR /C30odds ratio.Conditions of the household and peridomicile in Brazil Citation: Infection Ecology and Epidemiology 2014, 4: 22110 - http://dx.doi.org/10.3402/iee.v4.22110 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a2/8d/IEE-4-22110.PMC3959429.pdf
"Acknowledgments The results presented here are part of the project Factors Associated with the Occurrence of Severe Dengue: From Assistance and Envi- ronment to Immunology and Genetics, funded by Fundac ¸a˜o Carlos Chagas Filho de Amparo a ´ Pesquisa do Estado do Rio de Janeiro - FAPERJ (http://www.faperj.br/interna.phtml?obj_id=4702).",Non-OADS,/arxiv_data1/oa_pdf/a2/8d/IEE-4-22110.PMC3959429.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2014, 4: 22110 - http://dx.doi.org/10.3402/iee.v4.22110",Non-OADS,/arxiv_data1/oa_pdf/a2/8d/IEE-4-22110.PMC3959429.pdf
"Available from: SciELO Books, http://books.scielo.org.",Non-OADS,/arxiv_data1/oa_pdf/a2/8d/IEE-4-22110.PMC3959429.pdf
"Cad Sau ´de Colet 2009; 17: 301 /C14.Conditions of the household and peridomicile in Brazil Citation: Infection Ecology and Epidemiology 2014, 4: 22110 - http://dx.doi.org/10.3402/iee.v4.22110 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/a2/8d/IEE-4-22110.PMC3959429.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/awu015.PMC3959555.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/ab/awu027.PMC3959559.pdf
"Anatomical masks of the precentral gyrus from each hemi- sphere were created using the Harvard-Oxford cortical structural atlas,as available in the FSL suite (http://fsl.fmrib.ox.ac.uk/).",OADS,/arxiv_data1/oa_pdf/9e/ab/awu027.PMC3959559.pdf
A monoclonal antibody reactive with Type II collagen (11-116B3) was obtained from the Developmental Studies Hybridoma Bank ( http://dshb.biology.uiowa.edu/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/43/nihms529418.PMC3959644.pdf
Available at: http://www.hospitalcompare.hhs.gov.,Non-OADS,/arxiv_data1/oa_pdf/12/3b/jah3-3-e000404.PMC3959669.pdf
Available at: http://www.premierinc.com/ quality-safety/tools-services/p4p/hqi/index.jsp.,Non-OADS,/arxiv_data1/oa_pdf/12/3b/jah3-3-e000404.PMC3959669.pdf
"Accompanying Appendix S1 is available at http://jaha.ahajournals.org/ content/3/1/e000472/suppl/DC1 Correspondence to: Cary P. Gross, MD, Yale School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520.",Non-OADS,/arxiv_data1/oa_pdf/07/0e/jah3-3-e000472.PMC3959671.pdf
Available at: http://www.nejm.org/doi/suppl/10.1056/nejmoa0910383/ suppl_ ﬁle/nejmoa0910383_appendix.Pdf.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/jah3-3-e000472.PMC3959671.pdf
Available at http://seer.Cancer.Gov/statfacts/html/breast.Html.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/jah3-3-e000472.PMC3959671.pdf
Available at: http://www.nccn.org.,Non-OADS,/arxiv_data1/oa_pdf/07/0e/jah3-3-e000472.PMC3959671.pdf
Available at: http://support.sas.com/documentation/ cdl/en/statug/63033/HTML/default/viewer.htm#statug_glm_a0000000866.,OADS,/arxiv_data1/oa_pdf/02/1e/jah3-3-e000584.PMC3959672.pdf
‡See http://www.genpat.uu.se/mtDB.,Non-OADS,/arxiv_data1/oa_pdf/30/de/jah3-3-e000437.PMC3959674.pdf
†See the online mitochondrial genome database http://www.mitomap.org and http://www.genpat.uu.se/mtDB/ DOI: 10.1161/JAHA.113.000437 Journal of the American Heart Association 10tRNA Variants Linked With Coronary Heart Disease Qin et alORIGINAL RESEARCH,Non-OADS,/arxiv_data1/oa_pdf/30/de/jah3-3-e000437.PMC3959674.pdf
Available at: http://www.cdc.gov/nchs/fastats/ heart.htm.,Non-OADS,/arxiv_data1/oa_pdf/c3/70/jah3-3-e000615.PMC3959678.pdf
Available at: http://www.cdc.gov/growthcharts/ percentile_data_ ﬁles.htm.,OADS,/arxiv_data1/oa_pdf/c3/70/jah3-3-e000615.PMC3959678.pdf
Available at: http://www.cdc.gov/healthyweight/assessing/bmi/child- rens_bmi/about_childrens_bmi.html.,Non-OADS,/arxiv_data1/oa_pdf/c3/70/jah3-3-e000615.PMC3959678.pdf
Available at: http://www.cdc.gov/healthyyouth/yrbs/pdf/us_tobacco_tren- d_yrbs.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c3/70/jah3-3-e000615.PMC3959678.pdf
Using the Greedy matching macro (http://mayoresearch.mayo.edu/mayo/ DOI: 10.1161/JAHA.113.000382 Journal of the American Heart Association 2New-Onset AF in MI and Outcome Bang et alORIGINAL RESEARCH,Non-OADS,/arxiv_data1/oa_pdf/62/e1/jah3-3-e000382.PMC3959680.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/ content/3/1/e000400/suppl/DC1 Correspondence to: Raina M. Merchant, MD, MSHP, University of Pennsyl- vania, 423 Guardian Street 1022 Blockley Hall, Philadelphia, PA 19104.",Non-OADS,/arxiv_data1/oa_pdf/09/b6/jah3-3-e000400.PMC3959682.pdf
"The corrections have been made to the current online version of the article, which is available at http://jaha.aha-journals.org/content/3/1.toc.",Non-OADS,/arxiv_data1/oa_pdf/a7/11/jah3-3-e000792.PMC3959687.pdf
"An analysis of gene expression in relation to cellular components was performed using the Database for Annotation Visualization and Integrated Discovery (http://david.abcc.n-cifcrf.gov/), 17according to the classi ﬁcation of cellular components assigned by the Gene Ontology (GO) Consortium.",OADS,/arxiv_data1/oa_pdf/f8/d4/jah3-3-e000662.PMC3959693.pdf
"Primers were chosen based on a kB site in the dysferlin variant 1 promoter predicted by the TFSearch (http://www.cbrc.jp/research/db/ TFSEARCH.html), Promo (http://alggen.lsi.upc.es/cgi-bin/ promo_v3/promo/promoinit.cgi?dirDB=TF_8.3), and TFBIND (http://tfbind.hgc.jp/) programs.",OADS,/arxiv_data1/oa_pdf/f8/d4/jah3-3-e000662.PMC3959693.pdf
version of this table that includes gene function (neXProt [http://www.nextprot.org/db/]) and the GO biological pro- cesses for each gene (http://www.geneontology.org) is presented in Table 3.,OADS,/arxiv_data1/oa_pdf/f8/d4/jah3-3-e000662.PMC3959693.pdf
Available at: http://www.rcplondon.ac.uk/ sites/default/ ﬁles/national-sentinel-stroke-audit-2010-public-report-and- appendices_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/8e/jah3-3-e000408.PMC3959696.pdf
Available at: https://sitsinternational.org/homefoldercontent/publications/sits-publi cations.,Non-OADS,/arxiv_data1/oa_pdf/d8/8e/jah3-3-e000408.PMC3959696.pdf
Available at: http://data.gov.uk/publisher/nhs-information-centre-for-health-and-social-care.,Non-OADS,/arxiv_data1/oa_pdf/d8/8e/jah3-3-e000408.PMC3959696.pdf
Available at: http://www.basp.ac.uk/Portals/2/BASP%20Masterclass%20Mar%202011% 20Thrombolysis%20evidence%20update%20handout.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/8e/jah3-3-e000408.PMC3959696.pdf
Available at: http://www.rcplondon.ac.uk/ sites/default/ ﬁles/sinap-comprehensive-public-report-2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/8e/jah3-3-e000408.PMC3959696.pdf
Available at: http://www.shapeup.org/resources/10ksteps.,Non-OADS,/arxiv_data1/oa_pdf/2a/79/jah3-3-e000702.PMC3959701.pdf
"Accompanying Figures S1 through S4 are available at http://jaha.ahajour- nals.org/content/3/1/e000493/suppl/DC1 Correspondence to: Laura J. Parry, PhD, Gate 12, Department of Zoology, The University of Melbourne, Parkville, VIC, 3010 Australia.",Non-OADS,/arxiv_data1/oa_pdf/d7/b2/jah3-3-e000493.PMC3959707.pdf
Available at: http://www.capc.org/tools-for-palliative-care-programs/ marketing/public-opinion-research/2011-public-opinion-research-on-palliative- care.pdf.,Non-OADS,/arxiv_data1/oa_pdf/52/d9/jah3-3-e000742.PMC3959710.pdf
"Accompanying Tables S1 through S3 are available at http://jaha.ahajour- nals.org/content/3/1/e000394/suppl/DC1 Correspondence to: Raphael Schiffmann, MD, Institute of Metabolic Disease 3812 Elm Street, Dallas, TX 75226.",Non-OADS,/arxiv_data1/oa_pdf/8a/a4/jah3-3-e000394.PMC3959711.pdf
Available at: http://knhanes.cdc.go.kr/.,Non-OADS,/arxiv_data1/oa_pdf/4c/e2/jah3-3-e000650.PMC3959713.pdf
A copy of the document is available at http://my.americanheart.org/statements by selecting either the “By Topic ”link or the “By Publication Date ”link.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
"For more on AHA statements and guidelines development, visit http://my.americanheart.org/statements and select the “Policies and Development ”link.",Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
http://www.fda.gov/TobaccoProducts/Labeling/ucm259214.htm.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/.,OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.thecommunityguide.org/tobacco/RRincreasingunitprice.html.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.tobaccofreekids.org/research/factsheets/ pdf/0097.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.nytimes.com/1994/05/ 24/us/mississippi-seeks-damages-from-tobacco-companies.html.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.naag.org/tobac/cigmsa.rtf.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.tobaccofreekids.org/press_ releases/post/2011_11_30_state_report.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.tobaccofreekids.org/press_ releases/post/2013_05_21_minnesota.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://newsroom.heart.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.gpo.gov/ fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.gpo.gov/ fdsys/pkg/PLAW-111publ31/pdf/PLAW-111publ31.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: https://www.tobaccofreekids.org/research/factsheets/pdf/0352.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://news.yahoo.com/apnewsbreak- us-revise-cigarette-warning-190137686.html.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.surgeongeneral.gov/ library/reports/.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.mdanderson.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: https://extranet.who.int/iris/restricted/bitstream/10665/85381/1/WHO_ NMH_PND_13.2_eng.pdf.,OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.tobaccofreekids.org/what_we_do/state_local/ tobacco_settlement/california.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
"November 2, 2013. http://thehill.com/blogs/ regwatch/pending-regs/189030-e-cigarette-makers-ramp-up-lobbying-efforts.",Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.prweekus.com/rise-of-e-cigarettes-sparks- tobacco-industry-plans/article/317734/.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.allgov.com/news/top-stories/2-billion-dollar-e-cigarette-industry- unleashes-lobbying-blitz-to-limit-taxes-and-regulation-131010?news=851357.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
- Available at: http://www.heart.org/idc/groups/heart-public/@wcm/@adv/ documents/downloadable/ucm_321035.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.no-smoke.org/pdf/100ord- listtabs.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Available at: http://www.tobaccofreekids.,Non-OADS,/arxiv_data1/oa_pdf/8a/e0/jah3-3-e000740.PMC3959714.pdf
Accompanying Figures S1 through S10 are available at http://jaha.ahajour- nals.org/content/3/1/e000520/suppl/DC1 *Drs.,Non-OADS,/arxiv_data1/oa_pdf/d4/0e/jah3-3-e000520.PMC3959719.pdf
"An accompanying supplemental material is available at http://jaha.aha journals.org/conten/3/1/e000467/suppl/DC1 Correspondence to: Sabine Eichinger, MD, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Wien/Austria.E-mail: sabine.eichinger@meduniwien.ac.at Received October 2, 2013; accepted November 13, 2013.ª2013 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d6/d7/jah3-3-e000467.PMC3959721.pdf
"On the basis of these variables, we developed a nomogram and a web-based risk calculator (http://cemsiis.meduniwien.ac.at/en/kb/science- research/software/clinical-softw are/recurrent-vte/) to calculate risk scores and to estimate the cumulative probability of recurrence in an individual patient.",OADS,/arxiv_data1/oa_pdf/d6/d7/jah3-3-e000467.PMC3959721.pdf
"All analyses were carried out using SAS Version 9.3 (2011 SAS Institute Inc, Cary, NC) and R version 2.12.2 (http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/d6/d7/jah3-3-e000467.PMC3959721.pdf
"To facilitate application of this model in routine clinical care, a web-based calculator is provided at http://www.meduniwien.ac.at/ user/georg.heinze/dvpm/.",Non-OADS,/arxiv_data1/oa_pdf/d6/d7/jah3-3-e000467.PMC3959721.pdf
Available at: http://cemsiis.meduniwien.ac.at/en/kb/science- research/software/statistical-software/pshreg.,OADS,/arxiv_data1/oa_pdf/d6/d7/jah3-3-e000467.PMC3959721.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/a0/jir-7-019.PMC3959804.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Inflammation Research 2014:7 19–27Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  19RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S3807 9Alemtuzumab in the treatment   of multiple sclerosis Óscar Fernandez Institute of Clinical Neuroscience,   Neurology Department, Hospital  Regional Universitario Carlos Haya,   FIMABIS, Malaga, Spain Correspondence: Óscar Fernandez   Institute of Clinical Neuroscience,  Neurology Department, IBIMA   (Instituto de Investigación Biomédica   de Málaga), Hospital Universitario  Regional de Málaga - Universidad de  Málaga Avda, de Carlos Haya sn,   29010 Málaga, Spain   Tel +34 95 1291 135   Fax +34 95 1291 157   email oscar.fernandez.sspa@ juntadeandalucia.e sAbstract:  Alemtuzumab (formerly known as Campath-1H) has recently been approved by the  European Medicines Agency for highly-active, relapsing-remitting multiple sclerosis (MS).",Non-OADS,/arxiv_data1/oa_pdf/79/a0/jir-7-019.PMC3959804.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/79/a0/jir-7-019.PMC3959804.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/a0/jir-7-019.PMC3959804.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/5f/jir-7-029.PMC3959805.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Inflammation Research 2014:7 29–38Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  29ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S5567 2systemic sensitization with the protein   allergen ovalbumin augments local   sensitization in atopic dermatitis Jane Y oo1 anne M Manicone2 John K Mcguire3 Ying Wang2 William c Parks2 1center for lung Biology, Department  of Medicine, Division of Dermatology,   2Division of Pulmonary and critical  care Medicine, 3Department of  Pediatrics, Division critical care  Medicine, University of Washington,   seattle, W a, Usa correspondence: William c Parks   Women’s guild lung Institute,   cedars-sinai Medical center,   8700 Beverly Blvd, los angeles,   ca 90048 Usa   Tel +1 424 315 4307   Fax +1 310 967 8370   email bill.parks@cshs.or gAbstract:  Mouse models of atopic dermatitis based on epicutaneous sensitization have shed light  on the role of epicutaneous allergen entry in the development of respiratory and gastrointestinal  allergy.",Non-OADS,/arxiv_data1/oa_pdf/5a/5f/jir-7-029.PMC3959805.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/5a/5f/jir-7-029.PMC3959805.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/5f/jir-7-029.PMC3959805.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/3c/pgpm-7-079.PMC3959807.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPharmacogenomics and Personalized Medicine 2014:7 79–85Pharmacogenomics and Personalized Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  79Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S5770 0Role of brentuximab vedotin in the treatment   of relapsed or refractory Hodgkin lymphoma Tanya Siddiqi Sandra H Thomas Robert Chen City of Hope, Department of  Hematology and Hematopoietic Cell  Transplantation, Duarte, CA, USAAbstract:  Brentuximab vedotin (BV) is an antibody-drug conjugate that targets CD30-positive  malignancies via an anti-CD30 monoclonal antibody linked to monomethyl auristatin E,  a microtubule-disrupting agent, by a protease-cleavable linker.",Non-OADS,/arxiv_data1/oa_pdf/47/3c/pgpm-7-079.PMC3959807.pdf
"Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journa lPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype  on pharmacology leading to the development of personalized treatment  programs and individualized drug selection for improved safety, efficacy  and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/47/3c/pgpm-7-079.PMC3959807.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/47/3c/pgpm-7-079.PMC3959807.pdf
Available from http://clinicaltrials.gov/show/NCT0139371 7.,Non-OADS,/arxiv_data1/oa_pdf/47/3c/pgpm-7-079.PMC3959807.pdf
Available from http://clinicaltrials.gov/ct2/show/NCT015083 12?term=NCT01508312&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/47/3c/pgpm-7-079.PMC3959807.pdf
Available from  http://clinicaltrials.gov/ct2/show/NCT01712490?term=NCT01712490& rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/47/3c/pgpm-7-079.PMC3959807.pdf
Available  from http://clinicaltrials.gov/show/NCT0171680 6.,Non-OADS,/arxiv_data1/oa_pdf/47/3c/pgpm-7-079.PMC3959807.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/80/jet187.PMC3959994.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 10744 - DOI: 10.3402/snp.v2i0.10744",Non-OADS,/arxiv_data1/oa_pdf/a0/bf/SNP-2-10744.PMC3960018.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 14874 - DOI: 10.3402/snp.v2i0.14874",Non-OADS,/arxiv_data1/oa_pdf/22/9e/SNP-2-14874.PMC3960019.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) Licence (http://creativecommons.org/licenses/by/3.0/), permitting all non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20767 - http://dx.doi.org/10.3402/snp.v3i0.20767",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"What Kuhn would term a para- digmatic ‘crisis’ has emerged with neuroscience develop- ing what is essentially a parallel /C1and, obviously to theDonald L. Hilton 2 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20767 - http://dx.doi.org/10.3402/snp.v3i0.20767",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"For that matter, where are the prospective child-based cocaine, heroin, and alcohol studies?Pornography addiction Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20767 - http://dx.doi.org/10.3402/snp.v3i0.20767 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"Sex, as a powerful brain reward, has shown evidence of increasing silent synapses, which manifest as an increase in the NMDA /C1AMPA receptor ratio, aDonald L. Hilton 4 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20767 - http://dx.doi.org/10.3402/snp.v3i0.20767",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"Even public opinion seems to be trying to describe this biologic phenomenon, as in this statement from NaomiPornography addiction Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20767 - http://dx.doi.org/10.3402/snp.v3i0.20767 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"It is notsurprising that Thomas Insel, director of the NationalInstitute of Mental Health, has lamented this continueddeficiency in the DSM in stating, ‘‘ A diagnostic approachbased on the biology as well as the symptoms must not be constrained by the current DSM categories ...’’ (April 29, 2013, http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml).",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"Mayo Clinic Proceedings ,83(2), 226 /C1230.Donald L. Hilton 6 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20767 - http://dx.doi.org/10.3402/snp.v3i0.20767",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"Retrieved June 14, 2013, from http://www.salon.com/ 2012/03/20/santorums_bad_porn_science/ Coq, J. O., & Xerri, C. (1999).",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"Hippocampus ,16, 1091 /C11101.Pornography addiction Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20767 - http://dx.doi.org/10.3402/snp.v3i0.20767 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"Retrieved June 14, 2013, from http://archive.org/details/tobacco_mmp91f00 Wallace, D. L., Vialou, V ., Rios, L., Carle-Florence, T. L., Chakravarty, S., Arvind Kumar, A., et al.",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"Retrieved June 14, 2013, from http://nymag.com/nymetro/news/trends/n_9437/ Yamamoto, K., & Vernier, P .",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"*Donald L. Hilton Jr. 4410 Medical DriveSuite 610San Antonio Texas, 77829 USAEmail: dhiltonjr@sbcglobal.netDonald L. Hilton 8 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20767 - http://dx.doi.org/10.3402/snp.v3i0.20767",Non-OADS,/arxiv_data1/oa_pdf/4c/a9/SNP-3-20767.PMC3960020.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) Licence (http://creativecommons.org/licenses/by/3.0/), permitting all non-commercial use, distribution , and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"In some instances, they canprove to be misleading, such as when a gambler interprets the near-miss as a positive sign of their strategy or whenDamien Brevers and Xavier Noe ¨l 2 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"For instance, Dixon, Trigg, &Pathological Gambling and the Loss of Willpower Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"PutDamien Brevers and Xavier Noe ¨l 4 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"This associationPathological Gambling and the Loss of Willpower Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"a little man) toward substance-related pictures and away from neutral pictures (the ‘approach substance’ block), and, in another block, to move the manikin away from the substance-related pictures andDamien Brevers and Xavier Noe ¨l 6 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"Using the fMRI technique, Power andcollaborators (2012) have observed that, during high-risk choice in the IGT, pathological gamblers exhibited increased activation in regions encompassing the ex- tended reward pathway, including brain areas involved in the integration of emotional and cognitive input (i.e.the OFC; Rolls & Grabenhorst, 2008) and in reactivityPathological Gambling and the Loss of Willpower Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"Indeed, pathological gamblers are less sensitive to monetary reward and loss than non-gamblers (de Ruiter et al., 2009; Reuter et al., 2005; Tanabe et al., 2007; but seeDamien Brevers and Xavier Noe ¨l 8 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"With regard to pathological gambling, a couple of studies showed thatproblem gamblers exhibit high gambling-related crav- ings after viewing a series of gambling-related pictures (Goudriaan et al., 2010) or videos (Crockford, Goodyear,Pathological Gambling and the Loss of Willpower Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"The development ofDamien Brevers and Xavier Noe ¨l 10 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"Finally, with regard to clinical practice, the adoption of cognitive interventions aiming at moderating the actions of impulsive processes or at boosting reflective resourcesmay provide a useful tool for helping pathologicalPathological Gambling and the Loss of Willpower Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"Impulsive actionDamien Brevers and Xavier Noe ¨l 12 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"Drug and Alcohol Dependence ,84, 231/C1239.Pathological Gambling and the Loss of Willpower Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"Automaticity of cognitive biases in addictive behaviours: Further evidence with gamblers.The British Journal of Clinical Psychology ,36, 543/C1554.Damien Brevers and Xavier Noe ¨l 14 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"Neuron ,36, 241/C1263.Pathological Gambling and the Loss of Willpower Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"*Damien Brevers Laboratory of Medical Psychology and Addictology, CHU-Brugmann Universite ´Libre de Bruxelles Van Gehuchten 4, 1020, BrusselsBelgium Email: dbrevers@ulb.ac.beDamien Brevers and Xavier Noe ¨l 16 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21592 - http://dx.doi.org/10.3402/snp.v3i0.21592",Non-OADS,/arxiv_data1/oa_pdf/16/3d/SNP-3-21592.PMC3960021.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) Licence (http://creativecommons.org/licenses/by/3.0/), permitting all non-commercial use, distribution , and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"2 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"Initial plans called for patients in treatment for sexual addiction to be recruited, but the local InstitutionalReview Board prohibited this recruitment on the grounds Table 1 .Demographic characteristics of sample ( N/C3052) Demographic Mean (SD) Age 24.35 (4.92)Group Frequency % of sample Ethnicity White 45 86.5 Asian 1 1.9Hispanic 4 7.7Native American 2 3.8 Relationship status Exclusive 28 53.8Nonexclusive 12 23.1Not in relationship 11 21.2No answer 1 1.9 Sexual behavior with partner (past month) Not once 5 9.6 Once a month 2 3.8Several times a month 6 11.5Once or twice a week 11 21.2Several times a week 22 42.3At least once a day 6 11.5 Different sexual partners (past year) 0 1 1.91 25 48.12/C15 16 30.8 6/C110 6 11.5 11/C120 3 5.8 No answer 1 1.9Neurophysiological measure of sexual motivation Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"4 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"The scale has beenshown to be internally consistent for positive (Cronbach’sa/C300.91) and negative (Cronbach’s a/C300.82) effect dimen-Neurophysiological measure of sexual motivation Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"6 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"In addition,forcing entry of hypersexual measures before the sexual desiremeasure still resulted in only sexual desire significantly predictingP300 amplitude.Neurophysiological measure of sexual motivation Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"8 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"A scatter plot depicting the relationship between P300 amplitude to neutral stimuli, P300 amplitude to pleasant /C1sexual stimuli, and the measure of sexual desire (dyadic).Neurophysiological measure of sexual motivation Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"10 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"Sexual Addiction & Compulsi vity,8(3/C14), 301/C1307.Neurophysiological measure of sexual motivation Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"12 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20770 - http://dx.doi.org/10.3402/snp.v3i0.20770",Non-OADS,/arxiv_data1/oa_pdf/02/64/SNP-3-20770.PMC3960022.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2011, 1: 5892 - DOI: 10.3402/snp.v1i0.5892",Non-OADS,/arxiv_data1/oa_pdf/cb/04/SNP-1-5892.PMC3960023.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) Licence (http://creativecommons.org/licenses/by/3.0/), permitting all non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"2 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"Image preprocessing and statistics Standard spatial preprocessing was conducted using SPM5 (Wellcome Trust Centre for Neuroimaging, London, UK;http://www.fil.ion.ucl.ac.uk/spm/).",OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"a scrambled face).Assessing facial attractiveness Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"4 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"Neural activity in females’ left insula to attractive in contrast to unattractive male faces ( pB0.001).Assessing facial attractiveness Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"6 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"Neural activity in females’ right superior temporal gyrus to attractive in contrast to unattractive male faces ( pB0.001).Assessing facial attractiveness Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"8 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"Electrophysiological correlates of processing facialAssessing facial attractiveness Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"10 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"6, 7624Pe´cs, Hungary Email: kocsorferenc@gmail.comAssessing facial attractiveness Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21432 - http://dx.doi.org/10.3402/snp.v3i0.21432 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/48/a1/SNP-3-21432.PMC3960024.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"2 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"Though this component appears not to be affected by the emo- tional content of stimuli (Macnamara et al., 2009), when participants are instructed to change the way they think about a photograph in order to alter their emotional experience (Bernat, Cadwallader, Seo, Vizueta, & Patrick,2011; Langeslag & Van Strien, 2010) or when con- textual information is provided about a photograph to implicitly alter the associated emotional experienceResponses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"4 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"For the measurement of regulation of particularemotions during the experimental paradigm, we separated items referring to positive from those referring to negativeResponses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"6 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"An additional sample of 38 Chinese females(mean age 21 years; SD: 2.56; range: 18 /C126) rated pho- tographs of the two researchers (in counterbalancedorder; all rated both researchers as completely unfamiliar).The British and Chinese researchers did not signifi-cantly differ in perceived attractiveness, trustworthi- ness, friendliness, generosity, authority, how nervousResponses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"8 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"(B /C1D) Illustrate the comparison of dissimilar versus alone, dissimilar versus similar and similar versus alone conditions respectively and show (i) differential N1 amplitudes to positive relative to neutral and negative relative to neutral stimuli (signiﬁcant simple effects marked with an asterisk) and (ii) topography maps for the relevant contrast in differential N1 across conditions.Responses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"10 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"(C) Illustrates the topography map for the amplitude decrease in responses to positive trials in the similar relative to the alone condition.Responses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"12 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"These findings will be discussed in turn below.Responses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"14 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"Thus, it is possible that increased informationwas available to participants on the similar researcher’snegative emotions compared to the dissimilar researcher’s emotions, resulting in a more negative interpretation ofResponses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"16 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"Reduced facial expression and social context in major depression: Discrepancies betweenResponses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 17 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"doi: http://dx.doi.org/10.1093/ scan/nss036 Ochsner, K. N., Bunge, S. A., Gross, J. J., & Gabrieli, J. D. E. (2002).",OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"18 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"Appendix B Block 1: Negative: 9265; 9419; 3061; 9560; 9480; 9409; 9901; 9611; 2703; 9433; 9425; 9570; 6570; 3140; 6260; 9635.1; 3068;6510; 3500; 3010; mean arousal: 6.03; mean valence: 2.30 Neutral: 7175; 7080; 7100; 7059; 7205; 7052; 7500; 7043; 7190; 7054 mean arousal: 3.05; mean valence: 5.13 Block 2: Negative: 9041; 9340; 9426; 2800; 9495; 3101; 9571; 9490; 9042; 2691; 3015; 9620; 6834; 6210; 9921; 3102; 3266; 3130; 9410; 3080; mean arousal: 6.02; mean valence: 2.35 Neutral: 7187; 7041; 7025; 7140; 7009; 7170; 7186; 7242; 7042; 7188; mean arousal: 3.25; mean valence: 5.12Block 3: Negative: 9561; 6610; 6825; 9520; 9427; 3062; 6555; 9120; 9420; 9500; 9902; 9405; 6415; 3064; 9600; 6300; 3530; 3100; 3069; 3000; mean arousal: 6.01; mean valence: 2.36 Responses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 19 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"20 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"(yes, no) if ‘‘yes’’ go to question 15, if ‘‘no’’ go to question 16Responses to emotional stimuli across social contexts Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500 21 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"22 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20500 - http://dx.doi.org/10.3402/snp.v3i0.20500",Non-OADS,/arxiv_data1/oa_pdf/56/6c/SNP-3-20500.PMC3960026.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 17340 - DOI: 10.3402/snp.v2i0.17340",Non-OADS,/arxiv_data1/oa_pdf/67/66/SNP-2-17340.PMC3960032.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 17337 - DOI: 10.3402/snp.v2i0.17337",Non-OADS,/arxiv_data1/oa_pdf/1b/4b/SNP-2-17337.PMC3960033.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction i n any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21840 - http://dx.doi.org/10.3402/snp.v3i0.21840",Non-OADS,/arxiv_data1/oa_pdf/a3/b0/SNP-3-21840.PMC3960034.pdf
"New Y ork: Harper Perennial.Adam Safron 2 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21840 - http://dx.doi.org/10.3402/snp.v3i0.21840",Non-OADS,/arxiv_data1/oa_pdf/a3/b0/SNP-3-21840.PMC3960034.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2011, 1: 6420 - DOI: 10.3402/snp.v1i0.6420",Non-OADS,/arxiv_data1/oa_pdf/66/07/SNP-1-6420.PMC3960045.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 17336 - DOI: 10.3402/snp.v2i0.17336",Non-OADS,/arxiv_data1/oa_pdf/c9/0e/SNP-2-17336.PMC3960046.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 11814 - DOI: 10.3402/snp.v2i0.11814",Non-OADS,/arxiv_data1/oa_pdf/f6/25/SNP-2-11814.PMC3960064.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"Researchers have since learned about the epigenetic effects of nutrient chemicals and food odors on energyJames Vaughn Kohl 2 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"Sensory input is the proximate cause of hormone release, which means that hormone release correlated with brain imagery isNutrient-dependent/pheromone-controlled adaptive evolution Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"That fact can now be discussed in the context ofJames Vaughn Kohl 4 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"The mammalian model.Nutrient-dependent/pheromone-controlled adaptive evolution Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"The recently detailed mouse model (Li et al., 2013) builds on what is known about olfactory/pheromonalcommunication in species from microbes to manand incorporates works from mammals that elucidatethe molecular mechanisms that are clearly involved.Sex-dependent production of a mouse ‘chemosignal’with incentive salience appears to have arisen de no vo via coincident adaptive evolution that involves an ob- vious two-step synergy between commensal bacteria andJames Vaughn Kohl 6 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"Thissuggests that questions about the adaptive evolution of species diversity (Papasaikas & Valcarcel, 2012) are notNutrient-dependent/pheromone-controlled adaptive evolution Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"However the nutrient-dependentsubstitution of alanine for valine (Grossman et al., 2013;Kamberov et al., 2013) appears to result in species-specific organism-level changes in skin, glands, and hair, through pheromone-controlled reproduction.James Vaughn Kohl 8 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"Issues for further consideration Highly conserved ligand /C1receptor signaling mechanisms are the biochemical mechanisms of ecological epigenetics.Nutrient-dependent/pheromone-controlled adaptive evolution Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"Maternal choline intake alters theJames Vaughn Kohl 10 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"Science ,211(4488), 1263 /C11264.Nutrient-dependent/pheromone-controlled adaptive evolution Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"Retrieved from: http://dx.doi.org/10.1016/j.pbiomolbio.2012.08.016 Stearns, S. C. (2012).",OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"*James Vaughn Kohl 175 Crimson LaneEpworth, Georgia USA 30541 Email: jvkohl@bellsouth.netJames Vaughn Kohl 12 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 20553 - http://dx.doi.org/10.3402/snp.v3i0.20553",Non-OADS,/arxiv_data1/oa_pdf/dc/31/SNP-3-20553.PMC3960065.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported (CC BY 3.0) License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, an d reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"2 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"Given the considerable volume of factors implicated inVulnerability factors to alcohol and problematic use in adolescent Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"4 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"Initial high levels of sensation seeking assessed at baseline in early adolescence haveVulnerability factors to alcohol and problematic use in adolescent Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"6 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"For example, neuropsychological deficiencies, weaksocial support, stressful life events, childhood mistreat- ment, alcohol availability (Clark & Winters, 2002), earlyVulnerability factors to alcohol and problematic use in adolescent Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"8 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"Retrieved April 2, 2009 from www.istrategylabs.comVulnerability factors to alcohol and problematic use in adolescent Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"10 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"Child de velopment ,75(5), 1357 /C11372.Vulnerability factors to alcohol and problematic use in adolescent Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"12 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"Mechanisms of attention: A developmental study.Journal of experimental child psychology ,48(3), 353 /C1378.Vulnerability factors to alcohol and problematic use in adolescent Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"14 (page number not for citation purpose)Citation: Socioaffective Neuroscience & Psychology 2013, 3: 21890 - http://dx.doi.org/10.3402/snp.v3i0.21890",Non-OADS,/arxiv_data1/oa_pdf/64/ee/SNP-3-21890.PMC3960066.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 17415 - DOI: 10.3402/snp.v2i0.17415",Non-OADS,/arxiv_data1/oa_pdf/1e/6f/SNP-2-17415.PMC3960067.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 17333 - DOI: 10.3402/snp.v2i0.17333",Non-OADS,/arxiv_data1/oa_pdf/b2/ef/SNP-2-17333.PMC3960068.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 17334 - DOI: 10.3402/snp.v2i0.17334",Non-OADS,/arxiv_data1/oa_pdf/74/2c/SNP-2-17334.PMC3960069.pdf
Available online at http://sierraclub.typepad.com/explore/2011/11/yosemite-frederick-law-olmstead.html??,Non-OADS,/arxiv_data1/oa_pdf/74/2c/SNP-2-17334.PMC3960069.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 17335 - DOI: 10.3402/snp.v2i0.17335",Non-OADS,/arxiv_data1/oa_pdf/72/a2/SNP-2-17335.PMC3960070.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Socioaffective Neuroscience & Psychology 2012, 2: 17338 - DOI: 10.3402/snp.v2i0.17338",Non-OADS,/arxiv_data1/oa_pdf/c0/6b/SNP-2-17338.PMC3960071.pdf
"Hormonesand Behavior , Retrieved 13 Jan 12 http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c0/6b/SNP-2-17338.PMC3960071.pdf
"OncoImmunology 2013; 2:e27359 http://dx.doi.org/10.4161/onci.27359Chemotherapeutic targeting   of myeloid-derived suppressor cells Darya a lizadeh1,2, emmanuel Katsanis1,2,3, and Nicolas Larmonier1,2,3,* 1Department of Pediatrics; s teele Children’s r esearch Center; the u niversity of a rizona Cancer Center; Tucson, a Z usa ;   2Cancer Biology Graduate Program; u niversity of a rizona; Tucson, a Z usa ; 3Department of Immunobiology and BIO5 Institute; u niversity of a rizona; Tucson, a Z usa Keywords:  cancer, chemoimmunomodulation, doxorubicin, helper T lymphocytes, myeloid-derived suppressor cells, ROS Abbreviations: IDO1, Indoleamine 2,3-dioxygenase 1; MDSC, myeloid-derived suppressor cell; ROS, reactive oxygen species Myeloid-derived suppressor cells (MD sCs), which expand in cancer-bearing hosts, contribute to the escape of malig - nant cells from immune destruction and impair the efficacy of immunotherapeutic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
Nat Rev Cancer 2008; 8:618- 31; PMID:18633355 ; http://dx.doi.org/10.1038/ nrc24443.,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
Cancer Immunol Immunother 2010; 59:1593-600;  PMID:20414655 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798 ; http://dx.doi.org/10.1038/ nrd36265.,OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
Cancer Res 2006; 66:9299-307; PMID:16982775 ;  http://dx.doi.org/10.1158/0008-5472.CAN-06-1690,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
Clin Cancer Res  2010; 16:4583-94;  PMID:20702612 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
Clin Cancer Res 2005; 11:6713-21;  PMID:16166452 ; http://dx.doi.org/10.1158/1078- 0432.CCR-05-08838.,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
Cancer Res 2010; 70:3052-61; PMID:20388795 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-36909.,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
Cancer Res  2013;Forthcoming; http://dx.doi.org/10.1158/0008- 5472.CAN-13-1545 ; PMID:24197130 10.,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
Blood 2013; 121:2402- 14; PMID:23325835 ; http://dx.doi.org/10.1182/ blood-2012-09-378653,Non-OADS,/arxiv_data1/oa_pdf/d0/b1/onci-3-e27359.PMC3960296.pdf
"OncoImmunology 2013; 2:e27258; http://dx.doi.org/10.4161/onci.27258A novel system for cloning human TCRs Cutting short the way to TCR-based anticancer therapy eiji Kobayashi, h iroyuki Kishi*, and a tsushi Muraguchi Department of Immunology; Graduate s chool of Medicine and Pharmaceutical s ciences; u niversity of Toyama; Toyama, Japan Keywords:  gene therapy, hTEC10, single-cell RT-PCR, T-cell receptor T-cell receptor (TC r)-based gene immunotherapy has emerged as a promising approach for the treatment of multiple  malignancies.",Non-OADS,/arxiv_data1/oa_pdf/3e/6d/onci-3-e27258.PMC3960297.pdf
Nat Med 2013;  19:1542-6 ; http://dx.doi.org/10.1038/nm.3358 ;  PMID:24121927 2.,OADS,/arxiv_data1/oa_pdf/3e/6d/onci-3-e27258.PMC3960297.pdf
Biochem Biophys  Res Commun  2008 ; 367:820-5; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3e/6d/onci-3-e27258.PMC3960297.pdf
J Clin  Invest  2011 ; 121:288-95; http://dx.doi.org/10.1172/ JCI44752 ; PMID:21135507 6.,Non-OADS,/arxiv_data1/oa_pdf/3e/6d/onci-3-e27258.PMC3960297.pdf
Sci Transl  Med 2013 ; 5:192ra87 ; http://dx.doi.org/10.1126/ scitranslmed.3005958 ; PMID:23825303 8.,OADS,/arxiv_data1/oa_pdf/3e/6d/onci-3-e27258.PMC3960297.pdf
Blood  2013 ; 122:863-71;  http://dx.doi.org/10.1182/blood-2013-03-490565 ;  PMID:23770775 9.,Non-OADS,/arxiv_data1/oa_pdf/3e/6d/onci-3-e27258.PMC3960297.pdf
J Immunol  2010 ; 184:4936 - 46; http://dx.doi.org/10.4049/jimmunol.1000173 ;  PMID:20351194,Non-OADS,/arxiv_data1/oa_pdf/3e/6d/onci-3-e27258.PMC3960297.pdf
"OncoImmunology 2013; 2:e27219; http://dx.doi.org/10.4161/onci.27219Early predictive value of multifunctional  skin-infiltrating lymphocytes in anticancer  immunotherapy Florian w immers1, erik h JG a arntzen2, Gerty s chreibelt1, Joannes FM Jacobs3,   Cornelis J a Punt4, Carl G Figdor1,and I Jolanda M de Vries1,2,* 1Department of Tumor Immunology; r adboud u niversity Nijmegen Medical Centre; Nijmegen, The Netherlands; 2Department of Medical Oncology;   radboud u niversity Nijmegen Medical Centre; Nijmegen, The Netherlands; 3Department of Laboratory Medicine; r adboud u niversity Nijmegen Medical Centre;   Nijmegen, The Netherlands; 4Department of Medical Oncology; a cademic Medical Center; u niversity of a msterdam; a msterdam, The Netherlands Keywords:  biomarker, DC-based vaccination, delayed-type hypersensitivity, immunomonitoring,  melanoma, multifunctional T cells, skin-infiltrating lymphocytes Abbreviations: DC, dendritic cell; DTH, delayed-type hypersensitivity; KLH, keyhole limpet hemocyanin;   SKIL, skin infiltrating lymphocyte, TAA, tumor-associated antigen.",Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
Clin Cancer Res 2012; 18:5460-70; PMID:22896657 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-3368 2.,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
Clin Cancer Res  2010; 16:5067-78;  PMID:20736326 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
Cancer Immunol Immunother  2011; 60:249-60;  PMID:21069321 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
J Clin Oncol 2012; 30:1835-41; PMID:22529253 ;  http://dx.doi.org/10.1200/JCO.2011.40.2271 5.,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
J Cancer Res Clin Oncol 2001;  127(Suppl 2):R1-2;  PMID:11768617 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
Curr Opin Immunol  2003 ; 15:131-7;  PMID:12633661 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
Cancer Immunol Immunother 2008; 57:303-15;  PMID:17721781 ;  http://dx.doi.org/10.1007/s00262-007-0380-68.,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
J Clin Oncol 2005; 23:5779- 87; PMID:16110035 ; http://dx.doi.org/10.1200/ JCO.2005.06.478 9.,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
Cancer Res 2012; 72:6102-10; PMID:23010076 ;  http://dx.doi.org/10.1158/0008-5472.CAN-12-2479 10.,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
Blood 2006; 107:4781-9;  PMID:16467198 ; http://dx.doi.org/10.1182/ blood-2005-12-4818,Non-OADS,/arxiv_data1/oa_pdf/d2/84/onci-3-e27219.PMC3960298.pdf
Published  by  Elsevier  Ltd.   http://dx.doi.org/10.1016/j.dcn.2013.09.007Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/11/fa/main.PMC3960306.pdf
"Supplementary  data Supplementary  data  associated  with  this  article  can  be found, in  the  online  version,  at  http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/11/fa/main.PMC3960306.pdf
Published by Elsevier Ltd.     http://dx.doi.org/10.1016/j.dcn.2013.10.002Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/a5/dc/main.PMC3960326.pdf
Published  by  Elsevier  Ltd.   http://dx.doi.org/10.1016/j.dcn.2013.12.003Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
ROIs  were  deﬁned  using  PickAtlas  3.0.3 (http://fmri.wfubmc.edu/software/PickAtlas).,OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"AlphaSim  (http://afni.nimh.nih.gov/afni/)  cluster extent thresholds  were  calculated  a  priori  to  determine the minimum  cluster  size  necessary  to  maintain  a  cor- rected p  <  0.05  for  each  ROI  (cluster  extent  thresholds: striatum =  189  voxels,  mPFC  =  178  voxels,  OFC  =  62  voxels, amygdala =  62  voxels).",OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"7  (4),  268–277, http://dx.doi.org/10.1038/nrn1884.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"31  (4), 183–191, http://dx.doi.org/10.1016/j.tins.2008.01.004.",OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Psychiatry  42  (12),  1469–1477, http://dx.doi.org/10.1097/00004583-200312000-00014.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"32  (1),  1–19, http://dx.doi.org/10.1016/j.neubiorev.2007.04.016.",OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"9 (4), 241–273, http://dx.doi.org/10.1207/s15327965pli0904  1.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Psychiatry  29  (4), 571–580, http://dx.doi.org/10.1097/00004583-199007000-00010.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"17  (03),  827–850,  http://dx.doi.org/10.1017/S095457940505039X.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"J.  Psychiatry  166 (1),  64–73,  http://dx.doi.org/10.1176/appi.ajp.2008.07081336.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"10  (1),  107–118, http://dx.doi.org/10.3758/CABN.10.1.107.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"30  (4),  467–483, http://dx.doi.org/10.1037/0012-1649.30.4.467.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"3  (2),  91–96, http://dx.doi.org/10.1093/scan/nsn003.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Psychiatry  45  (9),  1059–1067, http://dx.doi.org/10.1097/01.chi.0000227882.50404.11.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Psychiatry  41  (4),  441–455, http://dx.doi.org/10.1111/1469-7610.00629.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"36  (5),  663–677, http://dx.doi.org/10.1007/s10802-007-9206-4.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Child  Psychiatry  36  (7),  980–988, http://dx.doi.org/10.1097/00004583-199707000-00021.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"39  (4),  506–521, http://dx.doi.org/10.1080/15374416.2010.486320.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Health  47  (5), 526–528,  http://dx.doi.org/10.1016/j.jadohealth.2010.03.016.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Disorders 29 (2–3), 85–96, http://dx.doi.org/10.1016/0165-0327(93)90026-G. Kessler,  R.C.,  Berglund,  P.,  Demler,  O.,  Jin,  R.,  Merikangas,  K.R., Walters,  E.E.,  2005.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Gen.  Psychiatry  62  (6),  593–602, http://dx.doi.org/10.1001/archpsyc.62.6.593.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Psychiatry  38  (3),  287–298, http://dx.doi.org/10.1111/j.1469-7610.1997.tb01513.x.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"41  (6),  971–984,  http://dx.doi.org/10.1037/ 0012-1649.41.6.971.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"27  (8),  986–1003,  http://dx.doi.org/10.1016/ j.cpr.2007.03.001.",OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"16  (2),  361–388,  http://dx.doi.org/10.1111/ j.1467-9507.2007.00389.x.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"35  (2),  163–174, http://dx.doi.org/10.1017/S0033291704003915.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Psychiatry  69  (11),  1019–1025,  http://dx.doi.org/10.1016/ j.biopsych.2010.12.014.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"J. Psychiatry 166  (6),  702–710, http://dx.doi.org/10.1176/appi.ajp.2008.08081201.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"29  (4-5),  649–674, http://dx.doi.org/10.1016/j.neubiorev.2005.03.011.",OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"11  (4),  389–397, http://dx.doi.org/10.1038/nn2066.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"PLoS ONE  7  (4),  e35744,  http://dx.doi.org/10.1371/journal.pone.0035744.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Health  52  (S2), S7–S13, http://dx.doi.org/10.1016/j.jadohealth.2012.05.006.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"4  (2),  158–165, http://dx.doi.org/10.1093/scan/nsn051.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Brain  130  (9),  2367–2374, http://dx.doi.org/10.1093/brain/awm150.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"76  (Pt  3),  577–594, http://dx.doi.org/10.1348/000709905X49890.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"28  (3),  386–395, http://dx.doi.org/10.1207/S15374424jccp280311.",Non-OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
"Disorders  100  (1–3),  221–226, http://dx.doi.org/10.1016/j.jad.2006.11.003.",OADS,/arxiv_data1/oa_pdf/05/24/main.PMC3960334.pdf
Published  by  Elsevier  Ltd.   http://dx.doi.org/10.1016/j.dcn.2013.09.005Open access under CC BY-NC-SA license.,Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Neuropsychologia  48  (2),  498–506, http://dx.doi.org/10.1016/j.neuropsychologia.2009.10.007.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Developmental  Science  14 (4),  892–900,  http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Psychological  Science:  A  Jour- nal  of  the  American  Psychological  Society/APS  17  (2),  159–163, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Attention,  Perception  &  Psychophysics  72  (7),  1865–1874, http://dx.doi.org/10.3758/APP.72.7.1865.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Developmental  Psychobiology  40  (3),  200–212, http://dx.doi.org/10.1002/dev.10027.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Journal  of  Child  Psychol- ogy  and  Psychiatry,  and  Allied  Disciplines  45  (7),  1228–1234, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Developmental  Science  8  (6),  F31–F36, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Developmental  Psychobiology  53  (4),  416–424, http://dx.doi.org/10.1002/dev.20532.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Developmental  Psychology  27 (1), 50–58, http://dx.doi.org/10.1037/0012-1649.27.1.50.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Infant  Behavior  & Development 31  (4),  665–678, http://dx.doi.org/10.1016/j.infbeh.2008.04.009.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Psychological  Science:  A  Journal  of  the American  Psychological  Society/APS  20  (6),  676–680, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Journal  of  Cognitive  Neuroscience  18  (9),  1453–1465, http://dx.doi.org/10.1162/jocn.2006.18.9.1453.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Neuroreport  19 (5),  583–587,  http://dx.doi.org/10.1097/WNR.0b013e3282f97b4d.Tanaka, J.,  2001.",OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
"Cognitive,  Affective  &  Behavioral  Neuroscience  9  (1), 122–131, http://dx.doi.org/10.3758/CABN.9.1.122.",Non-OADS,/arxiv_data1/oa_pdf/c4/14/main.PMC3960339.pdf
Published  by  Elsevier  Ltd.   http://dx.doi.org/10.1016/j.dcn.2013.10.003Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/c9/ef/main.PMC3960349.pdf
"Even though CAUTI is a very common HAI, Krein and colleagues reported that CAUTI preventive prac- tice use is lagging behind efforts to prevent central line-associated bloodstream infection and ventilator-associated pneumonia, 68with room for improvement in adopting catheter removal and CAUTI preventive strategies demonstrated again in two recent largesurveys of hospitals 69and ICUs.70Fortunately, many resources exist (http://www.catheterout.org) to help hospitals develop and implement programmes todecrease catheter use and prevent CAUTI, including a range of tools and educational materials to address implementation challenges.",Non-OADS,/arxiv_data1/oa_pdf/7c/8b/bmjqs-2012-001774.PMC3960353.pdf
New national efforts to reduce CAUTI (http://www.onthecuspstophai.org/stop-cauti/) incorporate periodic feedback to participating units on urinary catheter use and CAUTI rates.,Non-OADS,/arxiv_data1/oa_pdf/7c/8b/bmjqs-2012-001774.PMC3960353.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Saint S, Lipsky BA, Baker PD, et al.",Non-OADS,/arxiv_data1/oa_pdf/7c/8b/bmjqs-2012-001774.PMC3960353.pdf
http://www.cdc.gov/hai/pdfs/hai/scott_costpaper.pdf; (accessed 10 May 2013).,OADS,/arxiv_data1/oa_pdf/7c/8b/bmjqs-2012-001774.PMC3960353.pdf
"HHS Action Plan to Prevent Healthcare-Associated Infections , Appendix G 2009. http://www.hhs.gov/ash/initiatives/hai/appendices.html#appendix_g (accessed 8 Dec 2012).14 Gould CV , Umscheid CA, Agarwal RK, et al.",Non-OADS,/arxiv_data1/oa_pdf/7c/8b/bmjqs-2012-001774.PMC3960353.pdf
"17 Greene L, Marx J, Oriola S. An APIC Guide to the elimination of catheter-associated urinary tract infections (CAUTIs): developing and applying facility-based prevention interventions in acute and long-term care settings 2008. http://www.apic.org/Resource_/EliminationGuideForm/c0790db8-2aca-4179-a7ae-676c27592de2/File/APIC-CAUTI-Guide.pdf (accessed 8 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/7c/8b/bmjqs-2012-001774.PMC3960353.pdf
http://www.ahrq.gov/clinic/ptsafety/pdf/chap15.,Non-OADS,/arxiv_data1/oa_pdf/7c/8b/bmjqs-2012-001774.PMC3960353.pdf
Published  by  Elsevier  Ltd.   http://dx.doi.org/10.1016/j.dcn.2013.09.006Open access under CC BY-NC-ND license.,Non-OADS,/arxiv_data1/oa_pdf/4a/92/main.PMC3960357.pdf
"Pediatrics  128  (September  (3)),  e488–e495, http://dx.doi.org/10.1542/peds.2010-2825.",Non-OADS,/arxiv_data1/oa_pdf/4a/92/main.PMC3960357.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Genome-wide response of Wolbachia to doxycycline AC Darby et al 937 The ISME Journal",OADS,/arxiv_data1/oa_pdf/a4/fe/ismej2013192a.PMC3960535.pdf
"developed and optimized custom electronics for the probe readout; all authors discussed the results and implications and commented on the manuscript at all stages.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests F.B., F.C., E.D.L., S.F., M.M., I.M., V.P., L.P., A.Sa., A.Sc., C.V. and R.F.",Non-OADS,/arxiv_data1/oa_pdf/fb/2a/srep04401.PMC3960579.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4401 | DOI: 10.1038/srep04401 5",Non-OADS,/arxiv_data1/oa_pdf/fb/2a/srep04401.PMC3960579.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1d/f3/srep04420.PMC3960580.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4420 | DOI: 10.1038/srep04420 6",Non-OADS,/arxiv_data1/oa_pdf/1d/f3/srep04420.PMC3960580.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/12/6d/srep04417.PMC3960581.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4417 | DOI: 10.1038/srep04417 8",Non-OADS,/arxiv_data1/oa_pdf/12/6d/srep04417.PMC3960581.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f9/83/srep04418.PMC3960582.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4418 | DOI: 10.1038/srep04418 7",Non-OADS,/arxiv_data1/oa_pdf/f9/83/srep04418.PMC3960582.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Steps in accessing NK cell cytotoxicity EM Mace et al 255 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/e5/dc/icb201396a.PMC3960583.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4416 | DOI: 10.1038/srep04416 5",Non-OADS,/arxiv_data1/oa_pdf/3b/ac/srep04416.PMC3960584.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/ heartjnl-2012-302925).,Non-OADS,/arxiv_data1/oa_pdf/e8/84/heartjnl-2012-302925.PMC3960593.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/,Non-OADS,/arxiv_data1/oa_pdf/e8/84/heartjnl-2012-302925.PMC3960593.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER ARamplification in human prostate cancer 1662 www.bjcancer.com | DOI:10.1038/bjc.2014.13,Non-OADS,/arxiv_data1/oa_pdf/33/9c/bjc201413a.PMC3960602.pdf
The primers and the probe were designed with the Probefinder software at the Universal ProbeLibrary Assay DesignCenter (Roche Diagnostics; http://www.roche-applied-science.com/ sis/rtpcr/upl/index.jsp?id=uplct_00000).,OADS,/arxiv_data1/oa_pdf/41/79/bjc201420a.PMC3960603.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Prokineticins in Merkel cell carcinoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.20 1455,Non-OADS,/arxiv_data1/oa_pdf/41/79/bjc201420a.PMC3960603.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER BMP-6 and WNT5A in CRPC 1644 www.bjcancer.com | DOI:10.1038/bjc.2014.23,Non-OADS,/arxiv_data1/oa_pdf/ac/ac/bjc201423a.PMC3960605.pdf
"The mapped Entrez Gene IDs from the differential expression analyses were used to identify enriched pathways and diseases in KOBAS 2.0 online tool (Xie et al, 2011), DAVID functional annotation tool (Huang da et al, 2009) and FLink(frequency-weighted links tool; http://www.ncbi.nlm.nih.gov/Structure/flink/flink.cgi).",OADS,/arxiv_data1/oa_pdf/b2/e6/bjc201424a.PMC3960606.pdf
Available from http://ncbi.nlm.nih.gov/Structure/flink/ flink.cgi.,OADS,/arxiv_data1/oa_pdf/b2/e6/bjc201424a.PMC3960606.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Quantitative proteomics in renal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.24 1633,Non-OADS,/arxiv_data1/oa_pdf/b2/e6/bjc201424a.PMC3960606.pdf
Available from http://www.nccn.org/professionals/physician_gls/pdf/ breast.pdf.Neoadjuvant chemotherapy plus BCS and RT BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.26 1425,Non-OADS,/arxiv_data1/oa_pdf/0e/39/bjc201426a.PMC3960607.pdf
Additional clinical variant annotation was obtained from NCBI ClinVar (last accessed July 2013; http://www.ncbi.nlm.nih.gov/clinvar/).,OADS,/arxiv_data1/oa_pdf/55/f6/bjc201430a.PMC3960610.pdf
"We carried out a modified segregation analysis of the seven genes found to contain putative LoF mutations in probands of European ancestry using estimatedmutation frequencies from previous UK studies, except for MUTYH where UK data was unavailable, and therefore we used the European ancestry data from the NHLBI GO ESP NHLBI GO Exome Sequencing Project (last accessed November 2013; http://evs.gs.washington.edu/EVS/) (Antoniou et al , 2002; The CHEK2 Breast Cancer Case–Control Consortium, 2004; Thompson et al, 2005; Seal et al, 2006; Rahman et al, 2007).",Non-OADS,/arxiv_data1/oa_pdf/55/f6/bjc201430a.PMC3960610.pdf
Available at http://CRAN.R-project.org/package=vcdExtra.,Non-OADS,/arxiv_data1/oa_pdf/55/f6/bjc201430a.PMC3960610.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Frequency of deleterious mutations in PrCa 1672 www.bjcancer.com | DOI:10.1038/bjc.2014.30,Non-OADS,/arxiv_data1/oa_pdf/55/f6/bjc201430a.PMC3960610.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)RAD21 cohesin overexpression BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.31 1613,Non-OADS,/arxiv_data1/oa_pdf/96/06/bjc201431a.PMC3960611.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)TGFBI as a predictive factor in lung SCC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.33 1551,Non-OADS,/arxiv_data1/oa_pdf/27/ee/bjc201433a.PMC3960613.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER RET rearrangement in lung carcinoma 1578 www.bjcancer.com | DOI:10.1038/bjc.2014.36,Non-OADS,/arxiv_data1/oa_pdf/81/bf/bjc201436a.PMC3960615.pdf
"AGS, KatoIII, NCI-N87 and Hs746T were obtained from American Type Culture Collection (http://www.atcc.org/; Manassas, VA, USA) and cultured as recommended by thesupplier.",Non-OADS,/arxiv_data1/oa_pdf/02/91/bjc201445a.PMC3960617.pdf
"The AZ521, Fu97, IM95, Ist1, MKN1, MKN45, MKN7, MKN28, MKN45 and TMK1 cells were obtained from the Japanese Collection of Research Bioresources/Japan Health Science Research Resource Bank (http://cellbank.nibio.go.jp/) and cultured as recommended.",Non-OADS,/arxiv_data1/oa_pdf/02/91/bjc201445a.PMC3960617.pdf
Gene expression data and experimental details are available in MIAME compliant format in ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) accession number E-MEXP-3730.,OADS,/arxiv_data1/oa_pdf/02/91/bjc201445a.PMC3960617.pdf
"DATA ARCHIVING Gene expression data and experimental details are available in MIAME compliant format in ArrayExpress (http://www.ebi.ac.uk/ arrayexpress/), accession number E-MEXP-3730.",OADS,/arxiv_data1/oa_pdf/02/91/bjc201445a.PMC3960617.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Predictive impact of leptin in gastro-oesophageal cancer 1534 www.bjcancer.com | DOI:10.1038/bjc.2014.45,Non-OADS,/arxiv_data1/oa_pdf/02/91/bjc201445a.PMC3960617.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Tumour-infiltrating inflammation in CRC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.46 1605,Non-OADS,/arxiv_data1/oa_pdf/76/2c/bjc201446a.PMC3960618.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER FoxP3 role in tumour–lymphocyte interaction 1560 www.bjcancer.com | DOI:10.1038/bjc.2014.47,Non-OADS,/arxiv_data1/oa_pdf/3b/22/bjc201447a.PMC3960619.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Genistein and miRNA in PC 1654 www.bjcancer.com | DOI:10.1038/bjc.2014.48,Non-OADS,/arxiv_data1/oa_pdf/fa/49/bjc201448a.PMC3960620.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Gemcitabine plus iRGD peptide chemotherapy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.49 1487,Non-OADS,/arxiv_data1/oa_pdf/47/af/bjc201449a.PMC3960621.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Oestrogen and paclitaxel-induced apoptosis 1496 www.bjcancer.com | DOI:10.1038/bjc.2014.50,Non-OADS,/arxiv_data1/oa_pdf/7a/c6/bjc201450a.PMC3960622.pdf
We downloaded and analysed data publicly available from the Cancer Genome Atlas Project (TCGA; https://tcga-data.nci.nih.gov/tcga/) for colon cancer patients.,OADS,/arxiv_data1/oa_pdf/b2/6d/bjc201451a.PMC3960623.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)miR-200a expression in CRC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.51 1621,Non-OADS,/arxiv_data1/oa_pdf/b2/6d/bjc201451a.PMC3960623.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Elevated serum CXCL16 predicts poor survival in ovarian cancer 1544 www.bjcancer.com | DOI:10.1038/bjc.2014.55,Non-OADS,/arxiv_data1/oa_pdf/76/2f/bjc201455a.PMC3960624.pdf
Melanoma is the deadliest form of skin cancer with increasing prevalence and incidence over the last decades (http://seer.can- cer.gov/statfacts/html/melan.html).,Non-OADS,/arxiv_data1/oa_pdf/c4/9b/bjc201462a.PMC3960625.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CVAD use and infusion pump function in mCRC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.74 1445,Non-OADS,/arxiv_data1/oa_pdf/85/c0/bjc201474a.PMC3960626.pdf
"http://seer.cancer.gov/csr/1975_2010/ (based on November 2012 SEER data submission, posted to the SEER web site, April 2013).",OADS,/arxiv_data1/oa_pdf/5d/01/bjc201475a.PMC3960627.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Prediction of tumour response based on CA-125 1524 www.bjcancer.com | DOI:10.1038/bjc.2014.75,Non-OADS,/arxiv_data1/oa_pdf/5d/01/bjc201475a.PMC3960627.pdf
"For a complete list of donors, see the Foundation website at http://www.fnih.org/work/programs- development/medical-research-scholars-program.",Non-OADS,/arxiv_data1/oa_pdf/f5/be/bjc201479a.PMC3960628.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER ABCB1 andIL15 genotypes affect paediatric ALL outcome 1680 www.bjcancer.com | DOI:10.1038/bjc.2014.7,Non-OADS,/arxiv_data1/oa_pdf/1e/0d/bjc20147a.PMC3960629.pdf
"Statistical analyses were performed using GraphPad Prism version 5.04 (GraphPad Software, La Jolla, CA, USA) or R (v2.15.2, http://www.r-project.org/index.html) and SAS (v9.2 2M2, Cary, NC, USA) programs.",OADS,/arxiv_data1/oa_pdf/8d/29/bjc201480a.PMC3960630.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Eribulin reverses epithelial–mesenchymal transition BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.80 1505,Non-OADS,/arxiv_data1/oa_pdf/8d/29/bjc201480a.PMC3960630.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Dose intensification in TN breast cancers BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2014.81 1419,Non-OADS,/arxiv_data1/oa_pdf/39/8d/bjc201481a.PMC3960631.pdf
Further screens of the NCI diversity set (http://dtp.cancer.gov) and of a small-molecule library curatedat the Cancer Research Technology (CRT) identified several additional AKR1C3-selective inhibitors.,Non-OADS,/arxiv_data1/oa_pdf/91/03/bjc201483a.PMC3960632.pdf
"Searches of severaldatabases (www.chemspider.com, http://pubchem.ncbi.nlm.nih.gov) did not identify any other tetracycline derivatives with a similar structure.",OADS,/arxiv_data1/oa_pdf/91/03/bjc201483a.PMC3960632.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER AKR1C3 inhibitors lack anti-leukaemic activity 1516 www.bjcancer.com | DOI:10.1038/bjc.2014.83,Non-OADS,/arxiv_data1/oa_pdf/91/03/bjc201483a.PMC3960632.pdf
"In recent years the importance of the inflammatory responses in determining disease progression in patients with cancer hasbecome recognised (Hanahan and Weinberg, 2011) and has become a hot topic for scientists and clinicians with the termscancer and inflammation returning 1179 articles in 2002 compared with 3693 articles in 2012 (http://www.ncbi.nlm.nih.gov/pubmed/ ?term=cancer þandþinflammation).",Non-OADS,/arxiv_data1/oa_pdf/0d/16/bjc201490a.PMC3960633.pdf
; http://www.ncepod.,Non-OADS,/arxiv_data1/oa_pdf/0d/16/bjc201490a.PMC3960633.pdf
"University of Rhode Island, USA 2011. http://pqdtopen.proquest.com/#abstract?dispub=3450794 [7] Engqvist I, Nilsson K. Involving the family in the care and treat-ment of women with postpartum psychosis: Swedish psychiatrists’ experiences.",Non-OADS,/arxiv_data1/oa_pdf/8c/ab/TONURSJ-8-8.PMC3960751.pdf
"Psychiatry J, Retrieved 2013, January 11 from web-site: http://www.hindawi.com/journals/psychiatry/2013/897084/abs/ [8] Engqvist I, Nilsson K. Experiences of the first days of postpartum psychosis - an interview study with women and next of kin in Sweden.",Non-OADS,/arxiv_data1/oa_pdf/8c/ab/TONURSJ-8-8.PMC3960751.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/ab/TONURSJ-8-8.PMC3960751.pdf
Available from: http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM070107.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/57/JAPTR-5-13.PMC3960787.pdf
Available from:  http://www.fda.gov/drugs/developmentapprovalprocess/ developmentresources/druginteractionslabeling/ucm110632.htm  [Last accessed on 2014 Jan 20].,Non-OADS,/arxiv_data1/oa_pdf/ca/c9/JAPTR-5-2.PMC3960789.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/ca/c9/JAPTR-5-2.PMC3960789.pdf
Available from: http://www.cdc.gov/features/tbsymptoms/ [10/09/2013].,OADS,/arxiv_data1/oa_pdf/a2/93/JAPTR-5-28.PMC3960791.pdf
Available from: http://www.who.int/tb/challenges/mdr  [10/09/2013].,Non-OADS,/arxiv_data1/oa_pdf/a2/93/JAPTR-5-28.PMC3960791.pdf
Available from: http://www.rxlist.com/script/main/srchcont_rxlist.,Non-OADS,/arxiv_data1/oa_pdf/ce/40/JAPTR-5-33.PMC3960792.pdf
Available from: http://www.medicinenet.com/irbesartan/article.,Non-OADS,/arxiv_data1/oa_pdf/ce/40/JAPTR-5-33.PMC3960792.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/65/4d/JAPTR-5-4.PMC3960793.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/65/4d/JAPTR-5-4.PMC3960793.pdf
Available from: http://www.ojhas.org/issue41/2012-1-8.htm.,Non-OADS,/arxiv_data1/oa_pdf/ba/fe/LI-31-16.PMC3960803.pdf
Available from: http://www.who.int/leishmaniasis/   burden/en/.,Non-OADS,/arxiv_data1/oa_pdf/86/c4/LI-31-56.PMC3960813.pdf
Available from: http://www.hindawi.com/crim/medicine/2011/561985/.,Non-OADS,/arxiv_data1/oa_pdf/86/c4/LI-31-56.PMC3960813.pdf
Available from: http://www.nvbdcp.gov.in/kal8.html.,Non-OADS,/arxiv_data1/oa_pdf/86/c4/LI-31-56.PMC3960813.pdf
"Sun*1, Clarmyra A. Hayes*2, Jonghyeon Shin3, Filippo Caschera4, Richard M. Murray2, Vincent Noireaux4 1Department of Biology, California Institute of Technology 2Department of Bioengineering, California Institute of Technology 3Synthetic Biology Center, Department of Bioengineering, Massachusetts Institute of Technology 4School of Physics and Astronomy, University of Minnesota *These authors contributed equally URL: http://www.jove.com/video/50762 DOI: doi:10.3791/50762 Keywords: Cellular Biology, Issue 79, Bioengineering, Synthetic Biology, Chemistry Techniques, Synthetic, Molecular Biology, control theory, TX- TL, cell-free expression, in vitro, transcription-translation, cell-free protein synthesis, synthetic biology, systems biology, Escherichia coli cell extract, biological circuits, biomolecular breadboard Date Published: 9/16/2013 Citation: Sun, Z.Z., Hayes, C.A., Shin, J., Caschera, F., Murray, R.M., Noireaux, V. Protocols for Implementing an Escherichia coli  Based TX-TL Cell-Free Expression System for Synthetic Biology.",Non-OADS,/arxiv_data1/oa_pdf/a4/7e/jove-79-50762.PMC3960857.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50762/ Introduction Cell-free expression technology began in the 1950s as purely translational, advancing years later to encompass coupled transcription-translation mechanisms using T7 bacteriophage DNA.11,12  Since then, numerous efforts have been made to optimize the creation of crude cell extract (or E. coli  S30 extract).13,14  These optimizations include prolonging cell-free protein synthesis through ATP regeneration or strain modifications, and reducing protocol time and cost.15-17  Alternative cell-free expression systems exist that use reconstituted components in lieu of crude cell extract for expression.5  Both crude cell extract and reconstitution methods have been developed for commercial use.",Non-OADS,/arxiv_data1/oa_pdf/a4/7e/jove-79-50762.PMC3960857.pdf
Phenotypicscreeningofextended-spectrumß-lactamaseand metallo-ß-lactamaseinmultidrug-resistantPseudomonas aeruginosafrominfectedburns.AnnBurnsFireDisasters.2012 Jun30;25(2):78-81.Availablefrom:http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3506211/ 2.,Non-OADS,/arxiv_data1/oa_pdf/74/2f/HIC-09-06.PMC3960934.pdf
"AzimiL,RastegarLariA,AlaghehbandanR,AlinejadF, MohammadpoorM,RahbarM.KPC-producergramnegative bacteriaamongburnedinfantsinMotahariHospital,Tehran: firstreportfromIran.AnnBurnsFireDisasters.2012Jun 30;25(2):74-7.Availablefrom:http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC3506210/ 7.",Non-OADS,/arxiv_data1/oa_pdf/74/2f/HIC-09-06.PMC3960934.pdf
"[modified2012-04-03].Availablefrom:http://www.phac- aspc.gc.ca/nois-sinp/guide/ipcm-mpci/ipcm-mpci-eng.php 4/5 GMSHygieneandInfectionControl2014,Vol.9(1), ISSN2196-5226 Larietal.",Non-OADS,/arxiv_data1/oa_pdf/74/2f/HIC-09-06.PMC3960934.pdf
"DeVosD,LimAJr,PirnayJP,StruelensM,VandenveldeC, DuinslaegerL,VanderkelenA,CornelisP.Directdetectionand identificationofPseudomonasaeruginosainclinicalsamples suchasskinbiopsyspecimensandexpectorationsbymultiplex PCRbasedontwooutermembranelipoproteingenes,oprIand oprL.JClinMicrobiol.1997Jun;35(6):1295-9.Availablefrom: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC229737/ 14.",OADS,/arxiv_data1/oa_pdf/74/2f/HIC-09-06.PMC3960934.pdf
"DOI: 10.3205/dgkh000226,URN:urn:nbn:de:0183-dgkh0002269 Thisarticleisfreelyavailablefrom http://www.egms.de/en/journals/dgkh/2014-9/dgkh000226.shtml Published: 2014-03-07 Copyright ©2014 Larietal.",Non-OADS,/arxiv_data1/oa_pdf/74/2f/HIC-09-06.PMC3960934.pdf
"This is anOpenAccess articledistributedunderthe t ermsoftheCreative CommonsAttributionLicense (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en).You arefree:toShare—tocopy,distributeandtransmitthework,provided theoriginalauthorandsourcearecredited.",Non-OADS,/arxiv_data1/oa_pdf/74/2f/HIC-09-06.PMC3960934.pdf
Available from: http://www.cdc.gov/hiv/topics/over50/index.,Non-OADS,/arxiv_data1/oa_pdf/56/b6/CHIVR-11-570.PMC3960940.pdf
Statistical methods .The statistical analysis was carried out with R software version 3.0-2 (http://www.R-project.org/) using the package quantreg version 5.0-5 (http://cran.r-project.org/web/packages/quantreg/index.html) and the package frontier version 1.1-0 (http://cran.r-project.org/web/packages/frontier/index.html).,OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"FAO Statistical Databases, http://faostat.fao.org/site/567/default.aspx (accessed, October 2013).",OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"Official Journal of the European Communities, L330:32–54 (1998) http://eur-lex.europa.eu/LexUriServ/LexUriServ.",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"http://www.statistiques.developpement-durable.gouv.fr/lessentiel/ar/246/ 211/contamination-globale-cours-deau-pesticides.html (accessed, October 2014).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"Ecophyto 2018 – Plan ECOPHYTO 2018 de re ´duction de l’usage des pesticides 2008–2018 (2008) http://agriculture.gouv.fr/IMG/pdf/PLAN_ECOPHYTO_ 2018-2-2.pdf (accessed, January 2014).. 10. International Assessment of Agricultural Knowledge (IAASTD).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"Agriculture at a Crossroads, Synthesis Report (Island Press, 2009); http://www.unep.org/dewa/agassessment/reports/IAASTD/EN/Agriculture%20at%20a%20Crossroads_ Synthesis%20Report%20(English).pdf (accessed, January 2013).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"Earthscan Publications Ltd., London (2003).ftp://ftp.fao.org/docrep/fao/004/y3557e/y3557e.pdf(accessed, October 2014).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"World Population Prospects: The 2012 Revision, Press Release (13 June2013): ‘‘World Population to reach 9.6 billion by 2050 with most growth in developing regions, especially Africa’’http://esa.un.org/wpp/Documentation/pdf/ WPP2012_Press_Release.pdf (accessed, October 2013).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"http://www.agreste.agriculture.gouv.fr/IMG/pdf_ nese090332A3.pdf (accessed, September 2013).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"Enque ˆte sur les Pratiques Culturales en 2006. http://agreste.agriculture.gouv.fr/page-d-accueil/article/donnees-en-ligne (accessed, October 2013).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"Agreste Les Dossiers, N u18 (2013) http://www.agreste.agriculture.gouv.fr/IMG/pdf/dossier18_integral.pdf (accessed, January 2014).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"http://www.agreste.agriculture.gouv.fr/IMG/pdf/ conjsynt213201307cult.pdf (accessed, October 2013).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"FranceAgriMer, http://www.franceagrimer.fr/filiere-grandes-cultures/Cereales (accessed, October 2013).. www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4405 | DOI: 10.1038/srep04405 6",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"http://www.developpement-durable.gouv.fr/IMG/pdf/ED52-2.pdf(accessed, September 2013).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"French Ministry of Agriculture and Agribusiness.http://e-phy.agriculture.gouv.fr/ (accessed, October 2013).",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4405 | DOI: 10.1038/srep04405 7",Non-OADS,/arxiv_data1/oa_pdf/88/f8/srep04405.PMC3960944.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2013 |  80  | e51111 | Page 1 of 11Video Article Collection and Analysis of Arabidopsis  Phloem Exudates Using the EDTA- facilitated Method Olena Tetyuk1, Urs F. Benning1, Susanne Hoffmann-Benning1 1Biochemistry and Molecular Biology, Michigan State Universtiy Correspondence to: Susanne Hoffmann-Benning at hoffma16@msu.edu URL: http://www.jove.com/video/51111 DOI: doi:10.3791/51111 Keywords: Plant Biology, Issue 80, plant, long-distance transport, long-distance signaling, phloem, phloem exudate collection, assimilate transport, protein, RNA, lipids Date Published: 10/23/2013 Citation: Tetyuk, O., Benning, U.F., Hoffmann-Benning, S. Collection and Analysis of Arabidopsis  Phloem Exudates Using the EDTA-facilitated Method.",Non-OADS,/arxiv_data1/oa_pdf/48/ff/jove-80-51111.PMC3960974.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51111/ Introduction Plants cannot move to escape adverse conditions.,Non-OADS,/arxiv_data1/oa_pdf/48/ff/jove-80-51111.PMC3960974.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/88/ndt-10-479.PMC3961067.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 479–485Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  479open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/NDT .S5845 5CAse series improvement of gross motor and cognitive   abilities by an exercise training program:   three case reports Marianna Alesi1 Giuseppe Battaglia2 Michele roccella1 Davide T esta1 Antonio Palma2 Annamaria Pepi1 1Department of Psychology,   2Department of Law, social and  sport science, University of Palermo,   Palermo, italy Correspondence: Marianna Alesi   Department of Psychology, University   of Palermo, V.le delle scienze,   Edificio 15, 90128 Palermo, Italy   Tel +39 091 2389 7702   Fax +39 09 1651 3825   email marianna.alesi@unipa.i tBackground:  This work examined the efficacy of an integrated exercise training program  (coach and family) in three children with Down syndrome to improve their motor and cognitive  abilities, in particular reaction time and working memory.",Non-OADS,/arxiv_data1/oa_pdf/c2/88/ndt-10-479.PMC3961067.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c2/88/ndt-10-479.PMC3961067.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/88/ndt-10-479.PMC3961067.pdf
Available from: http://www.who.int/classifications/icf/.,OADS,/arxiv_data1/oa_pdf/c2/88/ndt-10-479.PMC3961067.pdf
The  full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/06/rmhp-7-061.PMC3961068.pdf
"Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpRisk Management and Healthcare Policy 2014:7 61–63Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  61LetteRopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/ 10.2147/RMHP .S5366 8the exclusion of hypochromia from the iron  deficiency screen Oscar MP Jolobe Manchester Medical Society,   Manchester, UK Correspondence: Oscar MP Jolobe   Manchester Medical Society,   1 Philip Godlee Lodge, 842 Wilmslow   Road, Manchester M20 2DS, UK   tel +44 161 448 9034   email oscarjolobe@yahoo.co.u kDear editor When the screening strategy for iron deficiency makes use of mean corpuscular volume  (MCV) to the exclusion of mean corpuscular hemoglobin (MCH), as was the case in  the recent study by Radia et al1 there is a risk of repeating the mistakes highlighted in  a retrospective analysis of the management of anemia, microcytosis, and hypochromia  in preoperative subjects in South Australia.2 In David et al’ s2 retrospective analysis of data from 943 adults, the overall prevalence  of anemia was 25.2%, and the median age of the 238 anemic subjects was 73 years  old.",Non-OADS,/arxiv_data1/oa_pdf/b9/06/rmhp-7-061.PMC3961068.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/b9/06/rmhp-7-061.PMC3961068.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/06/rmhp-7-061.PMC3961068.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/76/ijn-9-1413.PMC3961069.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1413–1421International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1413OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5794 6cytotoxicity of graphene oxide and graphene  oxide loaded with doxorubicin on human   multiple myeloma cells shaoling Wu1 Xindong Zhao2 Zhongguang cui1 chunting Zhao1 Yuzhen Wang1 li Du1 Yanhui li3 1Department of hematology, The  affiliated hospital of Medical  college, Qingdao University, Qingdao,   shandong, People’s republic of china;   2Department of hematology, Medical  college of Qingdao University,   Qingdao, shandong, People’s  republic of china; 3laboratory of  Fiber Materials and Modern T extile,   The growing Base for state Key  laboratory, Qingdao University,   Qingdao, shandong, People’s republic  of china correspondence : Xindong Zhao   38 Dengzhou road, Qingdao, shandong  266021, People’s republic of china   Tel +86 532 83780030   email qdzhaoxindong@163.co m    Yanhui li   308 Ningxia road, Qingdao, shandong  266071, People’s republic of china   Tel +86 532 85951842   email liyanhui@tsinghua.org.c nAbstract:  The purpose of this study was to evaluate the cytotoxicity of human multiple myeloma  cells (RPMI-8226) treated with graphene oxide (GO), doxorubicin (DOX), and GO loaded  with DOX (GO/DOX).",Non-OADS,/arxiv_data1/oa_pdf/c9/76/ijn-9-1413.PMC3961069.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c9/76/ijn-9-1413.PMC3961069.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/76/ijn-9-1413.PMC3961069.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/ahmt-5-025.PMC3961070.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdolescent Health, Medicine and Therapeutics 2014:5 25–34Adolescent Health, Medicine and Therapeutics Dove press submit your manuscript | www.dovepress.co m Dove press  25Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/AHMT .S3667 2Management of psoriasis in adolescence Christina Fotiadou elizabeth Lazaridou Demetrios ioannides First Department of Dermatology– venereology, Aristotle University  Medical School, Thessaloniki, Greece Correspondence: Christina Fotiadou   First Department of Dermatology– venereology,  Aristotle University  Medical School, 124 Delfon Street, 54643  Thessaloniki,  Greece   T el +30 23 1330 8822   Fax +30 23 1099 2255   email cifotiadou@hotmail.co mAbstract:  Psoriasis is a chronic inflammatory cutaneous disorder affecting 2%–4% of the  world’ s population.",Non-OADS,/arxiv_data1/oa_pdf/c3/ad/ahmt-5-025.PMC3961070.pdf
Paediatric Available from: http://www.clinicaltrials.gov/ct2/ show/NCT0125161 4.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/ahmt-5-025.PMC3961070.pdf
"Available from: http://www.ema.europa.eu/docs/ en_GB/document_library/Summary_of_opinion/human/000262/ WC500109249.pd f. Accessed December 7, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c3/ad/ahmt-5-025.PMC3961070.pdf
"Adolescent Health, Medicine and Therapeutics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/adolescent-health-medicine-and-therapeutics-journa lAdolescent Health, Medicine and Therapeutics is an international,  peer-reviewed, open access journal focusing on health, pathology,  and treatment issues specific to the adolescent age group.",Non-OADS,/arxiv_data1/oa_pdf/c3/ad/ahmt-5-025.PMC3961070.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/ad/ahmt-5-025.PMC3961070.pdf
"OncoImmunology 2013; 2:e27358; http://dx.doi.org/10.4161/onci.27358A novel pathway links telomeres to NK-cell activity Implications for immunotherapy Julien Cherfils-Vicini1, Pasquale Zizza2, eric Gilson1,3, and a nnamaria Biroccio2,* 1Institut for r esearch on Cancer and a ging; Nice (I rCaN); CN rs u Mr7284/IN serM u 1081; Faculty of Medicine; Nice u niversity; Nice, France;  2regina e lena National Cancer Institute; r ome, Italy; 3Department of Medical Genetics; a rchet 2 h ospital; C hu of Nice; Nice, France Keywords:  immunosurveillance, NK cells, telomeres, TERF2, tumorigenesis Abbreviations:  DAMP, damaged-associated molecular pattern; DDR, DNA damage response; HSPG, heparan-sulfate  proteoglycan; IFN γ, interferon γ ; ITS, interstitial telomeric sequence; NK, natural killer; SASP, senescence-associated secretory  profile; TERF2, telomeric repeat-binding factor 2 here, we describe a model in which telomeric repeat-binding factor 2 (T erF2) can control tumorigenesis not only via  cancer cell-intrinsic mechanisms but also via non-cancer cell autonomous pathways.",Non-OADS,/arxiv_data1/oa_pdf/18/bf/onci-3-e27358.PMC3961481.pdf
Mutat Res  2012; 730:85-9;  PMID:21878343 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/bf/onci-3-e27358.PMC3961481.pdf
PLoS Biol 2008; 6:2853- 68; PMID:19053174 ; http://dx.doi.org/10.1371/ journal.pbio.0060301 3.,Non-OADS,/arxiv_data1/oa_pdf/18/bf/onci-3-e27358.PMC3961481.pdf
Front Oncol 2013; 3:48;  PMID:23509004 ; http://dx.doi.org/10.3389/ fonc.2013.00048 5.,Non-OADS,/arxiv_data1/oa_pdf/18/bf/onci-3-e27358.PMC3961481.pdf
Nat Immunol  2008; 9:503-10;  PMID:18425107 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/bf/onci-3-e27358.PMC3961481.pdf
Nat Cell Biol 2013; 15:818-28;  PMID:23792691 ; http://dx.doi.org/10.1038/ ncb2774 7.,OADS,/arxiv_data1/oa_pdf/18/bf/onci-3-e27358.PMC3961481.pdf
J Immunol 2013; 191:5256-67; PMID:24127555 ;  http://dx.doi.org/10.4049/jimmunol.1302079 10.,Non-OADS,/arxiv_data1/oa_pdf/18/bf/onci-3-e27358.PMC3961481.pdf
Nat Rev Clin Oncol 2011; 8:151-60;  PMID:21364688 ; http://dx.doi.org/10.1038/ nrclinonc.2010.223,Non-OADS,/arxiv_data1/oa_pdf/18/bf/onci-3-e27358.PMC3961481.pdf
"OncoImmunology 2013; 2:e27317; http://dx.doi.org/10.4161/onci.27317Genetic variants of IgG1 antibodies and FcγRIIIa  receptors influence the magnitude of antibody- dependent cell-mediated cytotoxicity against  prostate cancer cells Janardan P Pandey* and a ryan M Namboodiri Department of Microbiology and Immunology; Medical University of South Carolina; Charleston, SC US a Keywords:  ADCC; anti-MUC1 antibodies; Fc γR genotypes; HuHMFG1; GM allotypes; prostate cancer Abbreviations: ADCC, antibody-dependent cell-mediated cytotoxicity; Fc γR, Fc γ receptor; GM, γ marker; mAb, monoclonal  antibody; MUC1, mucin 1; NK, natural killer antibody-dependent cell-mediated cytotoxicity ( aDCC) is one of the major mechanisms underlying the clinical effi - cacy of anticancer monoclonal antibodies (m abs), such as the mucin 1 (MUC1)-targeting molecule HuHM fG1.",Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Adv Immunol 2004; 82:249- 93; PMID:14975259 ; http://dx.doi.org/10.1016/ S0065-2776(04)82006-6 2.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Cancers (Basel)  2011 ; 3:3073 -103; PMID:24212946 ;  http://dx.doi.org/10.3390/cancers3033073 3.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Int J Cancer 2003 ; 103:97-100; PMID:12455059 ;  http://dx.doi.org/10.1002/ijc.10801 5.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Cancer Immunol  Immunother  1998 ; 46:245-52; PMID:9690452 ;  http://dx.doi.org/10.1007/s002620050484 6.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Am J Respir Crit Care Med 2000 ;  161:589-94; PMID:10673204 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Cancer Lett 2007 ; 257:47- 55; PMID:17692456 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Proc Natl Acad Sci U S A 2004 ; 101:811- 6; PMID:14711987 ; http://dx.doi.org/10.1073/ pnas.0304146101 11.,OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Exp Hematol  Oncol  2013 ; 2:6; PMID:23425356 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
J  Immunol Methods  1981 ; 46:69-76; PMID:7288199 ;  http://dx.doi.org/10.1016/0022-1759(81)90334-3 15.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Proc Natl Acad Sci U S A 2006 ;  103:4005 -10; PMID:16537476 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Nat Rev Immunol 2010 ; 10:317- 27; PMID:20414205 ; http://dx.doi.org/10.1038/ nri2744 17.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
J Exp Med 1987 ; 166:1351 - 61; PMID:3500259 ; http://dx.doi.org/10.1084/ jem.166.5.1351 18.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
Clin Cancer Res 2011 ;  17:6822 -30; PMID:21878535 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/41/08/onci-3-e27317.PMC3961482.pdf
"OncoImmunology 2013; 2:e27338http://dx.doi.org/10.4161/onci.27338Invadopodia formation in blood clots Not so SLUGgish after all Lynn M Knowles1, Jodi K Maranchie1,2, and Jan Pilch1,2,* 1Department of u rology; u niversity of Pittsburgh s chool of Medicine; s hadyside Medical Center; Pittsburgh, P a usa ;  2Prostate and u rological Cancers Program; u niversity of Pittsburgh Cancer Institute; Pittsburgh, P a usa Keywords:  fibrin, fibronectin, integrin α vβ3, metastasis, SLUG Blood clotting specifically supports the metastatic dissemination of malignant cells to the lung.",Non-OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
Blood 2005; 105:178- 85; PMID :15367435 ; http://dx.doi.org/10.1182/ blood-2004-06-2272 2.,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
Cancer Cell 2011; 20:576-90; PMID:22094253 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
Cancer Cell  2013; 24:130-7;  PMID:23810565 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
Cancer Res 2010; 70:4327-34;  PMID:20501851 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-3312 6.,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
J Angiogenes Res 2010; 2:14; PMID:20701757 ;  http://dx.doi.org/10.1186/2040-2384-2-14 7.,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
Cell 2008; 133:66-77; PMID:18394990 ;  http://dx.doi.org/10.1016/j.cell.2008.01.0468.,OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
Cancer Res 2013; 73:6175-84; PMID:23966293 ; http://dx.doi.org/10.1158/0008- 5472.CAN-13-0602 9.,Non-OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
Cell 1995; 83:715-24; PMID:8521488 ;  http://dx.doi.org/10.1016/0092-8674(95)90184-1 10.,OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
J Cell Sci 2011; 124:1195-205; PMID:21444750 ; http://dx.doi.org/10.1242/ jcs.067009,OADS,/arxiv_data1/oa_pdf/ac/b8/onci-3-e27338.PMC3961483.pdf
"OncoImmunology 2014; 3:e27297;   http://dx.doi.org/10.4161/onci.27297Trial Watch Immunostimulatory monoclonal antibodies   in cancer therapy Fernando a randa1,2,3,†, erika v acchelli1,2,3,4,†, alexander e ggermont1, Jerome Galon5,6,7, 8, wolf Hervé Fridman6,7,9,  Laurence Zitvogel1,10, Guido Kroemer2,3,5,11,12,‡,*, and Lorenzo Galluzzi1,3,5,‡,* 1Gustave r oussy; v illejuif, France; 2INSerM, U848; v illejuif, France; 3equipe 11 labellisée par la Ligue Nationale contre le Cancer; Centre de r echerche des Cordeliers;   Paris, France; 4Université Paris-Sud/Paris XI; Paris, France; 5Université Paris Descartes/Paris v ; Sorbonne Paris Cité; Paris, France; 6Université Pierre et Marie Curie/Paris v I;   Paris, France; 7INSerM, U872; Paris, France; 8equipe 15, Centre de r echerche des Cordeliers; Paris, France; 9equipe 13, Centre de r echerche des Cordeliers; Paris, France;  10INSerM, U1015; CICBT507; v illejuif, France; 11Pôle de Biologie, Hôpital e uropéen Georges Pompidou, a P-HP; Paris, France; 12Metabolomics and Cell Biology Platforms;   Gustave r oussy; v illejuif, France †These authors contributed equally to this work ‡These authors share senior co-authorship Keywords:  CD137, checkpoint blockade, immunogenic chemotherapy, immunosuppression, lirilumab, IPH2101, PD-L1 Abbreviations: CLL, chronic lymphocytic leukemia; CTLA4, cytotoxic T lymphocyte-associated protein 4; FDA, Food and Drug  Administration; GM-CSF, granulocyte macrophage colony-stimulating factor; KIR, killer cell immunoglobulin-like receptor; mAb,  monoclonal antibody; NHL, non-Hodgkin’s lymphoma; NK, natural killer; NSCLC, non-small cell lung carcinoma; TNFRSF,  tumor necrosis factor receptor superfamily, member; TLR, Toll-like receptor Immunostimulatory monoclonal antibodies (m abs) exert  antineoplastic effects by eliciting a novel or reinstating  a pre-existing antitumor immune response.",Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
"Update on Clinical Reports During the last 14 mo, the results of no less than 19  clinical trials investigating the therapeutic potential of immunostimulatory mAbs in cancer patients have been published in peer-reviewed scientific journals (source http://www.ncbi.nlm.nih.gov/pubmed).",OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
"82 Update on Clinical Trials Testing  Immunostimulatory Monoclonal Antibodies When this Trial Watch was being redacted (November 2013),  official sources listed 60 clinical trials launched after 2012, October 1st to evaluate the therapeutic profile of immunostimulatory mAbs in cancer patients (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
"As a matter of fact, the status of NCT01034787, a Phase 2 trial testing intravenous tremelimumab in patients affected by uveal melanoma, is no longer available because the information relative to this study has not been verified recently (source http://www.clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Immunol 2004; 4:153-6; PMID:15040588 ;  http://dx.doi.org/10.1038/nri1265 2.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat  Rev Immunol  2010 ; 10:317-27; PMID:20414205 ;  http://dx.doi.org/10.1038/nri2744 3.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Clin Cancer Res 2013 ; 19:997-1008 ;  PMID:23460531 ; http://dx.doi.org/10.1158/1078- 0432.CCR-12-2214 4.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Cancer 2007 ; 7:95-106;  PMID:17251916 ; http://dx.doi.org/10.1038/nrc2051 5.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Clin Sci (Lond) 2006 ; 111:93-106;  PMID:16831129 ; http://dx.doi.org/10.1042/ CS200600246.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2012 ; 1:28-37; PMID:22720209 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2013 ; 2:e22789 ;  PMID:23482847 ; http://dx.doi.org/10.4161/ onci.22789 8.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:1445 -7; PMID:23243624 ;  http://dx.doi.org/10.4161/onci.2131811.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
N Engl J Med  2002 ; 346:235-42; PMID:11807147 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:75-7; PMID:22720216 ;  http://dx.doi.org/10.4161/onci.1.1.17825 14.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Immunity   2006 ; 24:19-28; PMID:16413920 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:103- 5; PMID:22720225 ; http://dx.doi.org/10.4161/ onci.1.1.17963 16.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2012 ; 1:957-8; PMID:23162770 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:810-21; PMID:23162748 ;  http://dx.doi.org/10.4161/onci.20447 18.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Front Biosci (Landmark Ed)  2011 ; 16:277-306; PMID:21196171 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Cell  Res 2010 ; 20:34-50; PMID :20010915 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Clin Cancer Res  2008 ; 14:502-8; PMID:18223225 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2013 ; 2:e24677 ;  PMID:23894722 ; http://dx.doi.org/10.4161/ onci.24677 23.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Int J Cancer  2007 ; 120:781-7; PMID:17096332 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Clin Cancer Res  2013 ; 19:1858 -72; PMID:23444227 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Drug Discov 2012 ; 11:215- 33; PMID:22301798 ; http://dx.doi.org/10.1038/ nrd3626 26.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Immunity  2013 ; 39:74-88; PMID:23890065 ;  http://dx.doi.org/10.1016/j.immuni.2013.06.014 27.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
J Clin Oncol 2002 ;  20:2453 -63; PMID:12011122 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Immunol 2011 ; 11:852-63;  PMID:22116087 ; http://dx.doi.org/10.1038/nri3108 30.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:544-6; PMID:22754781 ;  http://dx.doi.org/10.4161/onci.19442 32.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2013 ; 2:e23991 ;  PMID:23734334 ; http://dx.doi.org/10.4161/ onci.23991 33.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2012 ; 1:1223 -5; PMID:23243584 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Immunol  2009 ; 10:1185 -92; PMID:19783989 ;  http://dx.doi.org/10.1038/ni.1790 35.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Immunol   2001 ; 2:261-8; PMID:11224527 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Immunol 2009 ; 9:568-80;  PMID:19629084 ; http://dx.doi.org/10.1038/ nri2604 38.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Cancer 2002 ; 2:850-61;  PMID :12415255 ; http://dx.doi.org/10.1038/nrc928 39.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Immunol Rev   2008 ; 224:85-97; PMID:18759922 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Immunol Rev  2008 ;  224:70-84; PMID:18759921 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Immunol Rev   2011 ; 244:134-48; PMID:22017436 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Immunol  2009 ; 9:271-85; PMID:19319144 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Immunol 2004 ; 4:420-31;  PMID:15173831 ; http://dx.doi.org/10.1038/nri1371 44.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2012 ; 1:458-66; PMID:22754764 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Immunol 2006 ; 6:613-8;  PMID:16868552 ; http://dx.doi.org/10.1038/nri1867 46.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Immunol  2002 ; 3:135-42;  PMID:11812990 ; http://dx.doi.org/10.1038/ni759 47.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Immunity  2001 ; 14:715- 25; PMID:11420042 ; http://dx.doi.org/10.1016/ S1074-7613(01)00147-9 48.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2013 ; 2:e24170 ; PMID:23762798 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Immunol 2002 ; 2:46- 53; PMID:11905837 ; http://dx.doi.org/10.1038/ nri704 50.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Cancer  2010 ; 10:415-24; PMID:20495575 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
J Natl Cancer  Inst 1988 ; 80:932-6; PMID:3398068 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Lancet  1982 ; 1:762- 5; PMID:6121224 ; http://dx.doi.org/10.1016/ S0140-6736(82)91811-6 56.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Annu Rev Immunol 1994 ; 12:991-1045 ;  PMID:8011301 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Science  2002 ; 296:301-5; PMID:11951032 ;  http://dx.doi.org/10.1126/science.1071059 58.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
N Engl J Med 2010 ; 363:711-23;  PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
N Engl J Med  2011 ; 364:2517-26; PMID:21639810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Lancet Oncol  2010 ; 11:155- 64; PMID:20004617 ; http://dx.doi.org/10.1016/ S1470-2045(09)70334-1 61.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
J Clin Oncol  2010 ; 28:3167-75; PMID:20516446 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
N Engl J Med 2012 ; 366:2443 -54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 65.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
J Clin Oncol 2007 ; 25:876- 83; PMID:17327609 ; http://dx.doi.org/10.1200/ JCO.2006.08.3311 68.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Haematologica  2010 ; 95:845-8; PMID:20133895 ;  http://dx.doi.org/10.3324/haematol.2009.008003 69.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Leuk  Lymphoma  2010 ; 51:228-35; PMID:20038235 ;  http://dx.doi.org/10.3109/10428190903440946 70.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Semin Oncol 2010 ; 37:508- 16; PMID:21074066 ; http://dx.doi.org/10.1053/j.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
J Hematol Oncol 2008 ; 1:20; PMID:18959794 ;  http://dx.doi.org/10.1186/1756-8722-1-20 72.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:1557- 76; PMID:23264902 ; http://dx.doi.org/10.4161/ onci.22428 74.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:179- 88; PMID:22720239 ;  http://dx.doi.org/10.4161/ onci.1.2.19026 75.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2013 ; 2:e23510 ;  PMID:23687621 ; http://dx.doi.org/10.4161/ onci.23510 76.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Br J Cancer 2013 ; 109:8-13; PMID:23787916 ;  http://dx.doi.org/10.1038/bjc.2013.298 77.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Cancer Immunol Immunother   2013 ; 62:245-56; PMID:22878899 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
N Engl J Med 2013 ; 368:1365 - 6; PMID:23550685 ; http://dx.doi.org/10.1056/ NEJMc1302338 79.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Ann Oncol  2013 ; 24:75-83; PMID:22858559 ;  http://dx.doi.org/10.1093/annonc/mds213 80.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
J Immunother  2013 ; 36:382-9; PMID:23924790 ;  http://dx.doi.org/10.1097/CJI.0b013e31829fb7a2 81.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
J Immunol  2012 ; 189:3759 - 66; PMID:22956585 ; http://dx.doi.org/10.4049/ jimmunol.1201529 82.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
N Engl J Med  2013 ; 369:122-33; PMID:23724867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
J Clin Oncol 2013 ; 31:616-22; PMID:23295794 ;  http://dx.doi.org/10.1200/JCO.2012.44.6112 85.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Br J  Cancer  2013 ; 108:1998 -2004 ; PMID:23652314 ;  http://dx.doi.org/10.1038/bjc.2013.227 86.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Clin Cancer Res 2013 ; 19:462-8;  PMID:23169436 ; http://dx.doi.org/10.1158/1078- 0432.CCR-12-2625 87.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
N Engl J Med  2013 ; 369:134-44; PMID:23724846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Blood  2012 ;  120:4324 -33; PMID:23033266 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2013 ; 2:e23033 ; PMID:23483678 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Leuk Lymphoma  2013 ; 54:277- 83; PMID:22775314 ; http://dx.doi.org/10.3109/10 428194.2012.710328 92.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Clin  Cancer Res 2013 ; 19:6286 -95; PMID:23983255 ;  http://dx.doi.org/10.1158/1078-0432.CCR-13-1320 93.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Leuk Lymphoma   2012 ; 53:2136 -42; PMID:22475052 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Cancer Res 2013 ; 73:7189 -98;  PMID:24177180 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-4174,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Invest New Drugs 2013 ; 31:707- 13; PMID:22864469 ; http://dx.doi.org/10.1007/ s10637-012-9866-y 96.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Cancer Res  2008 ; 68:5301 -8; PMID:18593931 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Science   2012 ; 337:1678 -84; PMID:23019653 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Cancer Res 2013 ; 73:2271 -80;  PMID:23554447 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-3000 99.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncogene   2012 ; 31:1869 -83; PMID:21892204 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:1111-34;  PMID:23170259 ; http://dx.doi.org/10.4161/ onci.21494 101.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2013 ; 2:e25771 ; PMID:24286020 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2013 ; 2:e24850 ; PMID:24073369 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2012 ; 1:493-506; PMID:22754768 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology   2012 ; 1:699-716; PMID:22934262 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:894-907;  PMID:23162757 ; http://dx.doi.org/10.4161/ onci.20931 106.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2013 ; 2:e25238 ;  PMID:24083080 ; http://dx.doi.org/10.4161/ onci.25238 107.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Immunotherapy  2013 ; 5:215- 29; PMID:23444951 ; http://dx.doi.org/10.2217/ imt.13.9 108.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Br J Haematol  2012 ; 159:58-66; PMID:22861192 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
PLoS One  2013 ; 8:e60031 ;  PMID:23560068 ; http://dx.doi.org/10.1371/jour - nal.pone.0060031 111.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2013 ; 2:e25595 ;  PMID:24319634 ; http://dx.doi.org/10.4161/ onci.25595 112.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Cancer 2009 ; 9:57-63;  PMID:19052556 ; http://dx.doi.org/10.1038/ nrc2541 114.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Annu Rev Immunol 2013 ; 31:51-72;  PMID :23157435 ; http://dx.doi.org/10.1146/ annurev-immunol-032712-100008115.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Cancer  2012 ; 12:860-75; PMID :23151605 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Clin Oncol  2009 ; 6:256-8; PMID:19390551 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nature  2007 ; 449:419-26;  PMID:17898760 ; http://dx.doi.org/10.1038/ nature06175 120.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Cancer 2012 ; 12:265- 77; PMID:22437871 ; http://dx.doi.org/10.1038/ nrc3258 121.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2013 ; 2:e24238 ;  PMID:23762803 ; http://dx.doi.org/10.4161/ onci.24238 122.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Oncoimmunology  2012 ; 1:306- 15; PMID:22737606 ; http://dx.doi.org/10.4161/ onci.19549 123.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Biotechnol   2013 ; 31:999-1008 ; PMID:24142051 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Nat Rev Immunol 2012 ; 12:269-81;  PMID:22437939 ; http://dx.doi.org/10.1038/ nri3191,Non-OADS,/arxiv_data1/oa_pdf/81/0a/onci-3-e27297.PMC3961485.pdf
Available at: http://www.hcup-us.ahrq.gov/db/state/costtocharge.,OADS,/arxiv_data1/oa_pdf/bd/17/cncr0120-1035.PMC3961514.pdf
"Washington, DC: The Advisory Board Company; 2012.Available at: http://www.advisory.com/Daily-Briefing/2012/02/14/ complications.",Non-OADS,/arxiv_data1/oa_pdf/bd/17/cncr0120-1035.PMC3961514.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/AF a r i n a et al.",Non-OADS,/arxiv_data1/oa_pdf/fe/ae/jid2013423a.PMC3961515.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/N Okiyama et al.",Non-OADS,/arxiv_data1/oa_pdf/07/9a/jid2013476a.PMC3961527.pdf
All patient-specific OCB peptides were analyzed via IgBlast (http://www.ncbi.nlm.nih.gov/igblast/) todetermine similarity with known IGHV germline gene sequences.,OADS,/arxiv_data1/oa_pdf/4e/27/ana0075-0266.PMC3961546.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/ott-7-433.PMC3961586.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 433–434OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  433LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/OTT .S6155 2Is combination of neutrophil to lymphocyte   ratio and platelet lymphocyte ratio a useful  predictor of postoperative survival in patients  with esophageal squamous cell carcinoma?,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/ott-7-433.PMC3961586.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/eb/e6/ott-7-433.PMC3961586.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/e6/ott-7-433.PMC3961586.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/c1/ott-7-425.PMC3961587.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 425–432OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  425Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5732 4additive effect by combination of akt inhibitor,  MK-2206, and PDgFr inhibitor, tyrphostin   ag 1296, in suppressing anaplastic thyroid  carcinoma cell viability and motility huan-yong che hang-yuan guo Xu-wei si Qiao-ying Y ou Wei-ying lou shaoxing People’s hospital, shaoxing  hospital of Zhejiang University,   shaoxing, Zhejiang, People’s republic  of china correspondence : hang-yuan guo   shaoxing People’s hospital, shaoxing  hospital of Zhejiang University,   568 Zhongxing north road,   shaoxing, Zhejiang 312000,   People’s republic of china   Tel: +86 0575 88228288617 636-0491   Fax: +86 0575 85228899   email drguohangyuan@sina.co mAbstract:  The phosphatidylinositol-3-kinase/Akt pathway and receptor tyrosine kinases  regulate many tumorigenesis related cellular processes including cell metabolism, cell survival,  cell motility, and angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/45/c1/ott-7-425.PMC3961587.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/45/c1/ott-7-425.PMC3961587.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/c1/ott-7-425.PMC3961587.pdf
Available from: http://www.idf.org/diabetesatlas/ .,Non-OADS,/arxiv_data1/oa_pdf/be/7b/12325_2014_Article_102.PMC3961596.pdf
Available from: http://www0.nih.go.jp/eiken/ english/research/project_nhns.html/ .,Non-OADS,/arxiv_data1/oa_pdf/be/7b/12325_2014_Article_102.PMC3961596.pdf
Available from: http://www.invokanahcp.com/ prescribing-information.pdf/ .,Non-OADS,/arxiv_data1/oa_pdf/be/7b/12325_2014_Article_102.PMC3961596.pdf
Available from: http://www.nihs.go.jp/ drug/be-guide(e)/Gen eric/GL-E_120229_BE.pdf .,Non-OADS,/arxiv_data1/oa_pdf/be/7b/12325_2014_Article_102.PMC3961596.pdf
http://www.aace.com/ﬁles/aace_ algorithm.pdf .,OADS,/arxiv_data1/oa_pdf/43/e3/12325_2014_Article_101.PMC3961598.pdf
"Diabetes; 2011. http://professional.diabetes.org/ Abstracts_Display.aspx?TYP=1&CID=87603 .A c c e s - sed Sep, 2013.",Non-OADS,/arxiv_data1/oa_pdf/43/e3/12325_2014_Article_101.PMC3961598.pdf
http://www.medscape.com/viewarticle/ 808830 .,Non-OADS,/arxiv_data1/oa_pdf/43/e3/12325_2014_Article_101.PMC3961598.pdf
MarketScanWhite Paper 2012. http://www.truvenhealth.com/ assets/2012_Truven_MarketScan_white_paper.pdf .,Non-OADS,/arxiv_data1/oa_pdf/8f/c0/12325_2014_Article_108.PMC3961599.pdf
http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/8f/c0/12325_2014_Article_108.PMC3961599.pdf
http://www.fda.gov/Safety/MedWatch/Safety Information/SafetyAlertsforHumanMedicalProducts/ ucm264204.htm .,Non-OADS,/arxiv_data1/oa_pdf/8f/c0/12325_2014_Article_108.PMC3961599.pdf
http://www.h2hquality.org .,Non-OADS,/arxiv_data1/oa_pdf/8f/c0/12325_2014_Article_108.PMC3961599.pdf
"Jean Adamus1,S i r p aA h o1, Helen Meldrum1, Carol Bosko1and Jian-Ming Lee1 1Skin Biosciences, Unilever R&D, Trumbull, Connecticut, USAE-mail: jean.adamus@unilever.com orjian-ming.lee@unilever.com SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Aho S, Harding CR, Lee J et al.",Non-OADS,/arxiv_data1/oa_pdf/51/ef/jid2013468a.PMC3961602.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Properly Selected Skin Cancer Treatments Are Very Effective Journal of Investigative Dermatology (2014) 134, 1133–1135; doi:10.1038/jid.2013.449; published online 21 November 2013 TO THE EDITOR We read with interest Chren et al.",Non-OADS,/arxiv_data1/oa_pdf/51/ef/jid2013468a.PMC3961602.pdf
"109Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/37/aps-41-109.PMC3961605.pdf
"111Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/33/aps-41-111.PMC3961606.pdf
"116Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/e6/aps-41-116.PMC3961607.pdf
Available from: http://www.yumpu.,Non-OADS,/arxiv_data1/oa_pdf/a7/e6/aps-41-116.PMC3961607.pdf
Avail - able from: http://www.cms.gov/Medicare/Medicare-Fee- for-Service-Payment/AcuteInpatientPPS/Readmissions- Reduction-Program.html.,Non-OADS,/arxiv_data1/oa_pdf/a7/e6/aps-41-116.PMC3961607.pdf
"122Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/1f/aps-41-122.PMC3961608.pdf
"126Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/de/aps-41-126.PMC3961609.pdf
"133Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/35/aps-41-133.PMC3961610.pdf
"140Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/a8/aps-41-140.PMC3961611.pdf
"148Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/64/aps-41-148.PMC3961612.pdf
"153Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/e9/aps-41-153.PMC3961613.pdf
"158Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/17/aps-41-158.PMC3961614.pdf
"163Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/eb/aps-41-163.PMC3961615.pdf
"171Copyright © 2014  The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1a/32/aps-41-171.PMC3961616.pdf
"Received: 26 Dec 2013 • Revised: 26 Dec 2013 • Accepted: 26 Dec 2013   pISSN: 2234-6163  • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2014.41.2.174 • Arch Plast Surg 2014;41:174-180 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.then, it has been performed worldwide in a total of 25 patients [2- 4].",Non-OADS,/arxiv_data1/oa_pdf/f4/1f/aps-41-174.PMC3961617.pdf
"Received: 17 Sep 2013 • Revised: 20 Oct 2013 • Accepted: 21 Oct 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/10.5999/aps.2014.41.2.181 • Arch Plast Surg 2014;41:181 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons Attribution  Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the  original work is properly cited.the article in question, Y oon et al.",Non-OADS,/arxiv_data1/oa_pdf/22/00/aps-41-181.PMC3961618.pdf
"Received: 19 Jun 2013 • Revised: 3 Sep 2013 • Accepted: 4 Sep 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.2.182 • Arch Plast Surg 2014;41:182-183 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/68/aps-41-182.PMC3961619.pdf
"Received: 22 Jul 2013 • Revised: 5 Sep 2013 • Accepted: 20 Sep 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.2.183 • Arch Plast Surg 2014;41:183-186 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/68/aps-41-182.PMC3961619.pdf
"Received: 22 Jul 2013 • Revised: 5 Sep 2013 • Accepted: 20 Sep 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.2.183 • Arch Plast Surg 2014;41:183-186 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/aps-41-183.PMC3961620.pdf
"Received: 27 May 2013 • Revised: 30 Jun 2013 • Accepted: 9 Jul 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.2.186 • Arch Plast Surg 2014;41:186-187 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/a0/aps-41-183.PMC3961620.pdf
"Received: 27 May 2013 • Revised: 30 Jun 2013 • Accepted: 9 Jul 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.2.186 • Arch Plast Surg 2014;41:186-187 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f2/8d/aps-41-186.PMC3961621.pdf
Available from: http://www.nice.org.uk/ nicemedia/live/10920/29094/29094.pdf.Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f2/8d/aps-41-186.PMC3961621.pdf
"Received: 16 Jul 2013 • Revised: 25 Sep 2013 • Accepted: 2 Oct 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.2.188 • Arch Plast Surg 2014;41:188-190 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/a8/aps-41-188.PMC3961622.pdf
"Received: 17 Sep 2013 • Revised: 17 Oct 2013 • Accepted: 26 Oct 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.2.190 • Arch Plast Surg 2014;41:190-192 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/a8/aps-41-188.PMC3961622.pdf
"Received: 17 Sep 2013 • Revised: 17 Oct 2013 • Accepted: 26 Oct 2013   pISSN: 2234-6163 • eISSN: 2234-6171   http://dx.doi.org/ 10.5999/aps.2014.41.2.190 • Arch Plast Surg 2014;41:190-192 Copyright  2014 The Korean Society of Plastic and Reconstructive Surgeons This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/58/aps-41-190.PMC3961623.pdf
"Importantly, new toolsincluding proprietary software packages such as Prioritize Software ( http://www.prioritizesoftware.com ) from Can- ada and 1000 Minds ( http://www.1000minds.com/ ) from New Zealand are available to assist decision makers in the implementation of a formal process for priority setting and speciﬁcally in improving key aspects of the process such asstaff and clinician engagement.",Non-OADS,/arxiv_data1/oa_pdf/25/fa/40258_2013_Article_74.PMC3961627.pdf
http://www.cochrane.org/glossary .,OADS,/arxiv_data1/oa_pdf/e9/6a/423_2013_Article_1136.PMC3961630.pdf
http://www.consort-statement.org/resources/ glossary/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/6a/423_2013_Article_1136.PMC3961630.pdf
http://www.invo.org.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/6a/423_2013_Article_1136.PMC3961630.pdf
http://www.lindalliance.org/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/6a/423_2013_Article_1136.PMC3961630.pdf
http://www.rcseng.ac.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/6a/423_2013_Article_1136.PMC3961630.pdf
http://www.asit.org/resources/ collaboratives .,Non-OADS,/arxiv_data1/oa_pdf/e9/6a/423_2013_Article_1136.PMC3961630.pdf
http://www.methodologyhubs.mrc.ac.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/6a/423_2013_Article_1136.PMC3961630.pdf
http://www.comet-initiative.org/ .,Non-OADS,/arxiv_data1/oa_pdf/e9/6a/423_2013_Article_1136.PMC3961630.pdf
https://www.npeu.ox.ac.uk/files/ downloads/coronis-follow-up/CORONIS-Follow-up-Protocol-V5- Nov-2012.pdf .,OADS,/arxiv_data1/oa_pdf/e9/6a/423_2013_Article_1136.PMC3961630.pdf
"Acknowledgments The present contribution is a project of Sys- tematic Investigation and Research on Interventions and Outcomes(SIRIO)-MEDICINE, a selected group of senior scientists and fellows collaborating worldwide to pursue research and innovation in medi- cine ( http://www.siriomedicine.com ).",Non-OADS,/arxiv_data1/oa_pdf/f6/3d/40256_2013_Article_53.PMC3961631.pdf
http://www.fda.gov/ForConsumers/ ConsumerUpdates/ucm293330.htm .,Non-OADS,/arxiv_data1/oa_pdf/f6/3d/40256_2013_Article_53.PMC3961631.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/86/3b/srep04425.PMC3961733.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4425 | DOI: 10.1038/srep04425 5",Non-OADS,/arxiv_data1/oa_pdf/86/3b/srep04425.PMC3961733.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e3/b5/srep04426.PMC3961734.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4426 | DOI: 10.1038/srep04426 6",Non-OADS,/arxiv_data1/oa_pdf/e3/b5/srep04426.PMC3961734.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/31/54/srep04424.PMC3961736.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4424 | DOI: 10.1038/srep04424 5",Non-OADS,/arxiv_data1/oa_pdf/31/54/srep04424.PMC3961736.pdf
All oligonu- cleotide sequences were ordered from Intergrated DNA Technologies and analyzed in silico for potential non-specific interactions using the IDT heterodimer oligoanalyzer algorithm: http://www.idtdna.com/analyzer/applications/oligoanalyzer.,OADS,/arxiv_data1/oa_pdf/ef/43/srep04432.PMC3961737.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4432 | DOI: 10.1038/srep04432 8",Non-OADS,/arxiv_data1/oa_pdf/ef/43/srep04432.PMC3961737.pdf
TCGA_BRCA1 andTCGA_BRCA2 breast cancer datasets originate from The Cancer Genome Atlas (https://tcga-data.nci.nih.gov/tcga/).,OADS,/arxiv_data1/oa_pdf/38/29/srep04411.PMC3961740.pdf
"We accessed the MSKCC Cancer Genomics data portal (http://cbio.mskcc.org/cancergenomics/prostate/data/) on 7/27/2012 anddownloaded clinical and publicly available genomic data for the following modalities:gene expression, microRNA expression, and copy number (Table S1, Table S2).",OADS,/arxiv_data1/oa_pdf/38/29/srep04411.PMC3961740.pdf
"For ease of reproducing the results of this study, all datasets (excluding a few ones with special permission requirements which can be requested by their authors) areavailable online in Matlab format from http://www.nyuinformatics.org/downloads/ supplements/MultiModal/.",Non-OADS,/arxiv_data1/oa_pdf/38/29/srep04411.PMC3961740.pdf
"Technical report, http://clopinet.com/ isabelle/Projects/ETH/KernelRidge.pdf (2005, accessed on 10/10/2013).",Non-OADS,/arxiv_data1/oa_pdf/38/29/srep04411.PMC3961740.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/29/srep04411.PMC3961740.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4411 | DOI: 10.1038/srep04411 10",Non-OADS,/arxiv_data1/oa_pdf/38/29/srep04411.PMC3961740.pdf
"NIST X-ray Photoelectron Spectroscopy Database, Version 4.1 (National Institute of Standards and Technology, Gaithersburg, 2012); http://srdata.nist.gov/xps.",OADS,/arxiv_data1/oa_pdf/ee/75/srep04429.PMC3961741.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ee/75/srep04429.PMC3961741.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4429 | DOI: 10.1038/srep04429 6",Non-OADS,/arxiv_data1/oa_pdf/ee/75/srep04429.PMC3961741.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3c/e0/srep04430.PMC3961742.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4430 | DOI: 10.1038/srep04430 7",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/srep04430.PMC3961742.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0d/75/srep04422.PMC3961746.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4422 | DOI: 10.1038/srep04422 10",Non-OADS,/arxiv_data1/oa_pdf/0d/75/srep04422.PMC3961746.pdf
"36 http://j-stroke.orgCopyright © 2014  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/e6/jos-16-36.PMC3961813.pdf
Keywords Cerebrovascular occlusion; Stroke; Cerebral arteries; Magnetic Resonance ImagingOriginal ArticleJournal of Stroke  2014;16(1):36- 43 http://dx.doi.org/10.5853/jos.2014.16.1.36,Non-OADS,/arxiv_data1/oa_pdf/c3/e6/jos-16-36.PMC3961813.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.36 http://j-stroke.org  37Introduction Evidence suggests that symptomatic steno-occlusion (SYSO)  in acute ischemic stroke is associated with initial neurologic se - verity1 and stroke outcome.2-4 For the treatment of acute stroke,  SYSO is not only the conceptual therapeutic target of intrave - nous thrombolysis5 but also the main target of intra-arterial  thrombolysis,6 emergency endarterectomy,7 stent placement,8-10  and bypass operation.",Non-OADS,/arxiv_data1/oa_pdf/c3/e6/jos-16-36.PMC3961813.pdf
Burden of Symptomatic Steno-Occlusion http://dx.doi.org/10.5853/jos.2014.16.1.36 38 http://j-stroke.orgwith a relevant ischemic lesion.,Non-OADS,/arxiv_data1/oa_pdf/c3/e6/jos-16-36.PMC3961813.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.36 http://j-stroke.org  39In patients with a single SYSO (n = 1,339), MCA was the  most affected vessel, followed by EICA, VA, and BA (Figure 1).",Non-OADS,/arxiv_data1/oa_pdf/c3/e6/jos-16-36.PMC3961813.pdf
Burden of Symptomatic Steno-Occlusion http://dx.doi.org/10.5853/jos.2014.16.1.36 40 http://j-stroke.orgwas no additional effect of severity and location of a single SYSO  (P for interaction effect = 0.45).,OADS,/arxiv_data1/oa_pdf/c3/e6/jos-16-36.PMC3961813.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.36 http://j-stroke.org  41jects in the study) had 2 or more symptomatic vascular lesions.,Non-OADS,/arxiv_data1/oa_pdf/c3/e6/jos-16-36.PMC3961813.pdf
Burden of Symptomatic Steno-Occlusion http://dx.doi.org/10.5853/jos.2014.16.1.36 42 http://j-stroke.org10.,Non-OADS,/arxiv_data1/oa_pdf/c3/e6/jos-16-36.PMC3961813.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.36 http://j-stroke.org  43Supplementary Table 1.,Non-OADS,/arxiv_data1/oa_pdf/c3/e6/jos-16-36.PMC3961813.pdf
"Copyright © 2014  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  27Intracranial Atherosclerosis: Current Understanding  and Perspectives Oh Y oung Bang Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Correspondence:  Oh Young Bang Department of Neurology, Samsung  Medical Center, Sungkyunkwan  University, 81 Irwon-ro, Gangnam-gu,  Seoul 135-710, Korea Tel: +82-2-3410-3599 Fax: +82-2-3410-1430  E-mail: neuroboy50@naver.com Received: September 18, 2013 Revised: October 12, 2013 Accepted: October 14, 2013 This study was supported by the Korean  Healthcare Technology R&D Project,  Ministry of Health & Welfare (A110208).",Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
Keywords Atherosclerosis; Stroke; Intracranial; Plaque ReviewJournal of Stroke  2014;16(1):27- 35 http://dx.doi.org/10.5853/jos.2014.16.1.27 Introduction The importance of intracranial atherosclerotic disease (ICAD)  as a cause of stroke is underscored as compared to that of extra - cranial carotid stenosis and nonvalvular atrial fibrillation.,Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
Bang Intracranial Atherosclerosis http://dx.doi.org/10.5853/jos.2014.16.1.27 28 http://j-stroke.orgous mechanisms of stroke will be discussed because treatment  effects may differ among the different types of ICAD.,Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.27 http://j-stroke.org  29Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
Bang Intracranial Atherosclerosis http://dx.doi.org/10.5853/jos.2014.16.1.27 30 http://j-stroke.orgpoorly controlled in terms of mean systolic blood pressure and  LDL level.,Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.27 http://j-stroke.org  31erosclerosis.48-50 Because ICAD risk could not be fully explain ed  by conventional risk factors, there have been efforts to find risk  factors specific to ICAD.",Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
"Bang Intracranial Atherosclerosis http://dx.doi.org/10.5853/jos.2014.16.1.27 32 http://j-stroke.orgmechanisms are associated with stroke in patients with ICAD,  as compared to those with extracranial carotid stenosis or atrial  fibrillation.",Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.27 http://j-stroke.org  33tomi T , et al.",OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
"Bang Intracranial Atherosclerosis http://dx.doi.org/10.5853/jos.2014.16.1.27 34 http://j-stroke.orgof ipsilateral stroke in patients with asymptomatic carotid ste - nosis on best medical treatment: a prospective, population- based study.",Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.27 http://j-stroke.org  35ography.,Non-OADS,/arxiv_data1/oa_pdf/18/7d/jos-16-27.PMC3961814.pdf
"Copyright © 2014  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/9d/jos-16-51.PMC3961815.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  51A Case of Delayed Neurological Recovery with  Luxury Perfusion and a High Intracranial Arterial  Calcification Burden Hong-Il Suh, Seon-Wook Lee, Y oung-In Eom, Jin Soo Lee Department of Neurology, Ajou University Medical Center, Suwon, KoreaLetter to the EditorJournal of Stroke  201 4;16(1):51- 53 http://dx.doi.org/10.5853/jos.2014.16.1.51 Dear Sir,  Although patients with acute ischemic stroke achieve recana - lization, approximately 37%-65% of them do not show immedi - ate improvement.1 The term “stunned brain syndrome” refers  to delayed neurological recovery after an ischemic insult to the  brain.1 We describe the case of a patient with delayed neurologi - cal recovery who had a small cerebral infarction but relatively  rapid compensatory perfusion and high calcification burden in  the intracranial arteries.",Non-OADS,/arxiv_data1/oa_pdf/9d/9d/jos-16-51.PMC3961815.pdf
"Luxury Perfusion and Cerebral Arterial Calcification http://dx.doi.org/10.5853/jos.2014.16.1.51 52 http://j-stroke.orghowever, a previous report has shown a relationship with perfu - sion deficit.",Non-OADS,/arxiv_data1/oa_pdf/9d/9d/jos-16-51.PMC3961815.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.51 http://j-stroke.org  532257-2262.,OADS,/arxiv_data1/oa_pdf/9d/9d/jos-16-51.PMC3961815.pdf
"Copyright © 2014  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
"pISSN: 2287-6391 • eISSN: 2287-6405 http://j-stroke.org  1Stroke Epidemiology in Thailand Nijasri C. Suwanwela Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Correspondence:  Nijasri C. Suwanwela Division of Neurology, Department of  Medicine, Faculty of Medicine,  Chulalongkorn University, Bangkok,  Thailand Received: November 6, 2013 Revised: November 29, 2013 Accepted: November 29, 2013 The authors have no financial conflicts of  interest.Stroke is a major health burden in Thailand.",Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
Keywords Stroke; Epidemiology; ThailandReviewJournal of Stroke  2014;16(1):1-7 http://dx.doi.org/10.5853/jos.2014.16.1.1 Introduction Thailand is a country located in South-east Asia with an ap - proximate current population of 67 million people.,Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
Suwanwela  Stroke Epidemiology in Thailand http://dx.doi.org/10.5853/jos.2014.16.1.1 2 http://j-stroke.orgeastern and Southern parts of Thailand.,Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.1 http://j-stroke.org  3Stroke incidence  T o date, there is little information on the incidence of stroke  in Thailand.",Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
Suwanwela  Stroke Epidemiology in Thailand http://dx.doi.org/10.5853/jos.2014.16.1.1 4 http://j-stroke.orgThailand.,Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.1 http://j-stroke.org  5thrombolysis was in 1996 and later on, the stroke fast track pro - gram was developed, initiated, and implemented by and at King  Chulalongkorn Memorial hospital.30,31 The stroke fast track  program is a hospital system designed to allow medical triage  personnel at the hospital to identify patients with stroke early  on in order to take proactive measures for prompt investigation  and management with the stroke team.",Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
"Suwanwela  Stroke Epidemiology in Thailand http://dx.doi.org/10.5853/jos.2014.16.1.1 6 http://j-stroke.orgkul S, Pimpak T , T atsanavivat P , et al.",Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
"Available at:  http://www.who.int/research/en/(accessed September 20,  2013.",OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
Available at: http://bps.ops.moph.,Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.1 http://j-stroke.org  7lytic therapy in acute ischemic stroke in Asia: the first prospec - tive evaluation.,Non-OADS,/arxiv_data1/oa_pdf/44/52/jos-16-1.PMC3961816.pdf
"8 http://j-stroke.orgCopyright © 2014  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
"Keywords Stroke classification; Asia; Intracranial atherosclerosis ReviewJournal of Stroke  2014;16(1):8-17 http://dx.doi.org/10.5853/jos.2014.16.1.8 Introduction The etiologies of ischemic stroke are diverse, making it diffi ­ cult to include all stroke subtypes within a single classification  system.1 Recent advances in neuroimaging have significantly  improved our understanding of the mechanisms of ischemic  stroke, allowing treatment strategies to be individualized in ac ­ cord with the particular stroke pathophysiology.2 Appropriate  classification of ischemic stroke subtypes, based upon causative mechanism, therefore is critical for guiding treatment decisions  and determining the prognosis of individual patients.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.8 http://j-stroke.org  9may not be applicable to other populations, such as Asians, in  which stroke etiologies occur in different proportions.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
Asian View of Stroke Classification  http://dx.doi.org/10.5853/jos.2014.16.1.8 10 http://j-stroke.orgally presents as SSI.,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.8 http://j-stroke.org  11sponding artery were classified as large­artery atherosclerosis;  mild stenosis ( < 50%) with a potential to generate distal embo ­ lization, was ignored.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
Asian View of Stroke Classification  http://dx.doi.org/10.5853/jos.2014.16.1.8 12 http://j-stroke.orgment.,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.8 http://j-stroke.org  13tery is > 50%.50 In SSS ­TOAST , mild stenosis was regarded as a  source of stroke, but only when 2 or more transient ischemic  events were confirmed.37 ASCO also did not sufficiently con ­ sider SSI with mild parental arterial disease.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
"Asian View of Stroke Classification  http://dx.doi.org/10.5853/jos.2014.16.1.8 14 http://j-stroke.orgThis classification system also defined atherothrombosis with ­ out criteria limiting the degree of stenosis, but one or more pie­ ces of evidence of systemic atherosclerosis was needed to classi ­ fy the stroke as due to atherothrombosis.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.8 http://j-stroke.org  15vulnerable plaques,58 but its clinical utility remains limited due  to the need for lengthy and inconvenient monitoring.",Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
Asian View of Stroke Classification  http://dx.doi.org/10.5853/jos.2014.16.1.8 16 http://j-stroke.orgStroke 2011;42:2883­2890.,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.8 http://j-stroke.org  17renco P .,Non-OADS,/arxiv_data1/oa_pdf/af/b5/jos-16-8.PMC3961817.pdf
"44 http://j-stroke.orgCopyright © 2014  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/9f/jos-16-44.PMC3961818.pdf
"Keywords Ischemic stroke; Stroke subtypes; 25-hyderoxyvitamin D; Indian patientsOriginal ArticleJournal of Stroke  2014;16(1):44- 50 http://dx.doi.org/10.5853/jos.2014.16.1.44 Introduction Stroke is a sudden onset of focal neurological deficit, a major cause of morbidity and mortality and the second leading cause  of death worldwide.1 Stroke has a heterogeneous etiology, caused  by modifiable and un-modifiable risk factors.",Non-OADS,/arxiv_data1/oa_pdf/ed/9f/jos-16-44.PMC3961818.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.44 http://j-stroke.org  45have strongly suggested an association of deficiency of 25-hy - droxyvitamin D with ischemic stroke2,3 and cardiovascular dis - ease.4,5  Vitamin D is a 9,10 -seco steroid and the most common forms  in humans are vitamin D3 (cholecalciferol) and Vitamin D2  (ergocalciferol).2 Vitamin D is essential for the human body to  maintain a balance between calcium and phosphorus.",Non-OADS,/arxiv_data1/oa_pdf/ed/9f/jos-16-44.PMC3961818.pdf
25-Hydroxyvitamin D Deficiency in Ischemic Stroke  http://dx.doi.org/10.5853/jos.2014.16.1.44 46 http://j-stroke.orgTable 1.,Non-OADS,/arxiv_data1/oa_pdf/ed/9f/jos-16-44.PMC3961818.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.44 http://j-stroke.org  47nosis (2 patients), mitral valve stenosis (2 patients), and rheu - matic heart disease (3 patients).",Non-OADS,/arxiv_data1/oa_pdf/ed/9f/jos-16-44.PMC3961818.pdf
25-Hydroxyvitamin D Deficiency in Ischemic Stroke  http://dx.doi.org/10.5853/jos.2014.16.1.44 48 http://j-stroke.orgence from west may be due to the fact that as a tropical country  the temperature fluctuations are ± 10 degrees centigrade and  may not impact vitamin D levels.,Non-OADS,/arxiv_data1/oa_pdf/ed/9f/jos-16-44.PMC3961818.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.44 http://j-stroke.org  492389.,Non-OADS,/arxiv_data1/oa_pdf/ed/9f/jos-16-44.PMC3961818.pdf
25-Hydroxyvitamin D Deficiency in Ischemic Stroke  http://dx.doi.org/10.5853/jos.2014.16.1.44 50 http://j-stroke.org47.,Non-OADS,/arxiv_data1/oa_pdf/ed/9f/jos-16-44.PMC3961818.pdf
"18 http://j-stroke.orgCopyright © 2014  Korean Stroke Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
Keywords Vascular dementia; Vascular cognitive impairment; Subcortical ischemic vascular  dementia; Alzheimer’s diseaseReviewJournal of Stroke  2014;16(1):18- 26 http://dx.doi.org/10.5853/jos.2014.16.1.18 Introduction Vascular dementia (VaD) is caused by cerebrovascular dis - ease that directly or indirectly damages the brain structures as - sociated with cognitive functioning.,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.18 http://j-stroke.org  19pathogenesis associated with AD.3,4 With accumulating eviden- ces suggesting the role of vascular burden on cognitive func - tions, VaD has now evolved into the concept of vascular cogni - tive impairment (VCI), which encompasses not only VaD but  also AD with cerebrovascular disorder (AD with CVD or mixed  dementia) and VCI with no dementia (VCIND).",Non-OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
"Recent Updates on SIVD http://dx.doi.org/10.5853/jos.2014.16.1.18 20 http://j-stroke.orgAD or mixed demen  tia, which demonstrate fibrillar forms of am - yloid deposition in the brain.16,17 Finally, other forms of VaD in - clude dementia that is caused by heterogeneous etiologies (e.g.,  vasculitis, cerebral amyloid angiopathy, and hereditary diseases,  such as cerebral autosomal do minant arteriopathy with subcorti - cal infarcts and leukoencephalopathy [CADASIL]).18-20 There is growing consensus on the concept of mild cognitive  impairment (MCI) due to AD or very mild AD.",Non-OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
"1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.18 http://j-stroke.org  21Controlled Oral Word Association T est and the Stroop color test  (T able 1).17,31-33 Associations between the amount of white mat - ter pathology and impairments in daily living activities have also  been described.34  Beyond the signal changes visible on MRI, recent method - ological advances have enabled further image-based analyses to  investigate the integrity of normal-appearing white matter tracts  and the mechanisms that underlie cognitive dysfunctions asso - ciated with white matter changes.",Non-OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
"Recent Updates on SIVD http://dx.doi.org/10.5853/jos.2014.16.1.18 22 http://j-stroke.orghand, another study that compared the levels of CSF Aβ and tau  among non-dement  ed elderly persons who had mild, moderate  or severe white matter hyperintensities, demonstrated no differ - ences in the levels of CSF Aβand tau among the groups.50 In addition, other markers associated with BBB breakdown  have been introduced as alternative biomarkers associated with  SIVD.",Non-OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.18 http://j-stroke.org  23onstrated deficits in cholinergic fibers.,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
Recent Updates on SIVD http://dx.doi.org/10.5853/jos.2014.16.1.18 24 http://j-stroke.orgly population.,OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
1 / January 2014 http://dx.doi.org/10.5853/jos.2014.16.1.18 http://j-stroke.org  25205.,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
Recent Updates on SIVD http://dx.doi.org/10.5853/jos.2014.16.1.18 26 http://j-stroke.orgals with non-cholinergic drugs.,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/jos-16-18.PMC3961819.pdf
http://dx.doi.org/10.1001/archinternmed.2008.601 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1001/archinternmed.2009.125 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1186/1617-9625-1-3-213 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1111/j.1572-0241.2006.00405.x .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1097/01.mpa.0000226883.55828.e9 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1097/01.mpa.0000240601.80570.31 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1002/path.2542 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1097/00006676-200010000-00009 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1007/s002620000157 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1007/s00423-007-0265-3 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1016/j.lfs.2007.03.006 .,OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1021/ tx980005y .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1158/1055-9965.EPI-08-0320 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1093/ carcin/18.5.1085 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1097/00042737-200012080-00006 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1021/tx0101088 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1097/00006676-199003000-00016 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.3181/00379727-201-43494B .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1016/0024-3205(89)90083-0 .,OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
3):168– 173. http://dx.doi.org/10.3181/00379727-218-44284 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1097/MPA.0b013e31816a7744 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1111/j.1365-2184.2007.00418.x .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
1):1. http://dx.doi.org/ 10.1186/1617-9625-11-1 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1007/s00423-007-0267-1 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1152/ajpgi.00138.2012 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1152/ajpgi.00334.2004 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1097/00000658-200102000-00009 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1038/nrd1797 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1016/ j.coph.2009.06.011 .,OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1159/000069140 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
4):535– 545. http://dx.doi.org/10.1007/s00423-007-0266-2 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1159/000320068 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1038/ajg.2012.288 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1016/j.mrrev.2009.07.003 .,OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1093/carcin/22.3.473 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1007/s00432-005-0002-7 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1016/ j.metabol.2004.08.020 .,OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1097/MPA.0b013e3182762928 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1002/ijc.23894 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1159/000332196 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1016/0041-008X(88)90255-4 .,OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1016/0041-008X(90)90167-S .,OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/10.1152/ajpgi.00197.2005 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
http://dx.doi.org/ 10.1038/onc.2012.163 .,Non-OADS,/arxiv_data1/oa_pdf/6c/3b/nihms-558704.PMC3961826.pdf
Available from: http://www.WHO/ NMH/NHD/MNM/11.1.,OADS,/arxiv_data1/oa_pdf/40/aa/SAJC-3-38.PMC3961866.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/a5/91/SAJC-3-5.PMC3961869.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/a5/91/SAJC-3-5.PMC3961869.pdf
Available from: http://mohfw.nic.in/ pg56to67 .pdf.,Non-OADS,/arxiv_data1/oa_pdf/81/0a/SAJC-3-54.PMC3961870.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/56/4c/SAJC-3-57.PMC3961871.pdf
Available  from: http://www.cancer.org/.,Non-OADS,/arxiv_data1/oa_pdf/85/2a/SAJC-3-66.PMC3961873.pdf
Available from: http://www.cancer.gov/cancertopics/pdq/genetics/breast -and ovarian/HealthProfessional/ page3 [Last accessed on 2013 Sep 23].,Non-OADS,/arxiv_data1/oa_pdf/09/c7/SAJC-3-71.PMC3961874.pdf
Reproduced with kind permission from the Myanmar Information Management Unit (MIMU) http://www.themimu.info,Non-OADS,/arxiv_data1/oa_pdf/94/c4/SAJC-3-78.PMC3961876.pdf
Available from: http://www.moh.gov.mm [Last accessed on 2012  Feb 21].,OADS,/arxiv_data1/oa_pdf/94/c4/SAJC-3-78.PMC3961876.pdf
Available from: http://www.data.un.org/CountryProfile.,OADS,/arxiv_data1/oa_pdf/94/c4/SAJC-3-78.PMC3961876.pdf
Available from:  http://www.unicef.org/infobycountry/myanmar_statistics.html  [Last accessed on 2013 Jun 8].,Non-OADS,/arxiv_data1/oa_pdf/94/c4/SAJC-3-78.PMC3961876.pdf
Available from: http://Www.Nccn.Org/Professionals/ Physician -Gls/Pdf/Cml.Pdf.,Non-OADS,/arxiv_data1/oa_pdf/db/1f/SAJC-3-83.PMC3961878.pdf
"Available from: http://globocan.iarc.fr/Pages/fact_sheets_ population.aspx, [Last accessed on 2013 Dec 13].",OADS,/arxiv_data1/oa_pdf/46/9c/SAJC-3-93.PMC3961881.pdf
Available from: http://www.globocan.iarc.fr/ Pages/fact_sheets_ population.aspx.,Non-OADS,/arxiv_data1/oa_pdf/97/5c/SAJC-3-94.PMC3961882.pdf
Available from:  http://update.anaesthesiologists.org/wp -contentuploads/2009/09/ Acid-Base-Balance-Update-13.pdf [Last accessed on 2010 Jul 7].,OADS,/arxiv_data1/oa_pdf/ee/d1/NJMS-4-136.PMC3961885.pdf
Available from: http://www.out/our_organisation www.medicareaustralia.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/NJMS-4-151.PMC3961887.pdf
Available at:  http://meeting.jco.org/cgi/content/abstract/24/18_suppl/8528.,Non-OADS,/arxiv_data1/oa_pdf/c4/7a/NJMS-4-151.PMC3961887.pdf
Available from  http://www.bcm.edu/oto/grand/10072004.htm.,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/NJMS-4-181.PMC3961892.pdf
"Geometry  optimizations of  the ligands were performed according to the Hartree–Fock (HF) calculation method using ArgusLab 4.0.1 (Mark A. Thompson, Planaria Software LLC, Seattle, WA, USA, http://www.arguslab.com) software.",OADS,/arxiv_data1/oa_pdf/ce/0c/JNSBM-5-108.PMC3961913.pdf
Figure 1: Binding pose of quercetin (pink) in binding site (green) Figure 2:  Binding pose of quercetrin (pink) in binding site (green) Figure 3:  Binding pose of salanin (pink) in binding site (green) Binding site predictionN Q-SiteFinder (http://www.bioinformatics.leeds.ac.uk/ qsiteﬁ nder) is used for binding site prediction.,Non-OADS,/arxiv_data1/oa_pdf/ce/0c/JNSBM-5-108.PMC3961913.pdf
"Cdk1_yeast protein was docked against the bioactive  compounds from the leaves of  neem tree using ArgusLab 4.0.1 (Mark A. Thompson, Planaria Software LLC, Seattle, WA, USA, http://www.arguslab.com).",OADS,/arxiv_data1/oa_pdf/ce/0c/JNSBM-5-108.PMC3961913.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/ba/b2/JNSBM-5-123.PMC3961916.pdf
This  study has been designed and reported in accordance with the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) statement (http://www.strobe-statement.org).,Non-OADS,/arxiv_data1/oa_pdf/df/49/JNSBM-5-139.PMC3961919.pdf
Available from: http://www.health.bih.nic.in/Docs/Sub-Centers-(Revised)-2012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/86/JNSBM-5-144.PMC3961920.pdf
Available from:  http://www.ijph.in/temp/IndianJPublicHealth564269-858983_ 235138.pdf [Last accessed on 2013 Mar 20].,Non-OADS,/arxiv_data1/oa_pdf/ab/c8/JNSBM-5-15.PMC3961922.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/8d/de/JNSBM-5-21.PMC3961939.pdf
MATERIALS AND METHODS Ligand and protein preparation The X-ray crystal structure of  antithrombin 1e05[32]  was acquired from research collaboratory for structural bioinformatics (RCSB) (http://www.rcsb.org/pdb/).,OADS,/arxiv_data1/oa_pdf/a1/63/JNSBM-5-36.PMC3961949.pdf
The structures of  the  non-sulfated parent ligands were acquired from National Center for Biotechnology Information (NCBI) Pubchem compound (http://www.ncbi.nlm.nih/pccompound).,OADS,/arxiv_data1/oa_pdf/a1/63/JNSBM-5-36.PMC3961949.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/a2/ba/JNSBM-5-73.PMC3961957.pdf
"Rare Diseases 2013; 1:e24910; http://dx.doi.org/10.4161/rdis.24910Correspondence to: The ALS Association   Email: mediarelations@alsa-national.orgSince 1985, The ALS Association has  worked with people and their families living with amyotrophic lateral sclerosis (ALS) ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available from: http://www.alsa.org/commu - nity/services.html?service_type=chapters&state=–Select+State– 2.,Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available from: http://www.alsa.org/commu - nity/services.html?service_type=centers&state=–Select+State– 3.,OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available from: http://www.alsa.org/commu - nity/services.html?service_type=clinics&state=–Select+State– 4.,Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available from: http://web.alsa.org/site/ DocServer/at_Webinar.pdf?docID=101781 5.,Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available  from: http://web.alsa.org/site/DocServer/Adequate_Nutrition_and_Feeding_Tubes_Webinar_in_ALS_ Mar2.pdf?docID=101402 6.,Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available  from: http://web.alsa.org/site/DocServer/Berry_ Telemedicine_Webinar_032613.pdf?docID=100921 7.,Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available from http://www.alsconsortium.org/ 8.,OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available from: http://www.alsa.org/news/ media/press-releases/c9orf72-animal-model.html 9.,Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available from: http://www.alsa.org/news/ media/press-releases/diaphragm-pacing-trial.html 10.,Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available from: http://www.alsa.org/news/archive/als-association- treat-als.html 11.,Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
Available from: http://www.alsa.org/advocacy/ advocacy-day/funding for ALS research since The  Association established this department in 1998.,Non-OADS,/arxiv_data1/oa_pdf/df/60/rdis-1-e24910.PMC3962010.pdf
For further information of AHRQ ’s Desirable Attributes of a Quality Measure visit: http://www.qualitymeasures.ahrq.gov.,Non-OADS,/arxiv_data1/oa_pdf/18/66/bmjqs-2012-001473.PMC3962028.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1 Coleman EA, Boult C. Improving the quality of transitional care for persons with complex care needs.",Non-OADS,/arxiv_data1/oa_pdf/18/66/bmjqs-2012-001473.PMC3962028.pdf
"2001. http://hdl.handle.net/2027.42/61498 7 Behara R, W ears RL, Perry SJ, et al.",OADS,/arxiv_data1/oa_pdf/18/66/bmjqs-2012-001473.PMC3962028.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/af/ppa-8-323.PMC3962310.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 323–330Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  323OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5804 0health-related quality of life, anxiety, and  depressive symptoms in children with primary  immunodeficiencies nina B Kuburovic1 srdjan Pasic2 gordana susic3 Dejan stevanovic4 Vladimir Kuburovic5 slavisa Zdravkovic6 Mirjana Janicijevic Petrovic7 Tatjana Pekmezovic8 1Department of Public health, Mother  and child health care institute of  serbia, 2Department of immunology,   Pediatric clinic, Faculty of Medicine,   University of Belgrade, 3institute  for rheumatology, clinical center  of serbia, 4clinic for neurology  and Psychiatry for children and  Adolescents, 5Pediatric clinic, Mother  and child health care institute  of serbia, 6Pediatric Day hospital,   Mother and child health care  institute of serbia, Belgrade, 7Faculty  of Medical sciences, University of  Kragujevac, Kragujevac, 8serbia  institute of epidemiology, Faculty  of Medicine, University of Belgrade,   Belgrade, serbia correspondence: nina B Kuburovic   Department of Public health, Mother   and child health care institute of serbia,   6-8 Radoja Dakića, Belgrade 11070, Serbia   Tel +381 60 7187 190   Fax +381 11 2697 232   email nina.kuburovic@gmail.co mIntroduction:  The aims of this study were to evaluate levels of health-related quality of life  (HRQOL) and the presence of anxiety and depressive symptoms in children with primary  immunodeficiency disease (PID) in Serbia.",Non-OADS,/arxiv_data1/oa_pdf/cf/af/ppa-8-323.PMC3962310.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/cf/af/ppa-8-323.PMC3962310.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/af/ppa-8-323.PMC3962310.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/c4/nss-6-043.PMC3962311.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNature and Science of Sleep 2014:6 43–49Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  43OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NSS.S5785 2a pilot evaluation of an online cognitive  behavioral therapy for insomnia disorder –  targeted screening and interactive Web design  lead to improved sleep in a community population Kirstie N anderson Paul goldsmith alison gardiner regional Sleep Service, Freeman  hospital, Newcastle upon Tyne, UK correspondence: Kirstie N anderson   regional Sleep Service, Freeman hospital,  Newcastle upon Tyne Ne1 4lP, UK   Tel +44 191 282 3833   Fax +44 191 233 3435   email kirstie.anderson@nuth.nhs.u kIntroduction:  Computerized or online cognitive behavioral therapies (CBTs) are increasingly  being developed to deliver insomnia therapy (CBT -i).",Non-OADS,/arxiv_data1/oa_pdf/b7/c4/nss-6-043.PMC3962311.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/b7/c4/nss-6-043.PMC3962311.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b7/c4/nss-6-043.PMC3962311.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/d7/ppa-8-311.PMC3962312.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 311–322Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  311OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5796 1Usability testing of a monitoring and feedback  tool to stimulate physical activity sanne van der Weegen1 renée Verwey1,2 huibert J Tange3 Marieke D spreeuwenberg1 luc P de Witte1,2 1Department of health services  research, cAPhri school for  Public health and Primary care,   Faculty of health Medicine and life  sciences, Maastricht University,   the netherlands; 2research centre  T echnology in care, Zuyd University  of Applied sciences, heerlen, the  netherlands; 3Department of  general Practice, cAPhri school  for Public health and Primary care,   Faculty of health Medicine and life  sciences, Maastricht University, the  netherlands correspondence: sanne van der Weegen   school for Public health and Primary  care (c APhri), Maastricht University,  PO Box 616, 6200 MD, Maastricht,   the netherlands   Tel +31 43 388 1479   Fax +31 43 388 4162   email s.vanderweegen@ maastrichtuniversity.n lIntroduction : A monitoring and feedback tool to stimulate physical activity, consisting of an  activity sensor, smartphone application (app), and website for patients and their practice nurses,  has been developed: the ‘It’ s LiFe!’ tool.",Non-OADS,/arxiv_data1/oa_pdf/c2/d7/ppa-8-311.PMC3962312.pdf
Available from: http://www.webcitation.org/6MxYEo8 d6.,Non-OADS,/arxiv_data1/oa_pdf/c2/d7/ppa-8-311.PMC3962312.pdf
Available from: http://www.measuringusability.com/ blog/ut-bias.php .,Non-OADS,/arxiv_data1/oa_pdf/c2/d7/ppa-8-311.PMC3962312.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/c2/d7/ppa-8-311.PMC3962312.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/d7/ppa-8-311.PMC3962312.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/79/ott-7-441.PMC3962313.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 441–446OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  441Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5922 7cancer cell-oriented migration of mesenchymal  stem cells engineered with an anticancer gene  (PTEN ): an imaging demonstration Zhuo-shun Yang1,* Xiang-Jun Tang2,* Xing-rong guo1 Dan-Dan Zou1 Xu-Y ong sun3 Jing-Bo Feng1 Jie luo1 long-Jun Dai1,4 garth l Warnock4 1hubei Key laboratory of stem  cell research, Taihe hospital,   hubei University of Medicine,   shiyan, People’s republic of china;   2Department of n eurosurgery,   Taihe hospital, hubei University of  Medicine, shiyan, People’s republic  of china; 3guangxi Key laboratory  for Transplant Medicine, 303 hospital  of Pla, nanning, People’s republic  of china; 4Department of surgery,   University of British columbia,   Vancouver, Bc , canada *These authors contributed equally   to this work correspondence: long-Jun Dai   Department of surgery, University of   British columbia, 400-828 West 10th   avenue, Vancouver, Bc, V5Z 1l8, canada   Tel +1 604 875 4111 ext 62501   Fax +1 604 875 4376   email longjundai@gmail.co m    Jie luo   Taihe hospital, 32 renmin road, shiyan,   442000, People’s republic of china   Tel +86 719 880 1880   Fax +86 719 880 1218   email luojie_001@126.co mBackground:  Mesenchymal stem cells (MSCs) have been considered to hold great potential  as ideal carriers for the delivery of anticancer agents since the discovery of their tumor tropism.",Non-OADS,/arxiv_data1/oa_pdf/2b/79/ott-7-441.PMC3962313.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2b/79/ott-7-441.PMC3962313.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/79/ott-7-441.PMC3962313.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/37/51/ijwh-6-313.PMC3962314.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2014:6 313–325International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  313RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S3896 9Acupuncture and women’s health: an overview   of the role of acupuncture and its clinical  management in women’s reproductive health Suzanne Cochrane1 Caroline A Smith2 Alphia Possamai-Inesedy3 Alan Bensoussan2 1School of Science and Health,   2Centre for Complementary Medicine  Research, 3School of Social Sciences  and Psychology, University of Western  Sydney – Campbelltown Campus,   Penrith, NSW, AustraliaBackground:  Acupuncture and other modalities of Chinese/East Asian medicine have  been used to treat women’ s health for many centuries.",Non-OADS,/arxiv_data1/oa_pdf/37/51/ijwh-6-313.PMC3962314.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/37/51/ijwh-6-313.PMC3962314.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/51/ijwh-6-313.PMC3962314.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/7d/imcrj-7-049.PMC3962315.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2014:7 49–52International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  49Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S6004 9First report of MRI findings in a case   of an autoamputated wandering calcified ovary Parag Suresh Mahajan Nazeer Ahamad Sheik Akbar Hussain Department of Radiology,    Al-Khor Hospital, Hamad Medical  Corporation, Doha, Qatar Correspondence: Parag Suresh Mahajan   Department of Radiology, Al-Khor   Hospital, Hamad Medical Corporation,   PO Box 3050, Doha, Qatar   tel +974 663 476 94   email mdfrcr@gmail.co mAbstract:  An autoamputated wandering calcified ovary (AWCO) is an extremely rare cause of  abdominal calcification in the pediatric population.",Non-OADS,/arxiv_data1/oa_pdf/50/7d/imcrj-7-049.PMC3962315.pdf
Or use: http://dvpr.es/1fXmt5D,Non-OADS,/arxiv_data1/oa_pdf/50/7d/imcrj-7-049.PMC3962315.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/50/7d/imcrj-7-049.PMC3962315.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/7d/imcrj-7-049.PMC3962315.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/9a/dddt-8-315.PMC3962316.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2014:8 315–323Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  315ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5235 4Genistein suppresses tumor necrosis factor  α-induced inflammation via modulating reactive  oxygen species/Akt/nuclear factor κB and  adenosine monophosphate-activated protein kinase  signal pathways in human synoviocyte MH7A cells Jinchao Li1,* Jun Li2,* Ye Yue1 Yiping Hu1 Wenxiang Cheng1 Ruoxi Liu3 Xiaohua Pan4 Peng Zhang1 1Center for Translational Medicine  Research and Development, Shenzhen  Institute of Advanced T echnology,   Chinese Academy of Science,   Shenzhen, 2Emergency Surgery  Department, Shaanxi Provincial  People’s Hospital, Xi’an, 3Department  of Orthopedics, Shandong University  of Traditional Chinese Medicine,   Jinan, 4Department of Orthopedics,   Second Clinical Medical College,   Jinan University, Shenzhen, People’s  Republic of China *These authors contributed equally   to this work Correspondence: Peng Zhang; Jinchao Li   Center for Translational Medicine   Research and Development,   Shenzhen Institute of Advanced   Technology, Chinese Academy   of Science, 1068 Xueyuan Avenue,  Shenzhen, Guangdong 518055,   People’s Republic of China   Email peng.zhang@siat.ac.c n;  ljchz@hotmail.co mAims:  Genistein, an isoflavone derivative found in soy, is known as a promising treatment for  rheumatoid arthritis (RA).",Non-OADS,/arxiv_data1/oa_pdf/eb/9a/dddt-8-315.PMC3962316.pdf
"(Beyotime Institute of Biotechnology, Haimen, People’ s  Republic of China) Western blot results were quantified  using ImageJ software (downloaded from the NIH website  http://rsb.info.nih.gov/ij/download.htm l) after normalizing  to corresponding loading controls.",OADS,/arxiv_data1/oa_pdf/eb/9a/dddt-8-315.PMC3962316.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/eb/9a/dddt-8-315.PMC3962316.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/9a/dddt-8-315.PMC3962316.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/c5/cia-9-425.PMC3962317.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 425–432Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  425OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5771 4Age-associated alterations in cholesterol   homeostasis: evidence from a cross-sectional   study in a northern Italy population Marco Bertolotti1 Chiara Mussi1 elisa Pellegrini1 Alessandro Magni2 Marina Del Puppo2 silvia Ognibene1 lucia Carulli1 Claudia Anzivino1 enrica Baldelli1 Paola loria1 nicola Carulli1 1Department of Biomedical,    Metabolic and neural sciences,   University of Modena and reggio  emilia, Modena, Italy; 2Department   of health sciences, University of   Milano Bicocca, Monza, Italy Correspondence: Marco Bertolotti   Division of geriatric Medicine,   Department of Biomedical, Metabolic   and neural sciences, University of   Modena and reggio emilia, nuovo   Ospedale Civile di Modena,   via giardini 1355, Modena, Italy   Tel +39 059 3961802   Fax +39 059 3961335   email marco.bertolotti@unimore.i tBackground:  The modifications of cholesterol metabolism associated with aging are ill-defined.",Non-OADS,/arxiv_data1/oa_pdf/52/c5/cia-9-425.PMC3962317.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/52/c5/cia-9-425.PMC3962317.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/c5/cia-9-425.PMC3962317.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/b3/ijn-9-1423.PMC3962318.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 1423–1432International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1423OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5735 3Bone plate composed of a ternary   nano-hydroxyapatite/polyamide 66/glass   fiber composite: biomechanical properties   and biocompatibility Bo Qiao1 Jidong li2 Qingmao Zhu1 shuquan guo1 Xiaotong Qi1 Weichao li1 Jun Wu1 Yang liu3 Dianming Jiang1 1Department of Orthopaedics, The  First affiliated hospital of chongqing  Medical University, chongqing,   2research center for Nano- Biomaterials, analytical and Testing  center, sichuan University, chengdu,   3Department of Orthopaedics,   The second affiliated hospital  of chongqing Medical University,   Chongqing, People’s Republic of China correspondence: Dianming Jiang   Department of Orthopaedics, The First  Affiliated Hospital of Chongqing Medical  University, chongqing 400016,   People’s Republic of China   Tel +86 23 8901 1202   Fax +86 23 8901 1217   email jdm571026@vip.163.co mAbstract:  An ideal bone plate for internal fixation of bone fractures should have good  biomechanical properties and biocompatibility.",Non-OADS,/arxiv_data1/oa_pdf/77/b3/ijn-9-1423.PMC3962318.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/77/b3/ijn-9-1423.PMC3962318.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/b3/ijn-9-1423.PMC3962318.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/e2/btt-8-091.PMC3962319.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2014:8 91–105Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  91Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S2655 5Targeted therapy for sarcomas Charles Forscher1 Monica Mita2 Robert Figlin3 1Sarcoma Program, Samuel Oschin  Comprehensive Cancer institute,   Cedars-Sinai Medical Center, Los  Angeles, CA, USA; 2experimental  Therapeutics Program, Samuel Oschin  Comprehensive Cancer institute,   Cedars-Sinai Medical Center,    Los Angeles, CA, USA; 3Academic  Development Program, Samuel Oschin  Comprehensive Cancer institute, and  Division of Hematology/Oncology,   Cedars-Sinai Medical Center,    Los Angeles, CA, USA Correspondence: Charles Forscher   Samuel Oschin Cancer Center,   Cedars-Sinai Medical Center,   8700 Beverly Blvd, Los Angeles,   CA 90048, USA   Tel +1 310 423 8045   email charles.forscher@cshs.or gAbstract:  Sarcomas are tumors of mesenchymal origin that make up approximately 1% of  human cancers.",Non-OADS,/arxiv_data1/oa_pdf/6b/e2/btt-8-091.PMC3962319.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/6b/e2/btt-8-091.PMC3962319.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/6b/e2/btt-8-091.PMC3962319.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/e2/idr-7-063.PMC3962320.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2014:7 63–72Infection and Drug Resistance Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/e6/e2/idr-7-063.PMC3962320.pdf
"Or use: http://dvpr.es/1n0roM lDove press submit your manuscript | www.dovepress.co m Dove press  63RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S4678 0Community-acquired Clostridium difficile  infection:  an increasing public health threat Arjun Gupta Sahil Khanna Division of Gastroenterology   and Hepatology, Mayo Clinic,    Rochester, MN, USA Correspondence: Sahil Khanna   Division of Gastroenterology and   Hepatology, 200 1st Street Sw,   Rochester, MN 55905, USA   Tel +1 507 284 2468   Fax +1 507 284 0538   email khanna.sahil@mayo.ed uAbstract:  There has been a startling shift in the epidemiology of Clostridium difficile  infection  over the last decade worldwide, and it is now increasingly recognized as a cause of diarrhea  in the community.",Non-OADS,/arxiv_data1/oa_pdf/e6/e2/idr-7-063.PMC3962320.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/e6/e2/idr-7-063.PMC3962320.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/e2/idr-7-063.PMC3962320.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/96/be/tcrm-10-165.PMC3962321.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2014:10 165–172Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  165Sho RT Repo RTopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5919 9Injection device-related risk management toward  safe administration of medications: experience  in a university teaching hospital in The p eople’s  Republic of China Ling-ling Zhu1 Wei Li2 ping Song3 Quan Zhou3 1Geriatric VI p Ward, Division of  Nursing, 2Division of Medical  Administration, 3Department of  pharmacy, the Second Affiliated  hospital, School of Medicine,    Zhejiang University, hangzhou,   people’s Republic of China Correspondence: Quan Zhou   Department of pharmacy, the Second   Affiliated Hospital, School of Medicine,   Zhejiang University, hangzhou 310009,   Zhejiang province, people’s   Republic of China   Tel +86 571 8778 3690   Fax +86 571 8702 2776   email zhouquan142602@zju.edu.c nAbstract:  The use of injection devices to administer intravenous or subcutaneous  medications is common practice throughout a variety of health care settings.",Non-OADS,/arxiv_data1/oa_pdf/96/be/tcrm-10-165.PMC3962321.pdf
Available  from: http://www.rxlist.com/sandimmune-drug/medication-guide.htm.,Non-OADS,/arxiv_data1/oa_pdf/96/be/tcrm-10-165.PMC3962321.pdf
Available from:  http://www.rxlist.com/vumon-drug/indications-dosage.htm.,Non-OADS,/arxiv_data1/oa_pdf/96/be/tcrm-10-165.PMC3962321.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/96/be/tcrm-10-165.PMC3962321.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/be/tcrm-10-165.PMC3962321.pdf
"Avail - able from: http://www.bayerresources.com.au/resources/uploads/PI/ file9406.pd f. Accessed December 4, 2013.",OADS,/arxiv_data1/oa_pdf/96/be/tcrm-10-165.PMC3962321.pdf
"Available from: http://www.rxlist.com/pre - vacid-iv-drug/indications-dosage.ht m. Accessed December 4, 2013.",Non-OADS,/arxiv_data1/oa_pdf/96/be/tcrm-10-165.PMC3962321.pdf
"Available  from: http://www.rxlist.com/prevacid-iv-drug.ht m. Accessed December  4, 2013.",Non-OADS,/arxiv_data1/oa_pdf/96/be/tcrm-10-165.PMC3962321.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/67/ppa-8-301.PMC3962322.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 301–309Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  301OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5942 3Medical device design for adolescent adherence   and developmental goals: a case study of a cystic   fibrosis physiotherapy device Alexandra r lang1 Jennifer l Martin2 sarah sharples1 John A crowe3 1human Factors research group,   Faculty of engineering, University  of nottingham, nottingham, UK;   2Mindtech healthcare Technology  cooperative ( htc), Faculty of  Medicine and health sciences,   institute of Mental health,   nottingham, UK; 3Biomedical  engineering, Faculty of engineering,   University of nottingham, UK correspondence: Alexandra r lang   human Factors research group,   Faculty of engineering, room B03,   innovative Technologies research centre   (iTrc), University Park, University of   nottingham, nottingham, ng7 2rD, UK   Tel +44 7921 912 376   email alexandra.lang@nottingham.ac.u kPurpose:  This study investigates the psychosocial aspects of adolescent medical device use  and the impact on adolescent adherence and goals for the transitional years between child and  adulthood.",Non-OADS,/arxiv_data1/oa_pdf/52/67/ppa-8-301.PMC3962322.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/52/67/ppa-8-301.PMC3962322.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/67/ppa-8-301.PMC3962322.pdf
"OncoImmunology 2013; 2:e27400; http://dx.doi.org/10.4161/onci.27400Local immunotherapy based on agonistic   CD40 antibodies effectively inhibits   experimental bladder cancer Linda C s andin, Thomas h Tötterman, s ara M Mangsbo* Department of Immunology, Genetics and Pathology; u ppsala u niversity; u ppsala, s weden Keywords:  antibody, bladder cancer, CD40, local immunotherapy Local immunotherapy resurfaces in the field of cancer as a potential way to cure localized and metastatic disease with  limited toxic effects.",Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
Adv Urol 2012; 2012:181987; PMID:22778725 ;  http://dx.doi.org/10.1155/2012/181987 3.,Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
J Immunother 2010; 33:225- 35; PMID:20445343 ; http://dx.doi.org/10.1097/ CJI.0b013e3181c01fcb 4.,Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
J Immunother 2008; 31:34-42; PMID :18157010 ; http://dx.doi.org/10.1097/ CJI.0b013e3181587d295.,Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
J Immunother 2009; 32:785-92; PMID:19752755 ;  http://dx.doi.org/10.1097/CJI.0b013e3181acea69 6.,Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
Clin Cancer Res 2005; 11:8816-21;  PMID :16361570 ; http://dx.doi.org/10.1158/1078- 0432.CCR-05-1817 7.,Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
Clin  Cancer Res 2010; 16:3279-87; PMID:20448220 ;  http://dx.doi.org/10.1158/1078-0432.CCR-10-0385 8.,Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
J Clin Oncol 2007; 25:876- 83; PMID:17327609 ; http://dx.doi.org/10.1200/ JCO.2006.08.33119.,Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
Clin  Cancer Res 2011; 17:2270-80; PMID:21389097 ;  http://dx.doi.org/10.1158/1078-0432.CCR-10-2888 10.,Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
Cancer Immunology Research 2013; In press;  http://dx.doi.org/10.1158/2326-6066.CIR-13-0067 .,Non-OADS,/arxiv_data1/oa_pdf/e9/79/onci-3-e27400.PMC3962505.pdf
"OncoImmunology 2013; 2:e27402; http://dx.doi.org/10.4161/onci.27402Melanoma hijacks plasmacytoid dendritic cells   to promote its own progression Caroline a spord1,2,*, Marie-Therese Leccia1,3, Julie Charles1,3,†, and Joel Plumas1,2,† 1university Joseph Fourier; IN serM, u 823; Immunobiology & Immunotherapy of Cancers; Grenoble, France;   2French Blood s ervice; r hone- alpes; r &D-Laboratory; Grenoble, France; 3Dermatology Department; Grenoble u niversity h ospital; Grenoble, France †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/47/c2/onci-3-e27402.PMC3962506.pdf
Oncoimmunology  2012 ; 1:726- 34; PMID:22934264 ; http://dx.doi.org/10.4161/ onci.20171 3.,Non-OADS,/arxiv_data1/oa_pdf/47/c2/onci-3-e27402.PMC3962506.pdf
Immunity   2008 ; 29:352-61; PMID:18799143 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/c2/onci-3-e27402.PMC3962506.pdf
Ann N Y Acad Sci 2010 ;  1183 :89-103; PMID:20146710 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/47/c2/onci-3-e27402.PMC3962506.pdf
Cancer Res 2012 ; 72:5188 -97;  PMID:22836755 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3468 7.,Non-OADS,/arxiv_data1/oa_pdf/47/c2/onci-3-e27402.PMC3962506.pdf
Oncoimmunology  2012 ; 1:109-11; PMID:22720227 ;  http://dx.doi.org/10.4161/onci.1.1.179948.,Non-OADS,/arxiv_data1/oa_pdf/47/c2/onci-3-e27402.PMC3962506.pdf
J Invest Dermatol  2010 ; 130:1646 - 56; PMID:20220766 ; http://dx.doi.org/10.1038/ jid.2010.24 9.,Non-OADS,/arxiv_data1/oa_pdf/47/c2/onci-3-e27402.PMC3962506.pdf
Cancer  2012 ; 118:2476 -85; PMID:21953023 ;  http://dx.doi.org/10.1002/cncr.26511 10.,Non-OADS,/arxiv_data1/oa_pdf/47/c2/onci-3-e27402.PMC3962506.pdf
"OncoImmunology 2013; 2:e27414http://dx.doi.org/10.4161/onci.27414The anticancer effects of HDAC inhibitors  require the immune system alison C w est1,2, Mark J s myth3,4,†, and r icky w Johnstone1,5,†,* 1Cancer Therapeutics Program; The Peter MacCallum Cancer Centre; e ast Melbourne, VIC australia; 2Cancer Immunology Programs; The Peter MacCallum Cancer Centre;   east Melbourne, VIC australia; 3QIM r Berghofer Medical r esearch Institute; h erston, QLD australia; 4school of Medicine; u niversity of Queensland; h erston, QLD australia;  5sir Peter MacCallum Department of Oncology; u niversity of Melbourne; Parkville, VIC australia †These authors contributed equally to this work Keywords:  anticancer immunity, anticancer therapy, epigenetic regulatory agent, HDACi, immunogenic cell death, immunotherapy Abbreviations: DC, dendritic cell; HDACi, histone deacetylase inhibitor; HMGB1, high mobility group box 1; IFN, interferon;  NK, natural killer; NKT, natural killer T; SLE, systemic lupus erythematosus; WT, wild-type histone deacetylase inhibitors ( hDaCis) are known to exert immunomodulatory effects.",Non-OADS,/arxiv_data1/oa_pdf/ec/70/onci-3-e27414.PMC3962507.pdf
J Clin Oncol 2007; 25:3109-15; PMID:17577020 ;  http://dx.doi.org/10.1200/JCO.2006.10.2434 2.,Non-OADS,/arxiv_data1/oa_pdf/ec/70/onci-3-e27414.PMC3962507.pdf
J Clin Oncol 2010; 28:4485-91;  PMID:20697094 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/70/onci-3-e27414.PMC3962507.pdf
J Transl Med 2007; 5:64;  PMID:18070359 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ec/70/onci-3-e27414.PMC3962507.pdf
Cancer Res 2005;  65:11136-45;  PMID:16322264 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/70/onci-3-e27414.PMC3962507.pdf
Proc Natl Acad Sci U S A 2011; 108:4141-6;  PMID:21368108 ; http://dx.doi.org/10.1073/ pnas.1011037108 7.,OADS,/arxiv_data1/oa_pdf/ec/70/onci-3-e27414.PMC3962507.pdf
Cancer Res 2013; PMID :24158093 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/70/onci-3-e27414.PMC3962507.pdf
Proc Natl Acad Sci U S A 2002; 99:2995-3000;  PMID:11867742 ; http://dx.doi.org/10.1073/ pnas.052702999 9.,OADS,/arxiv_data1/oa_pdf/ec/70/onci-3-e27414.PMC3962507.pdf
Nat Med 2007; 13:1299-307;  PMID:17922010 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ec/70/onci-3-e27414.PMC3962507.pdf
"OncoImmunology 2014; 3:e27614; http://dx.doi.org/10.4161/onci.27614Local CTLA4 blockade   effectively restrains experimental   pancreatic adenocarcinoma growth in vivo Linda C Sandin1, Fredrik  eriksson1, Peter e llmark2,3, angelica SI Loskog1, Thomas H Tötterman1, and Sara M Mangsbo1,* 1Department of Immunology, Genetics and Pathology; Clinical Immunology; Uppsala University; Uppsala, Sweden; 2alligator Bioscience a B; Lund, Sweden;   3Department of Immunotechnology; Lund University; Lund, Sweden Keywords: local therapy, anti-CTLA4, checkpoint blockade, immunotherapy, pancreatic cancer Abbreviations:  ADCC, antibody-dependent cell-mediated cytotoxicity; ADP, antibody-dependent phagocytosis; CTLA4,  cytotoxic T-lymphocyte antigen-4; Fc γR, Fc gamma receptor; GM-CSF, granulocyte-macrophage colony-stimulating factor; mAb,  monoclonal antibody; p.t., peritumoral; TDLN, tumor-draining lymph node; Teff, effector T; Treg, regulatory T cell antibody-mediated blockade of CTL a4 has been shown to be effective in treating a select group of patients with  late-stage melanoma.",Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
CA Cancer J Clin 2012; 62:10-29;  PMID:22237781 ; http://dx.doi.org/10.3322/ caac.20138 2.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Gut 2013; 62:317-26; PMID:23112132 ; http://dx.doi.org/10.1136/ gutjnl-2012-303588 3.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Cancer J 2012; 18:653-64; PMID:23187854 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Annu Rev Immunol 2001; 19:565- 94; PMID:11244047 ; http://dx.doi.org/10.1146/ annurev.immunol.19.1.565 6.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
J Clin Invest 2006; 116:1935- 45; PMID:16778987 ; http://dx.doi.org/10.1172/ JCI27745 7.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
J Clin Oncol 2005; 23:6043-53;  PMID:16087944 ; http://dx.doi.org/10.1200/ JCO.2005.06.205 8.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Cancer 2010; 116:1767-75;  PMID:20143434 ; http://dx.doi.org/10.1002/ cncr.24951 9.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
N Engl J Med 2010; 363:711-23;  PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466 10.,OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Drugs 2011; 71:1093- 104; PMID:21668044 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
J Immunother 2010;  33:828-33;  PMID:20842054 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
J Immunother 2013; 36:382-9; PMID:23924790 ;  http://dx.doi.org/10.1097/CJI.0b013e31829fb7a2 13.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Clin Cancer Res 2013; 19:5381-9; PMID:23788581 ;  http://dx.doi.org/10.1158/1078-0432.CCR-12-078114.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Cancer Immunol Immunother 2008; 57:1263-70;  PMID:18236040 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
J Exp Med 2013; 210:1695-710; PMID:23897981 ;  http://dx.doi.org/10.1084/jem.20130579 17.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
J Exp Med 2013; 210:1685-93; PMID:23897982 ; http://dx.doi.org/10.1084/ jem.20130573 18.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Cancer Immunology Research  2013; 1:32-42; http://dx.doi.org/10.1158/2326- 6066.CIR-13-0013 19.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Clin Cancer Res 2013; 19:5261-3;  PMID:23965900 ; http://dx.doi.org/10.1158/1078- 0432.CCR-13-1923 20.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Cancer Immunol Res  2014; 2: 80; http://dx.doi.org/10.1158/2326-6066.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
J Immunother 2010; 33:225- 35; PMID:20445343 ; http://dx.doi.org/10.1097/ CJI.0b013e3181c01fcb 22.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Blood  2008; 112:1175-83;  PMID:18523152 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
PLoS One 2011; 6:e19499;  PMID :21559358 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
J Exp Med  2000; 192:295-302;  PMID:10899916 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
J Clin Immunol  2010; 30:80-9;  PMID:19936899 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Lancet Oncol 2010; 11:155- 64; PMID:20004617 ; http://dx.doi.org/10.1016/ S1470-2045(09)70334-1 31.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Int J Cancer 2013; 133:98- 107; PMID:23233419 ; http://dx.doi.org/10.1002/ ijc.27990 32.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Scand J Immunol 2010;  71:70-82;  PMID:20384858 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/e9/onci-3-e27614.PMC3962508.pdf
Sequence files are in CGHub (https://cghub.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/e1/67/41586_2014_Article_BFnature12965.PMC3962515.pdf
"The data can be explored through a compendium of next-generation clustered heat maps (http://bioinformatics.mdanderson.org/TCGA/NGCHMPortal/), the cBio Cancer Genomics Portal (http://cbioportal.org), TieDIE (http://sysbiowiki.soe.",OADS,/arxiv_data1/oa_pdf/e1/67/41586_2014_Article_BFnature12965.PMC3962515.pdf
"ucsc.edu/tiedie), SpliceSeq (http://bioinformatics.mdanderson.org/main/SpliceSeq: Overview), MBatch batch effects assessor (http://bioinformatics.mdanderson.org/ tcgambatch/) and Regulome Explorer (http://explorer.cancerregulome.org/).",Non-OADS,/arxiv_data1/oa_pdf/e1/67/41586_2014_Article_BFnature12965.PMC3962515.pdf
"1.2012, http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp#site (2012).",Non-OADS,/arxiv_data1/oa_pdf/e1/67/41586_2014_Article_BFnature12965.PMC3962515.pdf
Author Information The primary and processed data used to generate the analyses presented here can be downloaded by registered users from The Cancer Genome Atlas at https://tcga-data.nci.nih.gov/tcga/tcgaDownload.jsp.,OADS,/arxiv_data1/oa_pdf/e1/67/41586_2014_Article_BFnature12965.PMC3962515.pdf
"All of the primary sequence files are deposited in CGHub and all other data are deposited at the Data Coordinating Center (DCC) for public access (http://cancergenome.nih.gov/, https:// cghub.ucsc.edu/ and https://tcga-data.nci.nih.gov/docs/publications/blca_2013/).",OADS,/arxiv_data1/oa_pdf/e1/67/41586_2014_Article_BFnature12965.PMC3962515.pdf
"To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-sa/3.0 The Cancer Genome Atlas Research Network Analysis working group: TheUniversity of Texas MD Anderson Cancer Center John N. Weinstein1,2, Rehan Akbani1, Bradley M. Broom1, Wenyi Wang1, Roeland G. W. Verhaak1, David McConkey3;Baylor College of Medicine Seth Lerner4,5, Margaret Morgan5,6,C h a dJ .C r e i g h t o n7, Carolyn Smith8;Broad Institute David J.Kwiatkowski9,10,11, Andrew D. Cherniack9, Jaegil Kim9, Chandra Sekhar Pedamallu9,12, Michael S. Noble9;Memorial Sloan-Kettering Cancer Center Hikmat A. Al-Ahmadie13, Victor E. Reuter13,J o n a t h a nE .R o s e n b e r g13,D e a nF .B a j o r i n13, Bernard H. Bochner13, David B. Solit13;Oregon Health and Science University, Department of Urology Theresa Koppie14;Weill Medical College of Cornell University Brian Robinson15; National Institute of Environmental Health Sciences Dmitry A. Gordenin16,D a v i d Fargo16, Leszek J. Klimczak16, Steven A. Roberts16;Optimum Therapeutics LLC Jessie Au17;University of Southern California Epigenome Center Peter W. Laird18, Toshinori Hinoue18;Computational Biology Center, Memorial Sloan-Kettering Cancer Center Nikolaus Schultz19, Ricardo Ramirez19;UCSD Department of Pathology Donna Hansel20;Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill Katherine A. Hoadley21, William Y. Kim21,22,23;Department of Genetics, University of North Carolina at Chapel Hill Jeffrey S. Damrauer21,22;The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Stephen B. Baylin24;Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency Andrew J. Mungall30, A. Gordon Robertson30, Andy Chu30.",Non-OADS,/arxiv_data1/oa_pdf/e1/67/41586_2014_Article_BFnature12965.PMC3962515.pdf
"Correspondence to: Barbara P Rattner; Email: barbara@landesbioscience.com Submitted: 01/06/2014; Accepted: 01/06/2014; Published Online: 01/22/2014http://dx.doi.org/10.4161/epi.27834In this issue of Epigenetics Barbara P r attner Landes Bioscience; s an d iego, CA U sA",Non-OADS,/arxiv_data1/oa_pdf/ab/5c/epi-9-183.PMC3962527.pdf
"In particular, haplogroup J in the Euro - pean population appears to be linked to higher penetrance of Molecular Vision  2014; 20:334-340 <http://www.molvis.org/molvis/v 20/334> Received 12 November 2013 | Accepted 12 March 2014 | Published 14 March 2014© 2014 Molecular Vision 334Pan-American mDNA haplogroups in Chilean patients with  Leber’s hereditary optic neuropathy Pablo Romero,1,2 Verónica Fernández,3 Mark Slabaugh,2 Nicolás Seleme,1 Nury Reyes,4 Patricia Gallardo,1  Luisa Herrera,5 Luis Peña,6 Patricio Pezo,5 Mauricio Moraga5 1Departamento de Oftalmología, Hospital Clínico “José Joaquín Aguirre,” Universidad de Chile, Santiago, Chile; 2Department  of Ophthalmology, University of Washington, Seattle, WA; 3Departamento de Neuro-oftalmología Instituto Chileno de  Neurocirugía, Santiago, Chile; 4Servicio de Oftalmología, Hospital Regional de Concepción, Santiago, Chile; 5Programa de  Genética Humana, ICBM, Facultad de Medicina, Universidad de Chile, Santiago, Chile; 6Departamento de Oftalmología.",Non-OADS,/arxiv_data1/oa_pdf/c2/a4/mv-v20-334.PMC3962688.pdf
Molecular Vision  2014; 20:334-340 <http://www.molvis.org/molvis/v 20/334> © 2014 Molecular Vision  335the m.14484T>C mutation compared to carriers with different  haplogroups.,Non-OADS,/arxiv_data1/oa_pdf/c2/a4/mv-v20-334.PMC3962688.pdf
"Molecular Vision  2014; 20:334-340 <http://www.molvis.org/molvis/v 20/334> © 2014 Molecular Vision  336ggtaaggcgaggttagcg); MTND1*LHON3460A (F: TTC AAA  TTC CTC CCT GTA CG, R: GGC TAC TGC TCG CAG TG).",Non-OADS,/arxiv_data1/oa_pdf/c2/a4/mv-v20-334.PMC3962688.pdf
"Molecular Vision  2014; 20:334-340 <http://www.molvis.org/molvis/v 20/334> © 2014 Molecular Vision  337subjects (16.0%) had the m.14484T>C mutation, and four  subjects (5.3%) had the m.3460G>A mutation in this popula - tion (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/c2/a4/mv-v20-334.PMC3962688.pdf
Molecular Vision  2014; 20:334-340 <http://www.molvis.org/molvis/v 20/334> © 2014 Molecular Vision  338ANOVA) than those with other haplogroups (47.3 years on  average).,Non-OADS,/arxiv_data1/oa_pdf/c2/a4/mv-v20-334.PMC3962688.pdf
Molecular Vision  2014; 20:334-340 <http://www.molvis.org/molvis/v 20/334> © 2014 Molecular Vision  339on clinical expression of Leber hereditary optic neuropathy.,Non-OADS,/arxiv_data1/oa_pdf/c2/a4/mv-v20-334.PMC3962688.pdf
Mitomap; http://www.mitomap.org 13.,Non-OADS,/arxiv_data1/oa_pdf/c2/a4/mv-v20-334.PMC3962688.pdf
Molecular Vision  2014; 20:334-340 <http://www.molvis.org/molvis/v 20/334> © 2014 Molecular Vision  34030.,Non-OADS,/arxiv_data1/oa_pdf/c2/a4/mv-v20-334.PMC3962688.pdf
"We considered all studies that examined  the association of the rs577948 , rs11218544 , rs12716080 , and Molecular Vision  2014; 20:352-358 <http://www.molvis.org/molvis/v 20/352> Received 22 October 2013 | Accepted 19 March 2014 | Published 21 March 2014© 2014 Molecular Vision 352Polymorphism in the 11q24.1 genomic region is associated with  myopia: A comprehensive genetic study in Chinese and Japanese  populations Jie Liu,1 Hong-xin Zhang2 1Shanghai Institute of Orthopaedics and Traumatology, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of  Medicine, Shanghai, China; 2State Key Laboratory of Medical Genomics, Research Center for Experimental Medicine, Shanghai  Institute of Hematology, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China Purpose:  To evaluate the association of polymorphisms in the 11q24.1 genomic region and the CTNND2  gene with  myopia.",Non-OADS,/arxiv_data1/oa_pdf/2d/2f/mv-v20-352.PMC3962689.pdf
Molecular Vision  2014; 20:352-358 <http://www.molvis.org/molvis/v 20/352> © 2014 Molecular Vision  353rs6885224  polymorphisms with myopia.,Non-OADS,/arxiv_data1/oa_pdf/2d/2f/mv-v20-352.PMC3962689.pdf
Molecular Vision  2014; 20:352-358 <http://www.molvis.org/molvis/v 20/352> © 2014 Molecular Vision  354Table  1.,Non-OADS,/arxiv_data1/oa_pdf/2d/2f/mv-v20-352.PMC3962689.pdf
Molecular Vision  2014; 20:352-358 <http://www.molvis.org/molvis/v 20/352> © 2014 Molecular Vision  355 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/2d/2f/mv-v20-352.PMC3962689.pdf
"Molecular Vision  2014; 20:352-358 <http://www.molvis.org/molvis/v 20/352> © 2014 Molecular Vision  356namely, when one study was removed, the result was still  significant (Figure 3A-D).",Non-OADS,/arxiv_data1/oa_pdf/2d/2f/mv-v20-352.PMC3962689.pdf
Molecular Vision  2014; 20:352-358 <http://www.molvis.org/molvis/v 20/352> © 2014 Molecular Vision  357ACKNOWLEDGMENTS J. Liu designed the study.,Non-OADS,/arxiv_data1/oa_pdf/2d/2f/mv-v20-352.PMC3962689.pdf
Molecular Vision  2014; 20:352-358 <http://www.molvis.org/molvis/v 20/352> © 2014 Molecular Vision  35811.,Non-OADS,/arxiv_data1/oa_pdf/2d/2f/mv-v20-352.PMC3962689.pdf
"The absence of  functional protein, independent of the causative mutation,  opens up the possibility of performing the clinical diagnosis Molecular Vision  2014; 20:325-333 <http://www.molvis.org/molvis/v 20/325> Received 3 December 2012 | Accepted 12 March 2014 | Published 15 March 2014© 2014 Molecular Vision 325Clinical and genetic studies in a family with a new splice-site  mutation in the choroideremia gene Maria T. Contestabile,1 Maria Piane,2 Nikhil C. Cascone,1 Nadia Pasquale,1 Angela Ciarnella,1 Santi M.  Recupero,1 Luciana Chessa2 1NESMOS Department-Ophthalmology, School of Medicine and Psychology, University “La Sapienza,” Rome, Italy; 2Department  of Clinical and Molecular Medicine, School of Medicine and Psychology University “La Sapienza,” Rome, Italy Purpose:  To describe the clinical and molecular findings of an Italian family with a new mutation in the choroideremia  (CHM ) gene.",Non-OADS,/arxiv_data1/oa_pdf/24/7e/mv-v20-325.PMC3962727.pdf
"Molecular Vision  2014; 20:325-333 <http://www.molvis.org/molvis/v 20/325> © 2014 Molecular Vision  326of CHM with semiquantitative western blotting of REP-1,  followed by DNA and RNA analysis of the CHM  gene.",Non-OADS,/arxiv_data1/oa_pdf/24/7e/mv-v20-325.PMC3962727.pdf
"Molecular Vision  2014; 20:325-333 <http://www.molvis.org/molvis/v 20/325> © 2014 Molecular Vision  327was done as described for genomic DNA, except that 1 ng  of each primer was used.",Non-OADS,/arxiv_data1/oa_pdf/24/7e/mv-v20-325.PMC3962727.pdf
"Molecular Vision  2014; 20:325-333 <http://www.molvis.org/molvis/v 20/325> © 2014 Molecular Vision  328buffer (500 mM Tris/HCl, 100 mM KCl, 50 mM [NH4]2SO4,  20 mM MgCl2), 200 µM each deoxynucleotide, and 2 U Taq  DNA polymerase.",Non-OADS,/arxiv_data1/oa_pdf/24/7e/mv-v20-325.PMC3962727.pdf
Molecular Vision  2014; 20:325-333 <http://www.molvis.org/molvis/v 20/325> © 2014 Molecular Vision  329Patient I:2— The proband’s mother was a 75-year-old  Italian woman with no medical history of ophthalmologic  pathology.,Non-OADS,/arxiv_data1/oa_pdf/24/7e/mv-v20-325.PMC3962727.pdf
Molecular Vision  2014; 20:325-333 <http://www.molvis.org/molvis/v 20/325> © 2014 Molecular Vision  330Patient III:1— The first child of II:2 was a 9-year-old boy  (Figure 1).,Non-OADS,/arxiv_data1/oa_pdf/24/7e/mv-v20-325.PMC3962727.pdf
"Molecular Vision  2014; 20:325-333 <http://www.molvis.org/molvis/v 20/325> © 2014 Molecular Vision  331adapted function, assuming progression of rods before cone  degeneration.",Non-OADS,/arxiv_data1/oa_pdf/24/7e/mv-v20-325.PMC3962727.pdf
"Molecular Vision  2014; 20:325-333 <http://www.molvis.org/molvis/v 20/325> © 2014 Molecular Vision  332All mutations identified thus far in affected men, point  mutations or large genomic rearrangements, lead to a trun - cated unstable or absence of the REP-1 protein [ 14,15,20].",Non-OADS,/arxiv_data1/oa_pdf/24/7e/mv-v20-325.PMC3962727.pdf
Molecular Vision  2014; 20:325-333 <http://www.molvis.org/molvis/v 20/325> © 2014 Molecular Vision  3336.,Non-OADS,/arxiv_data1/oa_pdf/24/7e/mv-v20-325.PMC3962727.pdf
"After prolonged dark adaptation of 2–3 h, the  discoloration of the fundus returns to normal, and normal Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> Received 11 December 2013 | Accepted 18 March 2014 | Published 21 March 2014© 2014 Molecular Vision 341Molecular profiling of complete congenital stationary night  blindness: A pilot study on an Indian cohort Sivasankar Malaichamy,1 Parveen Sen,2 Ramya Sachidanandam,3 Tharigopala Arokiasamy,1 Marie Elise  Lancelot,4,5,6 Isabelle Audo,4,5,6,7,8 Christina Zeitz,4,5,6 Nagasamy Soumittra1 1SNONGC department of Genetics and Molecular Biology, Vision Research Foundation, Chennai, India; 2Department of Vitreo- Retinal Services, Medical Research Foundation, Chennai, India; 3Department of Optometry, Medical Research Foundation,  Chennai, India; 4INSERM, U968, Paris, F-75012, France; 5CNRS, UMR_7210, Paris, F-75012, France; 6Sorbonne Universités,  UPMC Univ Paris 06, UMR_S 968, Institut de la Vision, Paris, F-75012, France; 7Centre Hospitalier National d’Ophtalmologie  des Quinze-Vingts, INSERM-DHOS CIC 503, Paris F-75012, France; 8UCL-Institute of Ophthalmology, 11-43 Bath Street,  London, EC1V 9EL, UK Purpose:  Congenital stationary night blindness (CSNB) is a non-progressive retinal disorder that shows genetic and  clinical heterogeneity.",Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
"Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  342function of rod cells is resumed [ 28,29].",Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  343structure and function of the protein and the conservation  of a particular amino acid across closely related species.,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  344Table  1.,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  345mutations are reported either in the 1000 Genomes  database  or the Exome Variant Server  database.,OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  346Table  4.,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  347S.No Patient/ Family  No.Consanguinity Gene and Mutations  identifiedBioinformatics analysis Segregation analysis Number  of controls  screenedPopulation  frequency as  reported in 1000  genome and Exom - eVariant Server  database 6 Patient 6/ Family  6No TRPM1  c.[1870C>T];  [(2783G>A)]  p. ([R624C];[R928Q])  c.1870C>T- (rs387906862)  Reported  [23] c.2783G>A  - Novel  (compound  heterozygote)♦SIFT – not tolerated  ♦Polyphen – probably  damaging  ♦Conservation across  species – conserved across  vertebratesFather is heterozygous  for c.1870C>T.,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  348[48].,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  349confirm that TRPM1  as suggested by other cohorts [ 19-23]  is also a major gene defect in India.,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  350causes autosomal recessive cone dystrophy.,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Molecular Vision  2014; 20:341-351 <http://www.molvis.org/molvis/v 20/341> © 2014 Molecular Vision  35138.,Non-OADS,/arxiv_data1/oa_pdf/1b/1c/mv-v20-341.PMC3962728.pdf
Fam Cancer 1:197–206 2.http://www.srl.cam.ac.uk/genepi/boadicea/boadicea_intro.html .,Non-OADS,/arxiv_data1/oa_pdf/25/0c/10549_2014_Article_2902.PMC3962741.pdf
http://clinicaltrials.gov/ct2/show/record/NCT00320710 .,Non-OADS,/arxiv_data1/oa_pdf/d1/5f/10549_2014_Article_2906.PMC3962742.pdf
http://clinicaltrials.gov/ct2/ show/NCT00424983 .,Non-OADS,/arxiv_data1/oa_pdf/d1/5f/10549_2014_Article_2906.PMC3962742.pdf
http://www.clini caltrials.gov/ct2 /show/NCT00869206 .,Non-OADS,/arxiv_data1/oa_pdf/d1/5f/10549_2014_Article_2906.PMC3962742.pdf
The digital images were analyzed using Aperio ImageScope software ( http://www.aperio.,OADS,/arxiv_data1/oa_pdf/95/ca/10549_2014_Article_2896.PMC3962744.pdf
Susan G (2013) Komen for the Cure Tissue Bank at the IU SImon Cancer Center in Indianapolis http://komentissuebank.iu.edu/ .,Non-OADS,/arxiv_data1/oa_pdf/95/ca/10549_2014_Article_2896.PMC3962744.pdf
"Available at:  http://www.dailymail.co.uk/mews/article- 550610/nomophobia- fear-mobile-phone [Accessed on March18, 2012].",Non-OADS,/arxiv_data1/oa_pdf/13/dd/CPEMH-10-28.PMC3962983.pdf
Available: http://faostat.fao.org/.www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4444 | DOI: 10.1038/srep04444 4,Non-OADS,/arxiv_data1/oa_pdf/7d/d2/srep04444.PMC3963030.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7d/d2/srep04444.PMC3963030.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4444 | DOI: 10.1038/srep04444 5",Non-OADS,/arxiv_data1/oa_pdf/7d/d2/srep04444.PMC3963030.pdf
"For more information, visit http://light.ece.illinois.",Non-OADS,/arxiv_data1/oa_pdf/30/29/srep04434.PMC3963031.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: G.P.,Non-OADS,/arxiv_data1/oa_pdf/30/29/srep04434.PMC3963031.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4434 | DOI: 10.1038/srep04434 8",Non-OADS,/arxiv_data1/oa_pdf/30/29/srep04434.PMC3963031.pdf
planned the project.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/32/b0/srep04448.PMC3963032.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4448 | DOI: 10.1038/srep04448 8",Non-OADS,/arxiv_data1/oa_pdf/32/b0/srep04448.PMC3963032.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f7/29/srep04441.PMC3963033.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4441 | DOI: 10.1038/srep04441 8",Non-OADS,/arxiv_data1/oa_pdf/f7/29/srep04441.PMC3963033.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4438 | DOI: 10.1038/srep04438 7",Non-OADS,/arxiv_data1/oa_pdf/e9/9b/srep04438.PMC3963034.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4446 | DOI: 10.1038/srep04446 7",Non-OADS,/arxiv_data1/oa_pdf/77/da/srep04446.PMC3963035.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cb/97/srep04439.PMC3963064.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4439 | DOI: 10.1038/srep04439 9",Non-OADS,/arxiv_data1/oa_pdf/cb/97/srep04439.PMC3963064.pdf
http://data.worldbank.org/ indicator/SP.POP.TOTL 18.,Non-OADS,/arxiv_data1/oa_pdf/6c/14/bmjopen-2013-004308.PMC3963065.pdf
doi:10.1136/bmjopen-2013- 004441 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004441).,Non-OADS,/arxiv_data1/oa_pdf/55/eb/bmjopen-2013-004441.PMC3963066.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2013-004541).,Non-OADS,/arxiv_data1/oa_pdf/99/6e/bmjopen-2013-004541.PMC3963068.pdf
http://www.iaso.org/iotf/obesity/ (accessed 22 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/99/6e/bmjopen-2013-004541.PMC3963068.pdf
2012. https://catalogue.ic.nhs.uk/ publications/public-health/obesity/obes-phys-acti-diet-eng-2012/obes-phys-acti-diet-eng-2012-rep.pdf (accessed 22 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/99/6e/bmjopen-2013-004541.PMC3963068.pdf
2012. https://catalogue.ic.nhs.uk/ publications/public-health/obesity/nati-chil-meas-prog-eng-2010 – 2011/nati-chil-meas-prog-eng-2010 –2011-rep1.pdf (accessed 22 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/99/6e/bmjopen-2013-004541.PMC3963068.pdf
http://www.who.int/mediacentre/ factsheets/fs311/en/ (accessed 22 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/99/6e/bmjopen-2013-004541.PMC3963068.pdf
http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm (accessed 22 Nov 2013).,Non-OADS,/arxiv_data1/oa_pdf/99/6e/bmjopen-2013-004541.PMC3963068.pdf
2012. http://www.cochrane-handbook.org (accessed 22 Nov 2013).40.,OADS,/arxiv_data1/oa_pdf/99/6e/bmjopen-2013-004541.PMC3963068.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004648).,Non-OADS,/arxiv_data1/oa_pdf/17/f8/bmjopen-2013-004648.PMC3963069.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004393).,Non-OADS,/arxiv_data1/oa_pdf/e8/28/bmjopen-2013-004393.PMC3963070.pdf
"The Cochrane Collaboration, 2011. http://handbook.cochrane.org (accessed 10 March 2014).",OADS,/arxiv_data1/oa_pdf/e8/28/bmjopen-2013-004393.PMC3963070.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/53/6b/srep04436.PMC3963071.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4436 | DOI: 10.1038/srep04436 6",Non-OADS,/arxiv_data1/oa_pdf/53/6b/srep04436.PMC3963071.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003208).,Non-OADS,/arxiv_data1/oa_pdf/59/10/bmjopen-2013-003208.PMC3963072.pdf
Nat Precedings 2011. http://precedings.nature.com/ documents/6535/version/1.,Non-OADS,/arxiv_data1/oa_pdf/59/10/bmjopen-2013-003208.PMC3963072.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004096).,Non-OADS,/arxiv_data1/oa_pdf/c9/f0/bmjopen-2013-004096.PMC3963073.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003901).,Non-OADS,/arxiv_data1/oa_pdf/e0/f1/bmjopen-2013-003901.PMC3963074.pdf
http://www.ic.nhs.,Non-OADS,/arxiv_data1/oa_pdf/e0/f1/bmjopen-2013-003901.PMC3963074.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004542).,Non-OADS,/arxiv_data1/oa_pdf/a3/b4/bmjopen-2013-004542.PMC3963075.pdf
Registration details: The study protocol has been registered in PROSPERO (http://www.crd.york.ac.uk/PROSPERO/) under registration numberCRD42013006416.,Non-OADS,/arxiv_data1/oa_pdf/a3/b4/bmjopen-2013-004542.PMC3963075.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 26.",OADS,/arxiv_data1/oa_pdf/a3/b4/bmjopen-2013-004542.PMC3963075.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a2/4a/srep04447.PMC3963076.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4447 | DOI: 10.1038/srep04447 11",Non-OADS,/arxiv_data1/oa_pdf/a2/4a/srep04447.PMC3963076.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004468).,Non-OADS,/arxiv_data1/oa_pdf/bd/73/bmjopen-2013-004468.PMC3963077.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/73/bmjopen-2013-004468.PMC3963077.pdf
17. http://www.who.int/patientsafety/research/strengthening_capacity/ measuring_harm/en/index.html 2009.,Non-OADS,/arxiv_data1/oa_pdf/bd/73/bmjopen-2013-004468.PMC3963077.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9d/2a/jcav05p0221.PMC3963079.pdf
This is an open- access article distributed under the terms of the Creat ive Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/83/60/jcav05p0231.PMC3963080.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bd/99/jcav05p0242.PMC3963081.pdf
http://www.mhlw.go.jp/english/database/db -hw/dl/81 -1a2en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/99/jcav05p0242.PMC3963081.pdf
http://www.haigan.gr.jp/uploads/photos/320.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/99/jcav05p0242.PMC3963081.pdf
This is an open- access article distribu ted under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e8/68/jcav05p0248.PMC3963082.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/93/c2/jcav05p0253.PMC3963083.pdf
"Date of access: 05/11/2008, at ,http://www.hydrogen.energy.gov/pdfs/progress08/v_d_ 4_vogel.pdf .. 4.",OADS,/arxiv_data1/oa_pdf/af/0e/srep04437.PMC3963085.pdf
"Date of access: 01/10/2007 at ,http://www.nrel.gov/docs/fy08osti/39146.pdf .. 5.",OADS,/arxiv_data1/oa_pdf/af/0e/srep04437.PMC3963085.pdf
"Date of access: 13/05/2011 at ,http://www.hydrogen.",Non-OADS,/arxiv_data1/oa_pdf/af/0e/srep04437.PMC3963085.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/af/0e/srep04437.PMC3963085.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4437 | DOI: 10.1038/srep04437 11",Non-OADS,/arxiv_data1/oa_pdf/af/0e/srep04437.PMC3963085.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/18/22/srep04419.PMC3963086.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 4419 | DOI: 10.1038/srep04419 8",Non-OADS,/arxiv_data1/oa_pdf/18/22/srep04419.PMC3963086.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2013-004712).,Non-OADS,/arxiv_data1/oa_pdf/94/ad/bmjopen-2013-004712.PMC3963087.pdf
2007. http://www.statistics.gov.uk.stabase/product.asp?=6725 4.,OADS,/arxiv_data1/oa_pdf/94/ad/bmjopen-2013-004712.PMC3963087.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004372).,Non-OADS,/arxiv_data1/oa_pdf/51/4b/bmjopen-2013-004372.PMC3963088.pdf
http://www.measuredhs.com/ data/dataset/Nepal_Standard-DHS_2011.cfm?flag=0 (accessed 15Jan 2014).,OADS,/arxiv_data1/oa_pdf/51/4b/bmjopen-2013-004372.PMC3963088.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004088).,Non-OADS,/arxiv_data1/oa_pdf/56/a2/bmjopen-2013-004088.PMC3963089.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-004862).,Non-OADS,/arxiv_data1/oa_pdf/41/a5/bmjopen-2014-004862.PMC3963091.pdf
2010. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1267550166455 2.,Non-OADS,/arxiv_data1/oa_pdf/41/a5/bmjopen-2014-004862.PMC3963091.pdf
2013. http://www.chlamydiascreening.,Non-OADS,/arxiv_data1/oa_pdf/41/a5/bmjopen-2014-004862.PMC3963091.pdf
2007. http://data.gov.uk/dataset/index_of_multiple_deprivation_imd_2007 11.,Non-OADS,/arxiv_data1/oa_pdf/41/a5/bmjopen-2014-004862.PMC3963091.pdf
"Liverpool PCT, 2011.https://liverpool.gov.uk/media/100609/Liverpool-PCT-Current-and-Future-Health-and-Social-Care-Needs-2011.pdf (accessed 8 Jan2014).",Non-OADS,/arxiv_data1/oa_pdf/41/a5/bmjopen-2014-004862.PMC3963091.pdf
2013. http://www.chlamydiascreening.nhs.uk/ps/overview.asp(accessed 8 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/41/a5/bmjopen-2014-004862.PMC3963091.pdf
2012.https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/263658/2901502_PHOF_Improving_Outcomes_PT1A_v1_ 1.pdf (accessed 8 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/41/a5/bmjopen-2014-004862.PMC3963091.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004525).,Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2013-004525.PMC3963093.pdf
"19The information sheet will include a weblink to the Arrhythmia Alliance website(http://www.arrhythmiaalliance.org.uk), where informa- tion will be posted at the end of the trial explaining which manoeuvre has been shown to be most effective.",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2013-004525.PMC3963093.pdf
http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2013-004525.PMC3963093.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2013-004525.PMC3963093.pdf
2. http://www.heartrhythmcharity.org.uk/www/218/0/Patient_stories/ (accessed Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2013-004525.PMC3963093.pdf
"BestBets, 2005. http://www.bestbets.org 8.",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2013-004525.PMC3963093.pdf
"20. http://www.consort-statement.org/ 8 Appelboam A, Reuben A, Mann C, et al.BMJ Open 2014; 4:e004525.",Non-OADS,/arxiv_data1/oa_pdf/08/59/bmjopen-2013-004525.PMC3963093.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004480).,Non-OADS,/arxiv_data1/oa_pdf/c8/3f/bmjopen-2013-004480.PMC3963096.pdf
Detailed information on the design of the NIS is available at http://www.hcup-us.ahrq.gov.,Non-OADS,/arxiv_data1/oa_pdf/c8/3f/bmjopen-2013-004480.PMC3963096.pdf
http://www.cms.hhs.gov/nationalhealthexpenddata/downloads/proj2008.pds (accessed 13 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/3f/bmjopen-2013-004480.PMC3963096.pdf
US Census Bur 2010. https://www.census.gov/prod/2010pubs/p25-1138.,OADS,/arxiv_data1/oa_pdf/c8/3f/bmjopen-2013-004480.PMC3963096.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004197).,Non-OADS,/arxiv_data1/oa_pdf/da/24/bmjopen-2013-004197.PMC3963097.pdf
http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/10655/2003-112-3_20031123.pdf (accessed 4 Feb 2013).,Non-OADS,/arxiv_data1/oa_pdf/da/24/bmjopen-2013-004197.PMC3963097.pdf
2009. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/8316/2009-125-5_20091255_rev3.pdf (accessed 4 Feb2013).,Non-OADS,/arxiv_data1/oa_pdf/da/24/bmjopen-2013-004197.PMC3963097.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004058).,Non-OADS,/arxiv_data1/oa_pdf/38/69/bmjopen-2013-004058.PMC3963098.pdf
"New Zealand General Social Survey: 2010 , 2011. http://www.stats.govt.nz/nzgss (accessed 1 Feb 2013).",OADS,/arxiv_data1/oa_pdf/38/69/bmjopen-2013-004058.PMC3963098.pdf
"In: Research and evaluation unit , Ministry of Justice, New Zealand, 2002. http://www.justice.govt.nz/publications/crime (accessed 1 Feb 2013).",Non-OADS,/arxiv_data1/oa_pdf/38/69/bmjopen-2013-004058.PMC3963098.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-004388).,Non-OADS,/arxiv_data1/oa_pdf/e7/46/bmjopen-2013-004388.PMC3963099.pdf
The resource was accessed via an electronic virtual learn-ing environment (VLE) at UHL (http://www.euhl.nhs.,OADS,/arxiv_data1/oa_pdf/e7/46/bmjopen-2013-004388.PMC3963099.pdf
2011. http://www.renal.org/clinical/guidelinessection/AcuteKidneyInjury.aspx.,Non-OADS,/arxiv_data1/oa_pdf/e7/46/bmjopen-2013-004388.PMC3963099.pdf
Secondary ISB & JCB MCQ question development 2012. http://www.intercollegiate.org.uk/content/content.aspx?ID=5.,Non-OADS,/arxiv_data1/oa_pdf/e7/46/bmjopen-2013-004388.PMC3963099.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2013-004007).,Non-OADS,/arxiv_data1/oa_pdf/f3/11/bmjopen-2013-004007.PMC3963101.pdf
"We then used the Google Trends tool to quantify relative search volume by term, and by state, over the 12-month period from.25 Social media disclosuresTo understand instances ( ‘mentions ’) in which hospital quality terms and hospital quality reports were discussedin social and traditional media, we used a proprietary social media monitoring tool (MAP) from Marketwire/ Sysomos (http://www.sysomos.com).",OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
"From the infor- mation and news industry we selected Thomson Reuters ’ Best Hospitals ranking (http://www.100tophospitals.com), US News & World Report ’s ranking of top hospi- tals (http://health.usnews.com/best-hospitals) and Healthgrades, a large private supplier of national phys-ician and hospital quality information (http://www.",Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
From government sources we used Medicare ’s Hospital Compare tool (http://www.medicare.gov/ hospitalcompare/) and California ’s state Of ﬁce of Statewide Healthcare Planning and Development(OSHPD) reports (http://www.oshpd.ca.gov).,OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2011. http://www.qualityforum.org/Measures_List.aspx (accessed 20Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2011. https://www.talkingquality.ahrq.gov/content/reportcard/search.aspx (accessed 20 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2011. http://reportcard.ncqa.org/phq/external/phqsearch.aspx (accessed 20 Dec 2012).,OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
"10-0082-EF, Rockville, MD: Agency for HealthcareResearch and Quality, May 2010. http://www.ahrq.gov/qual/pubrptguide3.htm (accessed 20 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2006. http://www.pewinternet.org/Reports/2006/ The-Strength-of-Internet-Ties/01-Summary-of-Findings.aspx (accessed 20 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2010. http://www.pewinternet.org/Infographics/2010/Generations-2010-Heat-Map.aspx (accessed 13 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2012. http://ssrn.com/abstract=1989586 or http://dx.doi.org/10.2139/ssrn.1989586 (accessed 13 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2011. http://socialmarketing.blogs.com/r_craiig_ lefebvres_social/2011/02/ 5-fictions-about-social-media-for-public-health-and-healthcare.html(accessed 20 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2011. http://www.cmqcc.org/resources/2079 14.,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
http://searchenginewatch.com/ article/2307115/Google-Fails-to-Gain-Search-Market-Share-Bing-Steals-From-Yahoo (accessed 28 Jan 2014).,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2013. https://support.google.,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2013. http://www.sysomos.com/ social-media/case-studies/ (Accessed 13 Aug 2013).,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2012. http://www.cmqcc.org/ (accessed 20 Dec2012).,Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
"California Foundation Health Care Almanac, 2011. http://www.chcf.org/publications/2011/10/quality-care-facts-figures (accessed 20 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
2012. http://www.qualitymeasures.ahrq.gov/content.aspx?id=34144 (accessed 20 Dec 2012).,OADS,/arxiv_data1/oa_pdf/d0/8e/bmjopen-2013-004417.PMC3963102.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-004877).,Non-OADS,/arxiv_data1/oa_pdf/a6/e3/bmjopen-2014-004877.PMC3963103.pdf
"Methods and analysis: RODAM is a multicentre cross-sectional study among homogenous sub-Saharan African participants (ie, Ghanaians) aged>25 years living in rural and urban Ghana, theNetherlands, Germany and the UK (http://rod-am.eu/).Standardised data on the main outcomes, genetic andnon-genetic factors are collected in all locations.",OADS,/arxiv_data1/oa_pdf/a6/e3/bmjopen-2014-004877.PMC3963103.pdf
Using thestatistical power calculator on binary traits for a case – control study design (S Purcell; http://pngu.mgh.,Non-OADS,/arxiv_data1/oa_pdf/a6/e3/bmjopen-2014-004877.PMC3963103.pdf
"31Simultaneously, African countries are facing huge challenges regarding obesity and T2D and related complications.79This issue was recently highlighted in the meeting of the general assembly of the United Nations on Non-Communicable Diseases in 2011 as an important epidemic of our times (http://www.un.org/en/ga/president/65/issues/ncdis eases.shtml).",Non-OADS,/arxiv_data1/oa_pdf/a6/e3/bmjopen-2014-004877.PMC3963103.pdf
http://www.ic.,Non-OADS,/arxiv_data1/oa_pdf/a6/e3/bmjopen-2014-004877.PMC3963103.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-004973).,Non-OADS,/arxiv_data1/oa_pdf/31/7f/bmjopen-2014-004973.PMC3963104.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/31/7f/bmjopen-2014-004973.PMC3963104.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/85/8e/bmjopen-2013-004580.PMC3963121.pdf
"Leeds: The InformationCentre for Health and Social Care, 2009. http://www.ic.nhs.uk/pubs/hse08physicalactivity (accessed May 2010).",Non-OADS,/arxiv_data1/oa_pdf/85/8e/bmjopen-2013-004580.PMC3963121.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004253).,Non-OADS,/arxiv_data1/oa_pdf/a2/dd/bmjopen-2013-004253.PMC3963127.pdf
"Search methods for identification of studies Electronic searches The following electronic databases will be searched to 24 September 2013: MEDLINE, EMBASE, PsycINFO, Ebosco,Cochrane Database of Systematic Reviews, CINAHL, SCOPUS, SciELO, National Health Service (NHS) evi- dence, www.uptodate.com, http://clinicaltrials.gov/ , http:// www.who.int/ictrp/en/ , http:// www.controlled-trials.com/.",OADS,/arxiv_data1/oa_pdf/a2/dd/bmjopen-2013-004253.PMC3963127.pdf
http://www.cebm.net/?o=1025 27.,Non-OADS,/arxiv_data1/oa_pdf/a2/dd/bmjopen-2013-004253.PMC3963127.pdf
"http://dx.doi.org/10.1590/S0482-50042010000400006 [9] Vilar MJP, Rodrigues JM, Sato EI.",OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://www.scielo.br/scielo.php?script=sci_arttext& pid=S0482-50042003000600005&lng=en [10] Oliveira MA, Reis VL, Zanelato LS, Neme CMB.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://pepsic.bvsal ud.org/scielo.php?script=sci_arttext&pid=S1414-98932008000400008 [11] Carvalho FT, Morais NA, Koller SH, Piccinini CA.",OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://www.scielo.br/scielo.php?script=sci_arttext& pid=S0102-311X2007000900011&lng=en&nrm=iso&tlng=pt [12] Ferreira CL, Santos LMO, Maia EMC.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://www.scielo.br/scielo.php?script=sci_arttext&pid=S008 0-62342012000200009 [13] Poletto M, Koller SH.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://www.scielo.br/scielo.ph p?script=sci_arttext&pid=S0103-166X2008000300009&lng=en&n rm=iso&tlng=pt [14] Bianchini DCS, Dell’Aglio DD.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://www.scielo.br/pdf/paideia/v16n35/v16n 35a13.pdf [15] Sutanto B, Singh-Grewal D, McNeil HP.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://www.scielo.br/scielo.php?script=sci_arttext& pid=S0482-50042008000400002&lang=pt [17] Wagnild GM, Young HM.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://www.scielo.br/scielo.ph p?pid=S0102-311X2005000200010&script=sci_arttext [19] Baker K, Pope J.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
Available from http://onlinelibrary.wiley.com/doi/10.1002/acr.,Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://www.scielo.br/scielo.php?pid=S1413-294X2007000200003&script=sci_arttext [22] Aberer E. Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
Available from http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"Available from http://www.jle.com/e-docs/00/04/2 E/8D/vers_alt/VersionPDF.pdf [31] Lundman B, Strandberg C, Eisemann M, Gustafson Y, Brulin C. Psychometric properties of the swedish version of the resilience scale.",OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
Available from http://www.inca.gov.br/rbc/n_58/v04/pdf/07-artigo-enfrentamento-resiliencia-pacientes-tratamento-quimioterapico-familiares.pdf [33] Yunes MAM.,Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
Available from http://www.scielo.br/ scielo.php?script=sci_arttext&pid=S1413-73722003000300010&ln g=en&tlng=pt.,Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
Available from http://www.scielo.b r/scielo.php?script=sci_arttext&pid=S0104-07072011000400014&lng=en.,Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"http://dx.doi.org/10.1590/S0104-07072011000400014   Received: October 28, 2013 Revised: January 20, 2014 Accepted: January 20, 2014  © Faria et al.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/f8/TORJ-8-1.PMC3963129.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial L icense (http://creativecommons.org/licenses/   by-nc/3.0/) which permits unrestricted, non -commercial us e, distrib ution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/99/TOCMJ-8-18.PMC3963133.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004494).,Non-OADS,/arxiv_data1/oa_pdf/73/df/bmjopen-2013-004494.PMC3963151.pdf
Feb 9 2009. http://appliedresearch.cancer.gov/icsn/colorectal/screening.html 10.,Non-OADS,/arxiv_data1/oa_pdf/73/df/bmjopen-2013-004494.PMC3963151.pdf
"Secondary colon cancer check: Ontario ’s colorectal cancer screening program Feb 2, 2012. http://health.gov.on.ca/en/public/programs/coloncancercheck/11.",Non-OADS,/arxiv_data1/oa_pdf/73/df/bmjopen-2013-004494.PMC3963151.pdf
Secondary family practice models May 3 2013. http://www.healthforceontario.ca/Work/OutsideOntario/PhysiciansOutsideOntario/PractisingInOntario/ family_practice_models.aspx 14.,Non-OADS,/arxiv_data1/oa_pdf/73/df/bmjopen-2013-004494.PMC3963151.pdf
"July 22, 2008. http://www.health.gov.on.ca/en/pro/programs/ohip/bulletins/4000/bul4482.pdf 15.",Non-OADS,/arxiv_data1/oa_pdf/73/df/bmjopen-2013-004494.PMC3963151.pdf
Secondary Ontario ’s Local Health Integration Networks May 30 2013. http://www.lhins.on.ca/home.aspx 22.,Non-OADS,/arxiv_data1/oa_pdf/73/df/bmjopen-2013-004494.PMC3963151.pdf
http://www.acg.jhsph.edu/ 23.,Non-OADS,/arxiv_data1/oa_pdf/73/df/bmjopen-2013-004494.PMC3963151.pdf
http://www.csqi.on.ca/cms/one.aspx?portalId=258922&pageId=273238-.UijqNMakrmQ 40.,OADS,/arxiv_data1/oa_pdf/73/df/bmjopen-2013-004494.PMC3963151.pdf
Secondary Bowel Screening Pilot January toJune 2012 results 26 April 2013. http://www.health.govt.nz/our-work/diseases-and-conditions/cancer-programme/bowel-cancer-programme/bowel-screening-pilot/bowel-screening-pilot-results/bowel-screening-pilot-january-june-2012-results 43.,Non-OADS,/arxiv_data1/oa_pdf/73/df/bmjopen-2013-004494.PMC3963151.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/ce/hp-1-013.PMC3963164.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHypoxia 2013:1 13–27Hypoxia Dove press submit your manuscript | www.dovepress.co m Dove press  13Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HP .S5009 1Prolyl-hydroxylase 3: evolving roles   for an ancient signaling protein Trenton L Place1 Frederick e Domann1,2 1Molecular and Cellular Biology  Program, the University of iowa,    iowa City, iA, USA; 2Department   of Radiation Oncology, the University   of iowa, iowa City, iA, USA Correspondence: Frederick e Domann   B180 Medical Laboratories, the University   of iowa, iowa City, iA, USA 52242-1181   Tel +1 319 335 8019   Fax +1 319 335 8039   email frederick-domann@uiowa.ed uAbstract:  The ability of cells to sense oxygen is a highly evolved process that facilitates adap - tations to the local oxygen environment and is critical to energy homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/4c/ce/hp-1-013.PMC3963164.pdf
"Notes: The PHD3  gene with mammalian conservation is depicted in relation to its position on chromosome 14 q13.1 (modified from the UCSC Genome Browser hg19  [http://genome.ucsc.edu /]).49 The highly conserved region at ∼+12 kb upstream of exon 1 is expanded (bottom), and putative HRe are indicated (gray box), along with  conserved TF binding sites, as predicted by the UCSC hg19 “TFBS conserved” track.",Non-OADS,/arxiv_data1/oa_pdf/4c/ce/hp-1-013.PMC3963164.pdf
"Notes: The PHD3  locus is represented with mammalian conservation (modified from the UCSC Genome Browser hg19 [ http://genome.ucsc.edu /]).49 ChiP-Seq signal data  for polymerase 2 in H1-heSC, HeLa-S3, and HCT-116 cells were mined from several eNCODe data tracks (as indicated) using the UCSC Genome Browser hg19 ( http:// genome.ucsc.edu /).50 Abbreviations: PHD,  prolyl-4-hydroxylase; heSC, human embryonic stem cells; TFBS, transcription factor binding sites; eNCODe, encyclopedia of DNA elements; ChiA- PeT, chromatin interaction analysis with paired-end tag sequencing; ChiP-Seq, chromatin immunoprecipitation sequencing.",OADS,/arxiv_data1/oa_pdf/4c/ce/hp-1-013.PMC3963164.pdf
"Hypoxia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hypoxia-journa lHypoxia is an international, peer-reviewed, open access journal that aims  to improve understanding of the biological response to hypoxia.",Non-OADS,/arxiv_data1/oa_pdf/4c/ce/hp-1-013.PMC3963164.pdf
Visit http://www.dovepress.com/ testimonials .php to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/ce/hp-1-013.PMC3963164.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"In contrast,END3 and extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497 3 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"Total extracts were centrifuged at 3,000 /C29g for 5 min and thenEND3 and extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"Representative results from 3 experiments are shown.END3 and extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497 7 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"in this study (A) and the 92 proteins identiﬁed with more than 1 peptide having 95% conﬁdence in this study (B).END3 and extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
"2009;8:2851 /C162.END3 and extracellular vesicles Citation: Journal of Extracellular Vesicles 2014, 3: 23497 - http://dx.doi.org/10.3402/jev.v3.23497 11 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/67/24/JEV-3-23497.PMC3963178.pdf
All computations were computed using the R project for Statistical Computing (http://www.r-project.org ).,OADS,/arxiv_data1/oa_pdf/38/6d/nihms-558836.PMC3963281.pdf
Bisulfite sequencing data was analyzed with  QUMA (http://quma.cdb.riken.jp/) [32].,OADS,/arxiv_data1/oa_pdf/fd/7d/jrd-60-047.PMC3963299.pdf
"Results Identification of aberrantly hypomethylated genes on the X  chromosome in uterine leiomyomas We previously characterized the aberrant hypomethylation on  the X chromosome using the methylome data from the illumina  HumanMethylation450 BeadChip array (HumMeth450) and the  transcriptome data on three cases of leiomyoma and adjacent myome - trium [18] (these data are available at the Gene Expression Omnibus  Web Site; http://www.ncbi.nlm.nih.gov/geo, under accession No.",OADS,/arxiv_data1/oa_pdf/fd/7d/jrd-60-047.PMC3963299.pdf
Many human imprinted DMRs have been identified (WAMIDEX; https://atlas.genetics.kcl.ac.uk/) [34–36].,Non-OADS,/arxiv_data1/oa_pdf/fd/7d/jrd-60-047.PMC3963299.pdf
"news.cn, July 2010, http://http://news.xinhuanet.com/english2010/ world/2010‑07/16/c_111963155.htm How to cite this article:  Selvaraj P, Selvaraj K, Kalaichelvi S, Mahalakshmi R.  Semen preparation techniques in intrauterine insemination:   A comparison of non-temperature and temperature controlled centrifugation  in cases of unexplained infertility.",Non-OADS,/arxiv_data1/oa_pdf/9b/8a/JHRS-6-241.PMC3963306.pdf
Accessed 18 Dec 2013] from: http://www.vivo.colostate.edu./ hbooks/pathphys/reprod/semeneval/morph.html.,Non-OADS,/arxiv_data1/oa_pdf/6e/23/JHRS-6-267.PMC3963312.pdf
Retrieved from:  http://www.ilo.org/safework_bookshelf/english?content and nd=857170487.,Non-OADS,/arxiv_data1/oa_pdf/6b/3b/JRMS-19-33.PMC3963321.pdf
Available from: http://www.health.gov.au/ healthconnect.,Non-OADS,/arxiv_data1/oa_pdf/56/b5/JRMS-19-57.PMC3963324.pdf
Available from: http://www.ahlalhdeeth.com/vb/showthread.php?t=70050.,Non-OADS,/arxiv_data1/oa_pdf/a7/81/UA-6-1.PMC3963335.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/a7/81/UA-6-1.PMC3963335.pdf
Available from: http://www.seer.cancer.gov/statfacts.,Non-OADS,/arxiv_data1/oa_pdf/85/87/UA-6-13.PMC3963336.pdf
Start a QR‑code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR‑code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/28/65/UA-6-41.PMC3963342.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/28/65/UA-6-41.PMC3963342.pdf
Available from: https://docs.google.com/ viewer?url=http%3A%2F%2Fwww.stateclaims.ie%2FClinicalIndemnitySc heme%2Fpublications%2F2009%2FOLHSC.pdf [Last accessed on 2011  Jan 26].,Non-OADS,/arxiv_data1/oa_pdf/8d/69/UA-6-57.PMC3963345.pdf
Available from: http://www.rcseng.ac.uk/publications/docs/ good‑surgical‑practice‑1 [Last accessed on 2012 Mar 10].,Non-OADS,/arxiv_data1/oa_pdf/8d/69/UA-6-57.PMC3963345.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/0f/f6/UA-6-63.PMC3963346.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004260).,Non-OADS,/arxiv_data1/oa_pdf/f2/00/bmjopen-2013-004260.PMC3963385.pdf
"The topic areas of Eat Well and Drink Well, adapted from the DHSV Smiles 4 Miles pro-gramme (http://www.dhsv.org.au/smiles4miles/), focused on promoting healthy food and drink consump- tion, suitable foods for children, the bene ﬁts of ﬂuori- dated water consumption, limiting high sugar foods and drinks in the diet and linking these behaviours to tooth decay.",Non-OADS,/arxiv_data1/oa_pdf/f2/00/bmjopen-2013-004260.PMC3963385.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2013 |  80  | e51050 | Page 1 of 16Video Article Proprioception and Tension Receptors in Crab Limbs: Student Laboratory Exercises Zana R. Majeed1,2, Josh Titlow1,2, H. Bernard Hartman3, Robin Cooper1,2 1Department of Biology, University of Kentucky 2Center of Muscle Biology, University of Kentucky 3Oregon Institute of Marine Biology, University of Oregon Correspondence to: Robin Cooper at rlcoop1@uky.edu URL: http://www.jove.com/video/51050 DOI: doi:10.3791/51050 Keywords: Neuroscience, Issue 80, Crustacean, joint, Muscle, sensory, teaching, educational, neuroscience Date Published: 10/24/2013 Citation: Majeed, Z.R., Titlow, J., Hartman, H.B., Cooper, R. Proprioception and Tension Receptors in Crab Limbs: Student Laboratory Exercises.",Non-OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/51050/ Introduction Proprioception is the sensation of limb position and movement that enables coordinated motor behavior.,Non-OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
The muscle receptor organ in the abdomen of the crayfish is another well-documented preparation (see the Crawdad Project; http://www.crawdad.cornell.edu/) for teaching purposes of proprioception with only two neurons per abdominal hemi-segment23.,Non-OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
"U.K. 52 (3), 605-634, doi:http://dx.doi.org/10.1017/S0025315400021615 (1972).",Non-OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
"221 (2), 185-198, doi:http://dx.doi.org/10.1002/cne.902210207 (1983).",Non-OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
"168 (3), 337-349, doi:http://dx.doi.org/10.1007/BF00198353 (1991).",Non-OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
"88 (5), 2575-2588, doi:http://jn.physiology.org/cgi/content/abstract/88/5/2575 (2002).",OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
"78 (6), 3133-3143, doi:http://jn.physiology.org/cgi/content/abstract/78/6/3133 (1997).",OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
"U.K. 38 (01),143-152, doi:http://dx.doi.org/10.1017/ S0025315400015654 (1959).",Non-OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
"72 (2), 391-399, doi:http://dx.doi.org/10.1016/0300-9629(82)90236-5 (1982).",Non-OADS,/arxiv_data1/oa_pdf/8b/4f/jove-80-51050.PMC3963413.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2013 |  80  | e50719 | Page 1 of 9Video Article Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection Joseph W. Ndieyira1, Moyu Watari1, Rachel A. McKendry1 1London Centre for Nanotechnology and Departments of Medicine, University College London Correspondence to: Joseph W. Ndieyira at j.ndieyira@ucl.ac.uk URL: http://www.jove.com/video/50719 DOI: doi:10.3791/50719 Keywords: Immunology, Issue 80, Engineering, Technology, Diagnostic Techniques and Procedures, Early Diagnosis, Bacterial Infections and Mycoses, Lipids, Amino Acids, Peptides, and Proteins, Chemical Actions and Uses, Diagnosis, Therapeutics, Surface stress, vancomycin, mucopeptides, cantilever sensor Date Published: 10/25/2013 Citation: Ndieyira, J.W., Watari, M., McKendry, R.A. Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection.",Non-OADS,/arxiv_data1/oa_pdf/9b/08/jove-80-50719.PMC3963422.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50719/ Introduction The molecular recognition paradigm underpins large swathes of biology and medicine.,Non-OADS,/arxiv_data1/oa_pdf/9b/08/jove-80-50719.PMC3963422.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ To cite Makin SDJ, Wardlaw J. J Neurol Neurosurg Psychiatry 2014; 85:357.",Non-OADS,/arxiv_data1/oa_pdf/e1/41/jnnp-2013-305379.PMC3963526.pdf
"Received 28 April 2013 Accepted 13 May 2013Published Online First 13 September 2013 ▸http://dx.doi.org/10.1136/jnnp-2013-304920 J Neurol Neurosurg Psychiatry 2014; 85:357. doi:10.1136/jnnp-2013-305379 REFERENCES 1 Carin-Levy G, Mead GE, Nicol K, et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/41/jnnp-2013-305379.PMC3963526.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/injuryprev-2012-040748).,Non-OADS,/arxiv_data1/oa_pdf/8c/5e/injuryprev-2012-040748.PMC3963527.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Gunnell D, Eddleston M, Phillips MR, et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/5e/injuryprev-2012-040748.PMC3963527.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Cooke GS, Main J, Thursz MR. T reatment for hepatitis B. BMJ2010;340:b5429.",Non-OADS,/arxiv_data1/oa_pdf/4b/1f/flgastro-2013-100361.PMC3963528.pdf
"The Stationery Office, 2006. http://www.gov.uk/government/uploads/system/uploads/attachment_data/file/206232/Green-Book-updated-070513.pdf 17 van Nunen AB, de Man RA, Heijtink RA, et al.",Non-OADS,/arxiv_data1/oa_pdf/4b/1f/flgastro-2013-100361.PMC3963528.pdf
"2008. http://www.basl.org.uk/uploaded_files/Provision%20of%20antiviral%20services.pdf 22 Sarri G, W estby M, Bermingham S, et al.",Non-OADS,/arxiv_data1/oa_pdf/4b/1f/flgastro-2013-100361.PMC3963528.pdf
"http://www.APRegistry .com: Wilmington, NC: RegistryCoordinating Center, 2012.LIVER 116 Dyson JK, et al.Frontline Gastroenterology 2014; 5:111–117.",Non-OADS,/arxiv_data1/oa_pdf/4b/1f/flgastro-2013-100361.PMC3963528.pdf
"2012. http://www.nice.org.uk/nicemedia/live/14003/61863/61863.pdf 39 Giraudon I, Permalloo N, Nixon G, et al.",Non-OADS,/arxiv_data1/oa_pdf/4b/1f/flgastro-2013-100361.PMC3963528.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ jmedgenet-2013-102116).,OADS,/arxiv_data1/oa_pdf/70/9e/jmedgenet-2013-102116.PMC3963529.pdf
"6However, this observation has been disputed and may be attributable to various tech-nical sources of skewed allelic representation inRNA-seq data 7and, more recently, genome-wide bisulﬁte sequencing has allowed direct assessment of allele-speci ﬁc methylation;8taken together, these observations suggest that our current catalogue ofimprinted genes is approaching completion, withfew novel germline imprints remaining to be dis-covered (http://igc.otago.ac.nz).",Non-OADS,/arxiv_data1/oa_pdf/70/9e/jmedgenet-2013-102116.PMC3963529.pdf
Data preprocessing and quality control A pipeline was developed using the Illumina methylation ana-lysis (IMA) package within the R statistical analysis environment(http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/70/9e/jmedgenet-2013-102116.PMC3963529.pdf
DJGM is a member of the COST consortium for Imprinting disorders BM1208 (http://www.imprinting-disorders.eu).,Non-OADS,/arxiv_data1/oa_pdf/70/9e/jmedgenet-2013-102116.PMC3963529.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Messerschmidt DM, de Vries W, Ito M, Solter D, Ferguson-Smith A, Knowles BB.",Non-OADS,/arxiv_data1/oa_pdf/70/9e/jmedgenet-2013-102116.PMC3963529.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ gutjnl-2013-304738).,OADS,/arxiv_data1/oa_pdf/09/af/gutjnl-2013-304738.PMC3963530.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Katz MH.,Non-OADS,/arxiv_data1/oa_pdf/09/af/gutjnl-2013-304738.PMC3963530.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ thoraxjnl-2013-204176).,Non-OADS,/arxiv_data1/oa_pdf/f1/98/thoraxjnl-2013-204176.PMC3963531.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Brody AS.,Non-OADS,/arxiv_data1/oa_pdf/f1/98/thoraxjnl-2013-204176.PMC3963531.pdf
"Socioeconomic inequalities in all-cause mortality in the Czech Republic, Russia, Poland and Lithuania in the 2000s: ﬁndings from the HAPIEE Study Hadewijch Vandenheede,1,2Olga Vikhireva,1Hynek Pikhart,1Ruzena Kubinova,3 Soﬁa Malyutina,4,5Andrzej Pajak,6Abdonas Tamosiunas,7Anne Peasey,1 Galina Simonova,4Roman Topor-Madry,6Michael Marmot,1Martin Bobak1 1Research Department of Epidemiology and PublicHealth, University College London, London, UK 2Department of Sociology, Faculty of Economic, Social andPolitical Sciences and Solvay Business School, Vrije Universiteit Brussel, Brussels,Belgium 3National Institute of Public Health, Prague, Czech Republic 4Institute of Internal Medicine, Siberian Branch of the RussianAcademy of Medical Sciences, Novosibirsk, Russia 5Novosibirsk State Medical University, Novosibirsk, Russia 6Department of Epidemiology and Population Sciences, Institute of Public Health,Jagiellonian University MedicalCollege, Krakow, Poland 7Laboratory of Population Research, Institute ofCardiology, LithuanianUniversity of Health Sciences, Kaunas, Lithuania Correspondence to Professor HadewijchVandenheede, Department of Sociology, Faculty of Economic, Social and Political Sciencesand Solvay Business School,Vrije Universiteit Brussel, Pleinlaan 5, Brussels 1050, Belgium; hadewijch.vandenheede@vub.ac.be Received 3 July 2013 Revised 20 September 2013 Accepted 25 September 2013 Published Online First13 November 2013 ▸http://dx.doi.org/10.1136/ jech-2013-203655 To cite: Vandenheede H, Vikhireva O, Pikhart H, et al .",Non-OADS,/arxiv_data1/oa_pdf/0b/2d/jech-2013-203057.PMC3963532.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Stuckler D, King L, McKee M. Mass privatisation and the post-communist mortality crisis: a cross-national analysis.",Non-OADS,/arxiv_data1/oa_pdf/0b/2d/jech-2013-203057.PMC3963532.pdf
Working Paper 18589. http://www.nber.org/papers/w18589 (accessed 12 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/0b/2d/jech-2013-203057.PMC3963532.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Alonso JM, Junge A, Renström P, et al.",Non-OADS,/arxiv_data1/oa_pdf/bb/90/bjsports-2013-093222.PMC3963533.pdf
http://www.gmc-uk.org/education/sports_and_ exercise_medicine.asp (accessed 17 Oct 2013).,Non-OADS,/arxiv_data1/oa_pdf/bb/90/bjsports-2013-093222.PMC3963533.pdf
http://www.gmc-uk.org/doctors/revalidation.asp (accessed 12 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/bb/90/bjsports-2013-093222.PMC3963533.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Zin A, Gole GA. Retinopathy of prematurity-incidence today.",Non-OADS,/arxiv_data1/oa_pdf/cb/4f/bjophthalmol-2013-304109.PMC3963534.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Sacco RL, Kargman DE, Gu Q, et al.",Non-OADS,/arxiv_data1/oa_pdf/71/fb/neurintsurg-2012-010593.PMC3963535.pdf
"1Department of Surgery and Cancer, Imperial College London, London, UK 2National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for North-West London, London, UK Correspondence to Michael J Taylor, Academic Surgical Unit, 10th Floor, QEQM building, St Mary ’s Hospital, Paddington, London W2 1NY,UK; mtaylor3@imperial.ac.uk Received 29 January 2013 Revised 25 June 2013 Accepted 4 July 2013 Published Online First 23 August 2013 ▸http://dx.doi.org/10.1136/ bmjqs-2013-002703 To cite: Taylor MJ, McNicholas C, Nicolay C, et al.BMJ Qual Saf 2014; 23:290 –298.ABSTRACT Background Plan–do–study –act (PDSA) cycles provide a structure for iterative testing of changes to improve quality of systems.",Non-OADS,/arxiv_data1/oa_pdf/be/d8/bmjqs-2013-001862.PMC3963536.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Øvretveit J.,OADS,/arxiv_data1/oa_pdf/be/d8/bmjqs-2013-001862.PMC3963536.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/3f/f7/jech-2013-202756.PMC3963537.pdf
2008. http://www.who.int/social_determinants/thecommission/ ﬁnalreport/en/ index.html (accessed 26 Jul 2011).,OADS,/arxiv_data1/oa_pdf/3f/f7/jech-2013-202756.PMC3963537.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2012-303252).,OADS,/arxiv_data1/oa_pdf/52/d2/gutjnl-2012-303252.PMC3963538.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/REFERENCES 1 Luster AD.,Non-OADS,/arxiv_data1/oa_pdf/52/d2/gutjnl-2012-303252.PMC3963538.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ thoraxjnl-2013-203600).,Non-OADS,/arxiv_data1/oa_pdf/d8/22/thoraxjnl-2013-203600.PMC3963539.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Global Initiative for Asthma (GINA).,Non-OADS,/arxiv_data1/oa_pdf/d8/22/thoraxjnl-2013-203600.PMC3963539.pdf
Updated 2011. http://www.ginasthma.org/uploads/users/ ﬁles/GINA_ Report_2011.pdf (accessed 8 Jul 2013).,OADS,/arxiv_data1/oa_pdf/d8/22/thoraxjnl-2013-203600.PMC3963539.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Royal College of Physicians Research Unit Working Group.,Non-OADS,/arxiv_data1/oa_pdf/74/d4/archdischild-2013-304428.PMC3963540.pdf
2007. http://guidance.nice.org.uk/CG054 11 American Academy of Pediatrics.,Non-OADS,/arxiv_data1/oa_pdf/74/d4/archdischild-2013-304428.PMC3963540.pdf
2007. http://www.ucl.ac.uk/~ucakiko/software.html 17 McCullagh P. Regression models for ordinal data.,OADS,/arxiv_data1/oa_pdf/74/d4/archdischild-2013-304428.PMC3963540.pdf
Received 10 October 2013 Accepted 10 October 2013Published Online First 30 October 2013 ▸http://dx.doi.org/10.1136/thoraxjnl-2013-204476 Thorax 2014; 69:386 –387.,Non-OADS,/arxiv_data1/oa_pdf/4d/36/thoraxjnl-2013-204684.PMC3963541.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ To cite McConnell AK, Gosselink R. Thorax 2014; 69:387 –388.",Non-OADS,/arxiv_data1/oa_pdf/4d/36/thoraxjnl-2013-204684.PMC3963541.pdf
Received 14 October 2013 Accepted 12 December 2013 Published Online First 9 January 2014 ▸http://dx.doi.org/10.1136/thoraxjnl-2013-204754 Thorax 2014; 69:387 –388.,Non-OADS,/arxiv_data1/oa_pdf/4d/36/thoraxjnl-2013-204684.PMC3963541.pdf
Received 25 October 2013 Accepted 26 October 2013 Published Online First 15 January 2014 ▸http://dx.doi.org/10.1136/thoraxjnl-2013-204684 Thorax 2014; 69:388 –389.,Non-OADS,/arxiv_data1/oa_pdf/4d/36/thoraxjnl-2013-204684.PMC3963541.pdf
"See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 Dignass A, Lindsay JO, Sturm A, et al.",Non-OADS,/arxiv_data1/oa_pdf/24/a0/flgastro-2013-100357.PMC3963542.pdf
http://www.medicinescomplete.com (accessed Oct2012).,Non-OADS,/arxiv_data1/oa_pdf/24/a0/flgastro-2013-100357.PMC3963542.pdf
http://publications.nice.org.uk/ulcerative-colitis-cg166/introduction (accessed August 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/a0/flgastro-2013-100357.PMC3963542.pdf
http://www.improvement.nhs.uk/ Default.aspx?alias=www.improvement.nhs.uk/qipp [accessedDec 2012).,Non-OADS,/arxiv_data1/oa_pdf/24/a0/flgastro-2013-100357.PMC3963542.pdf
http://www.nacc.org.uk/content/ research.asp (accessed Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/24/a0/flgastro-2013-100357.PMC3963542.pdf
https://assuresupport.co.uk/ (accessed Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/24/a0/flgastro-2013-100357.PMC3963542.pdf
http://www.ucandme.co.,Non-OADS,/arxiv_data1/oa_pdf/24/a0/flgastro-2013-100357.PMC3963542.pdf
"http://www.nes.scot.nhs.uk/ (accessed Dec 2012).PROFESSIONAL MATTERS 142 Kemp K, et al.Frontline Gastroenterology 2014; 5:135–142.",Non-OADS,/arxiv_data1/oa_pdf/24/a0/flgastro-2013-100357.PMC3963542.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Schwappach DLB, Boluarte TA.",Non-OADS,/arxiv_data1/oa_pdf/f7/66/bmjqs-2013-002035.PMC3963543.pdf
http://www.msnbc.msn.com/id/ 43529641/ns/health-health_care/ (accessed 27 Jun 2011).,Non-OADS,/arxiv_data1/oa_pdf/f7/66/bmjqs-2013-002035.PMC3963543.pdf
See: http://creativecommons.org/licenses/by- nc/3.0/ REFERENCES 1 National Advisory Group on the Safety of Patients in England.,Non-OADS,/arxiv_data1/oa_pdf/f5/84/bmjqs-2013-002557.PMC3963544.pdf
"London: Department of Health, 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/226703/Berwick_Report.pdf 2 BMJ.",Non-OADS,/arxiv_data1/oa_pdf/f5/84/bmjqs-2013-002557.PMC3963544.pdf
"http://www.nhs.uk/NHSEngland/bruce-keogh-review/Documents/outcomes/keogh-review-final-report.pdf 4 Nashef SA, Roques F , Michel P ,et al.",Non-OADS,/arxiv_data1/oa_pdf/f5/84/bmjqs-2013-002557.PMC3963544.pdf
"London: CORC, 2013. http://www.corc.uk.net/wp-content/uploads/2012/03/CORCs-Position-on-CQUIN-targets-03042013.pdfViewpoint 276 Wolpert M, et al .BMJ Qual Saf 2014; 23:272–276.",Non-OADS,/arxiv_data1/oa_pdf/f5/84/bmjqs-2013-002557.PMC3963544.pdf
"8Originally developed in 1992 for use in elite Australian football, it is now in its 10thversion (OSICS-10, http://www.johnorchard.com/osics.html).",Non-OADS,/arxiv_data1/oa_pdf/b1/9b/bjsports-2012-091219.PMC3963545.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Finch C. A new framework for research leading to sports injury prevention.,Non-OADS,/arxiv_data1/oa_pdf/b1/9b/bjsports-2012-091219.PMC3963545.pdf
"(6/9/2011); http://injuryupdate.com.au/research/OSICS.htm 9 Fuller C, Ekstrand J, Junge A, et al.",OADS,/arxiv_data1/oa_pdf/b1/9b/bjsports-2012-091219.PMC3963545.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2012-304351).,OADS,/arxiv_data1/oa_pdf/7c/aa/gutjnl-2012-304351.PMC3963546.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.,Non-OADS,/arxiv_data1/oa_pdf/7c/aa/gutjnl-2012-304351.PMC3963546.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Wood D, Cottrell A, Baker SC, et al.",Non-OADS,/arxiv_data1/oa_pdf/2e/17/postgradmedj-2013-131776.PMC3963547.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Mavor G. The anterior tibial syndrome.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/bjsports-2012-091241.PMC3963548.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Brubaker RF, Pederson JE.",Non-OADS,/arxiv_data1/oa_pdf/1a/9e/bjophthalmol-2013-303559.PMC3963549.pdf
Whether CsA can actu-ally improve clinical outcomes in STEMI patients treated byPPCI is being investigated in the ongoing 900-patient CIRCUSstudy (http://www.clinicaltrials.gov NCT01502774).,Non-OADS,/arxiv_data1/oa_pdf/5a/23/heartjnl-2013-304845.PMC3963550.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Croal BL, Hillis GS, Gibson PH, et al.",Non-OADS,/arxiv_data1/oa_pdf/5a/23/heartjnl-2013-304845.PMC3963550.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ gutjnl-2012-304067).,OADS,/arxiv_data1/oa_pdf/27/79/gutjnl-2012-304067.PMC3963552.pdf
"See: http://creativecommons.org/ licenses/by/3.0/ REFERENCES 1 Snippert HJ, van der Flier LG, Sato T, et al.",Non-OADS,/arxiv_data1/oa_pdf/27/79/gutjnl-2012-304067.PMC3963552.pdf
"For this reason, and because of seem-ingly improved raw survival rates since2007 –2010 and with the prospect of further comparative analysis by NICOR, werecalibrated the PRAiS model on thismost recent 2009 –2012 dataset at NICOR ’s request (details of the current calibration of PRAiS will always be availableon: http://www.ucl.ac.uk/operational-research/AnalysisT ools/PRAiS).While we are proud of PRAiS and think itﬁt for the purpose of in-house monitor- ing, it is important to remember that amajor pitfall in risk-adjustment is believingone has completely adjusted for risk.",Non-OADS,/arxiv_data1/oa_pdf/52/5a/heartjnl-2013-304848.PMC3963553.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ To cite Pagel C, Crowe S, Brown K, et al .Heart 2014; 100:528 –529.",Non-OADS,/arxiv_data1/oa_pdf/52/5a/heartjnl-2013-304848.PMC3963553.pdf
"http://www.ucl.ac.uk/nicor/paediatric_cardiac_surgery_report 5 Crowe S, Brown KL, Pagel C, et al .",Non-OADS,/arxiv_data1/oa_pdf/52/5a/heartjnl-2013-304848.PMC3963553.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ To cite Mattes J, Murphy VE, Powell H, et al.Thorax 2014; 69:383 –384.",Non-OADS,/arxiv_data1/oa_pdf/48/71/thoraxjnl-2013-203388.PMC3963555.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Jemec GB, Heidenheim M, Nielsen NH.",Non-OADS,/arxiv_data1/oa_pdf/fa/11/postgradmedj-2013-131994.PMC3963556.pdf
"Details: Dr Charlotte Moonan, School of Life Sciences, University of W arwick, Coventry CV4 7AL, UK; T el: 024 7652 3540; Email: Charlotte.Moonan@warwick.ac.uk;W ebsite: http://www2.warwick.ac.uk/fac/sci/lifesci/study/shortcourses/molecularbiology).",Non-OADS,/arxiv_data1/oa_pdf/fa/11/postgradmedj-2013-131994.PMC3963556.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jmedgenet-2013-102122).,Non-OADS,/arxiv_data1/oa_pdf/64/63/jmedgenet-2013-102122.PMC3963557.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Ming JE, Stiehm ER, Graham JM Jr. Syndromic immunode ﬁciencies: genetic syndromes associated with immune abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/64/63/jmedgenet-2013-102122.PMC3963557.pdf
"To view please visit the journal online (http://dx.doi.org/10.1136/ bmjqs-2012-001797) ECRI Institute, Plymouth Meeting, Pennsylvania, USA Correspondence to Dr Jonathan R Treadwell, ECRI Institute, 5200 ButlerPike, Plymouth Meeting, PA 19462-1298, USA; jtreadwell@ecri.org Received 31 December 2012 Accepted 12 July 2013Published Online First 6 August 2013 To cite: Treadwell JR, Lucas S, Tsou AY.",Non-OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
"Launched in June 2008, it has been translated into at least six lan- guages.5The 2009 WHO checklist (http://www.who.",Non-OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
The website (http://www.surpass-checklist.nl/home.jsf?,Non-OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
"lang=en) describes a web version of the checklist(called SURPASS Digital), which allows one to modify the checklist, although the designers of SURPASS strongly discourage it (http://www.surpass-checklist.nl/content.jsf?pageId=FAQ&lang=en).",OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Gawande AA, Thomas EJ, Zinner MJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
"Oakbrook T errace, IL: The Joint Commission, 2004. http://www.jointcommission.org/assets/1/18/Universal%20Protocol%201%204%20111.PDF(accessed 9 Jan 2008).",Non-OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
"http://www.ahrq.gov/research/findings/evidence-based-reports/ptsafetyuptp.html 12 Haynes AB, W eiser TG, Berry WR, et al.",OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
http://www.ahrq.gov/qual/ nurseshdbk/docs/MulloyD_WSS.pdf 21 Using surgical checklists to comply with the Universal Protocol.,Non-OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
"Oakbrook T errace, IL: The Joint Commission, 2010. http://www.jointcommission.org/follow-up_survey_universal_protocol/ (accessed 18 Oct 2011).",OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
"London, UK: Imperial College, 2010. http://www.safesurgery.org.uk/ (accessed 6 Oct 2011).",Non-OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
"Rockville, MD: Agency for Healthcare Research and Quality (AHRQ), 2011:3. http://www.ahrq.gov/qual/qualimp.pdf 54 Safe surgery saves lives .",Non-OADS,/arxiv_data1/oa_pdf/f9/4d/bmjqs-2012-001797.PMC3963558.pdf
For a full list of donors supporting OxHA please go to http://www.oxha.org.,Non-OADS,/arxiv_data1/oa_pdf/66/7f/jech-2013-203356.PMC3963559.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 World Health Organization.,Non-OADS,/arxiv_data1/oa_pdf/66/7f/jech-2013-203356.PMC3963559.pdf
